id	sid	tid	token	lemma	pos
iajs-1064	1	1	microsoft	microsoft	PROPN
iajs-1064	1	2	word	word	PROPN
iajs-1064	1	3	107	107	NUM
iajs-1064	1	4	-	-	SYM
iajs-1064	1	5	117	117	NUM
iajs-1064	1	6	chemistry	chemistry	NOUN
iajs-1064	1	7	|	|	ADV
iajs-1064	1	8	107	107	NUM
iajs-1064	1	9	2017عام	2017عام	NUM
iajs-1064	1	10	)	)	PUNCT
iajs-1064	2	1	1(العدد	1(العدد	NUM
iajs-1064	2	2	30مجلة	30مجلة	NUM
iajs-1064	2	3	إبن	إبن	VERB
iajs-1064	2	4	الھيثم	الھيثم	NOUN
iajs-1064	2	5	للعلوم	للعلوم	PROPN
iajs-1064	2	6	الصرفة	الصرفة	PROPN
iajs-1064	2	7	والتطبيقية	والتطبيقية	PRON
iajs-1064	2	8	المجلد	المجلد	VERB
iajs-1064	2	9	ibn	ibn	PROPN
iajs-1064	2	10	al	al	PROPN
iajs-1064	2	11	-	-	PUNCT
iajs-1064	2	12	haitham	haitham	PROPN
iajs-1064	2	13	jour	jour	X
iajs-1064	2	14	.	.	PROPN
iajs-1064	3	1	for	for	ADP
iajs-1064	3	2	pure	pure	ADJ
iajs-1064	3	3	&	&	CCONJ
iajs-1064	3	4	appl	appl	PROPN
iajs-1064	3	5	.	.	PUNCT
iajs-1064	4	1	sci	sci	PROPN
iajs-1064	4	2	.	.	PUNCT
iajs-1064	4	3	vol	vol	NOUN
iajs-1064	4	4	.	.	PROPN
iajs-1064	4	5	30	30	NUM
iajs-1064	4	6	(	(	PUNCT
iajs-1064	4	7	1	1	NUM
iajs-1064	4	8	)	)	PUNCT
iajs-1064	4	9	2017	2017	NUM
iajs-1064	4	10	glucagon	glucagon	NOUN
iajs-1064	4	11	-	-	PUNCT
iajs-1064	4	12	like	like	ADJ
iajs-1064	4	13	peptide-1	peptide-1	NOUN
iajs-1064	4	14	levels	level	NOUN
iajs-1064	4	15	and	and	CCONJ
iajs-1064	4	16	related	related	ADJ
iajs-1064	4	17	parameters	parameter	NOUN
iajs-1064	4	18	in	in	ADP
iajs-1064	4	19	rheumatoid	rheumatoid	NOUN
iajs-1064	4	20	arthritis	arthritis	NOUN
iajs-1064	4	21	patients	patient	NOUN
iajs-1064	4	22	prone	prone	ADJ
iajs-1064	4	23	to	to	ADP
iajs-1064	4	24	atherosclerosis	atherosclerosis	NOUN
iajs-1064	4	25	noorhan	noorhan	PROPN
iajs-1064	4	26	k.	k.	PROPN
iajs-1064	4	27	shafeeq	shafeeq	PROPN
iajs-1064	4	28	.	.	PUNCT
iajs-1064	5	1	dept	dept	PROPN
iajs-1064	5	2	.	.	PROPN
iajs-1064	6	1	of	of	ADP
iajs-1064	6	2	chemistry	chemistry	NOUN
iajs-1064	6	3	/	/	SYM
iajs-1064	6	4	college	college	NOUN
iajs-1064	6	5	of	of	ADP
iajs-1064	6	6	education	education	NOUN
iajs-1064	6	7	for	for	ADP
iajs-1064	6	8	pure	pure	ADJ
iajs-1064	6	9	science	science	NOUN
iajs-1064	6	10	(	(	PUNCT
iajs-1064	6	11	ibn	ibn	PROPN
iajs-1064	6	12	alhaitham)/baghdad	alhaitham)/baghdad	NOUN
iajs-1064	6	13	university	university	NOUN
iajs-1064	6	14	ban	ban	VERB
iajs-1064	6	15	mahmood	mahmood	PROPN
iajs-1064	6	16	shaker	shaker	PROPN
iajs-1064	6	17	al	al	PROPN
iajs-1064	6	18	-	-	PUNCT
iajs-1064	6	19	joda	joda	PROPN
iajs-1064	6	20	dept.of	dept.of	PROPN
iajs-1064	6	21	biochemistry	biochemistry	NOUN
iajs-1064	6	22	/college	/college	NOUN
iajs-1064	6	23	of	of	ADP
iajs-1064	6	24	medicine	medicine	NOUN
iajs-1064	6	25	/babylon	/babylon	PUNCT
iajs-1064	7	1	university	university	PROPN
iajs-1064	7	2	tamara	tamara	PROPN
iajs-1064	7	3	ala	ala	PROPN
iajs-1064	7	4	,	,	PUNCT
iajs-1064	7	5	a	a	DET
iajs-1064	7	6	dept	dept	NOUN
iajs-1064	7	7	.	.	PROPN
iajs-1064	7	8	of	of	ADP
iajs-1064	7	9	basic	basic	ADJ
iajs-1064	7	10	sciences	science	NOUN
iajs-1064	7	11	/faculty	/faculty	NOUN
iajs-1064	7	12	of	of	ADP
iajs-1064	7	13	dentistry/	dentistry/	NUM
iajs-1064	7	14	kufa	kufa	PROPN
iajs-1064	7	15	university	university	NOUN
iajs-1064	7	16	received	receive	VERB
iajs-1064	7	17	in	in	ADP
iajs-1064	7	18	:	:	PUNCT
iajs-1064	7	19	27	27	NUM
iajs-1064	7	20	/	/	SYM
iajs-1064	7	21	april/2016	april/2016	NOUN
iajs-1064	7	22	,	,	PUNCT
iajs-1064	7	23	accepted	accept	VERB
iajs-1064	7	24	in	in	ADP
iajs-1064	7	25	:	:	PUNCT
iajs-1064	7	26	11	11	NUM
iajs-1064	7	27	/	/	SYM
iajs-1064	7	28	may/2016	may/2016	NOUN
iajs-1064	7	29	abstract	abstract	NOUN
iajs-1064	7	30	the	the	DET
iajs-1064	7	31	study	study	NOUN
iajs-1064	7	32	aimed	aim	VERB
iajs-1064	7	33	to	to	PART
iajs-1064	7	34	estimate	estimate	VERB
iajs-1064	7	35	the	the	DET
iajs-1064	7	36	role	role	NOUN
iajs-1064	7	37	of	of	ADP
iajs-1064	7	38	glucagon	glucagon	NOUN
iajs-1064	7	39	-	-	PUNCT
iajs-1064	7	40	like	like	ADJ
iajs-1064	7	41	peptide-1	peptide-1	PROPN
iajs-1064	7	42	(	(	PUNCT
iajs-1064	7	43	glp-1	glp-1	X
iajs-1064	7	44	)	)	PUNCT
iajs-1064	7	45	and	and	CCONJ
iajs-1064	7	46	visfatin	visfatin	NOUN
iajs-1064	7	47	as	as	ADP
iajs-1064	7	48	a	a	DET
iajs-1064	7	49	novel	novel	ADJ
iajs-1064	7	50	pro	pro	ADJ
iajs-1064	7	51	inflammatory	inflammatory	ADJ
iajs-1064	7	52	marker	marker	NOUN
iajs-1064	7	53	in	in	ADP
iajs-1064	7	54	rheumatoid	rheumatoid	NOUN
iajs-1064	7	55	arthritis	arthritis	NOUN
iajs-1064	7	56	(	(	PUNCT
iajs-1064	7	57	ra	ra	PROPN
iajs-1064	7	58	)	)	PUNCT
iajs-1064	7	59	according	accord	VERB
iajs-1064	7	60	to	to	ADP
iajs-1064	7	61	the	the	DET
iajs-1064	7	62	activity	activity	NOUN
iajs-1064	7	63	scores	score	NOUN
iajs-1064	7	64	of	of	ADP
iajs-1064	7	65	disease	disease	NOUN
iajs-1064	7	66	to	to	PART
iajs-1064	7	67	assess	assess	VERB
iajs-1064	7	68	the	the	DET
iajs-1064	7	69	possibility	possibility	NOUN
iajs-1064	7	70	of	of	ADP
iajs-1064	7	71	introducing	introduce	VERB
iajs-1064	7	72	glucagon	glucagon	NOUN
iajs-1064	7	73	-	-	PUNCT
iajs-1064	7	74	like	like	ADJ
iajs-1064	7	75	peptide-1	peptide-1	NOUN
iajs-1064	7	76	and	and	CCONJ
iajs-1064	7	77	visfatin	visfatin	NOUN
iajs-1064	7	78	in	in	ADP
iajs-1064	7	79	the	the	DET
iajs-1064	7	80	diagnosis	diagnosis	NOUN
iajs-1064	7	81	and	and	CCONJ
iajs-1064	7	82	monitoring	monitoring	NOUN
iajs-1064	7	83	of	of	ADP
iajs-1064	7	84	ra	ra	PROPN
iajs-1064	7	85	patients	patient	NOUN
iajs-1064	7	86	and	and	CCONJ
iajs-1064	7	87	to	to	PART
iajs-1064	7	88	found	find	VERB
iajs-1064	7	89	the	the	DET
iajs-1064	7	90	correlation	correlation	NOUN
iajs-1064	7	91	of	of	ADP
iajs-1064	7	92	visfatin	visfatin	NOUN
iajs-1064	7	93	level	level	NOUN
iajs-1064	7	94	with	with	ADP
iajs-1064	7	95	glp-1	glp-1	NOUN
iajs-1064	7	96	and	and	CCONJ
iajs-1064	7	97	aip	aip	PROPN
iajs-1064	7	98	in	in	ADP
iajs-1064	7	99	patients	patient	NOUN
iajs-1064	7	100	prone	prone	ADJ
iajs-1064	7	101	to	to	ADP
iajs-1064	7	102	atherosclerosis	atherosclerosis	NOUN
iajs-1064	7	103	,	,	PUNCT
iajs-1064	7	104	fifty	fifty	NUM
iajs-1064	7	105	healthy	healthy	ADJ
iajs-1064	7	106	individuals	individual	NOUN
iajs-1064	7	107	as	as	ADP
iajs-1064	7	108	control	control	NOUN
iajs-1064	7	109	group	group	NOUN
iajs-1064	7	110	(	(	PUNCT
iajs-1064	7	111	g1	g1	PROPN
iajs-1064	7	112	)	)	PUNCT
iajs-1064	7	113	and	and	CCONJ
iajs-1064	7	114	fifty	fifty	NUM
iajs-1064	7	115	rheumatoid	rheumatoid	NOUN
iajs-1064	7	116	arthritis	arthritis	NOUN
iajs-1064	7	117	(	(	PUNCT
iajs-1064	7	118	ra	ra	NOUN
iajs-1064	7	119	)	)	PUNCT
iajs-1064	7	120	patients	patient	NOUN
iajs-1064	7	121	(	(	PUNCT
iajs-1064	7	122	g2	g2	PROPN
iajs-1064	7	123	)	)	PUNCT
iajs-1064	7	124	were	be	AUX
iajs-1064	7	125	enrolled	enrol	VERB
iajs-1064	7	126	in	in	ADP
iajs-1064	7	127	this	this	DET
iajs-1064	7	128	study	study	NOUN
iajs-1064	7	129	with	with	ADP
iajs-1064	7	130	middle	middle	ADJ
iajs-1064	7	131	age	age	NOUN
iajs-1064	7	132	ranged	range	VERB
iajs-1064	7	133	(	(	PUNCT
iajs-1064	7	134	30	30	NUM
iajs-1064	7	135	–	–	SYM
iajs-1064	7	136	40	40	NUM
iajs-1064	7	137	)	)	PUNCT
iajs-1064	7	138	years	year	NOUN
iajs-1064	7	139	and	and	CCONJ
iajs-1064	7	140	bmi	bmi	X
iajs-1064	7	141	≥24	≥24	PROPN
iajs-1064	7	142	kg	kg	PROPN
iajs-1064	7	143	/	/	SYM
iajs-1064	7	144	m2	m2	PROPN
iajs-1064	7	145	.	.	PUNCT
iajs-1064	8	1	esr	esr	PROPN
iajs-1064	8	2	,	,	PUNCT
iajs-1064	8	3	rf	rf	PROPN
iajs-1064	8	4	,	,	PUNCT
iajs-1064	8	5	lipid	lipid	NOUN
iajs-1064	8	6	profile	profile	NOUN
iajs-1064	8	7	,	,	PUNCT
iajs-1064	8	8	crp	crp	PROPN
iajs-1064	8	9	,	,	PUNCT
iajs-1064	8	10	insulin	insulin	NOUN
iajs-1064	8	11	,	,	PUNCT
iajs-1064	8	12	visfatin	visfatin	NOUN
iajs-1064	8	13	and	and	CCONJ
iajs-1064	8	14	glp-1were	glp-1were	PROPN
iajs-1064	8	15	determined	determine	VERB
iajs-1064	8	16	.	.	PUNCT
iajs-1064	9	1	results	result	NOUN
iajs-1064	9	2	in	in	ADP
iajs-1064	9	3	table	table	NOUN
iajs-1064	9	4	(	(	PUNCT
iajs-1064	9	5	1	1	X
iajs-1064	9	6	)	)	PUNCT
iajs-1064	9	7	revealed	reveal	VERB
iajs-1064	9	8	highly	highly	ADV
iajs-1064	9	9	significant	significant	ADJ
iajs-1064	9	10	increase	increase	NOUN
iajs-1064	9	11	in	in	ADP
iajs-1064	9	12	esr	esr	PROPN
iajs-1064	9	13	,	,	PUNCT
iajs-1064	9	14	rf	rf	NOUN
iajs-1064	9	15	,	,	PUNCT
iajs-1064	9	16	tc	tc	NOUN
iajs-1064	9	17	,	,	PUNCT
iajs-1064	9	18	tg	tg	PROPN
iajs-1064	9	19	,	,	PUNCT
iajs-1064	9	20	ldl	ldl	NOUN
iajs-1064	9	21	,	,	PUNCT
iajs-1064	9	22	vldl	vldl	NOUN
iajs-1064	9	23	and	and	CCONJ
iajs-1064	9	24	aip	aip	PROPN
iajs-1064	9	25	level	level	NOUN
iajs-1064	9	26	in	in	ADP
iajs-1064	9	27	rheumatoid	rheumatoid	NOUN
iajs-1064	9	28	arthritis	arthritis	NOUN
iajs-1064	9	29	(	(	PUNCT
iajs-1064	9	30	g2	g2	PROPN
iajs-1064	9	31	)	)	PUNCT
iajs-1064	9	32	comparing	compare	VERB
iajs-1064	9	33	to	to	ADP
iajs-1064	9	34	(	(	PUNCT
iajs-1064	9	35	g1	g1	PROPN
iajs-1064	9	36	)	)	PUNCT
iajs-1064	9	37	while	while	SCONJ
iajs-1064	9	38	significant	significant	ADJ
iajs-1064	9	39	decrease	decrease	NOUN
iajs-1064	9	40	noticed	notice	VERB
iajs-1064	9	41	in	in	ADP
iajs-1064	9	42	(	(	PUNCT
iajs-1064	9	43	g2	g2	PROPN
iajs-1064	9	44	)	)	PUNCT
iajs-1064	9	45	group	group	NOUN
iajs-1064	9	46	comparing	compare	VERB
iajs-1064	9	47	to	to	ADP
iajs-1064	9	48	(	(	PUNCT
iajs-1064	9	49	g1	g1	PROPN
iajs-1064	9	50	)	)	PUNCT
iajs-1064	9	51	.	.	PUNCT
iajs-1064	10	1	results	result	NOUN
iajs-1064	10	2	in	in	ADP
iajs-1064	10	3	table(2	table(2	NOUN
iajs-1064	10	4	)	)	PUNCT
iajs-1064	10	5	showed	show	VERB
iajs-1064	10	6	highly	highly	ADV
iajs-1064	10	7	significant	significant	ADJ
iajs-1064	10	8	increase	increase	NOUN
iajs-1064	10	9	in	in	ADP
iajs-1064	10	10	insulin	insulin	NOUN
iajs-1064	10	11	,	,	PUNCT
iajs-1064	10	12	crp	crp	PROPN
iajs-1064	10	13	,	,	PUNCT
iajs-1064	10	14	visfatin	visfatin	NOUN
iajs-1064	10	15	and	and	CCONJ
iajs-1064	10	16	glp-1	glp-1	NOUN
iajs-1064	10	17	level	level	NOUN
iajs-1064	10	18	results	result	NOUN
iajs-1064	10	19	in	in	ADP
iajs-1064	10	20	table(3	table(3	PROPN
iajs-1064	10	21	)	)	PUNCT
iajs-1064	10	22	illustrated	illustrate	VERB
iajs-1064	10	23	correlation	correlation	NOUN
iajs-1064	10	24	relation	relation	NOUN
iajs-1064	10	25	data	datum	NOUN
iajs-1064	10	26	and	and	CCONJ
iajs-1064	10	27	results	result	NOUN
iajs-1064	10	28	revealed	reveal	VERB
iajs-1064	10	29	highly	highly	ADV
iajs-1064	10	30	significant	significant	ADJ
iajs-1064	10	31	,	,	PUNCT
iajs-1064	10	32	were	be	AUX
iajs-1064	10	33	r=0.035	r=0.035	NOUN
iajs-1064	10	34	for	for	ADP
iajs-1064	10	35	glp-1	glp-1	NOUN
iajs-1064	10	36	with	with	ADP
iajs-1064	10	37	visfatin	visfatin	NOUN
iajs-1064	10	38	for	for	ADP
iajs-1064	10	39	(	(	PUNCT
iajs-1064	10	40	g1	g1	PROPN
iajs-1064	10	41	)	)	PUNCT
iajs-1064	10	42	,	,	PUNCT
iajs-1064	10	43	and	and	CCONJ
iajs-1064	10	44	highly	highly	ADV
iajs-1064	10	45	significant	significant	ADJ
iajs-1064	10	46	,	,	PUNCT
iajs-1064	10	47	r=	r=	ADJ
iajs-1064	10	48	-0.089	-0.089	PUNCT
iajs-1064	10	49	for	for	ADP
iajs-1064	10	50	(	(	PUNCT
iajs-1064	10	51	g2	g2	PROPN
iajs-1064	10	52	)	)	PUNCT
iajs-1064	10	53	as	as	SCONJ
iajs-1064	10	54	shown	show	VERB
iajs-1064	10	55	in	in	ADP
iajs-1064	10	56	figure(1	figure(1	NOUN
iajs-1064	10	57	-	-	PUNCT
iajs-1064	10	58	a	a	NOUN
iajs-1064	10	59	)	)	PUNCT
iajs-1064	10	60	and(1	and(1	NOUN
iajs-1064	10	61	-	-	PUNCT
iajs-1064	10	62	b	b	NOUN
iajs-1064	10	63	)	)	PUNCT
iajs-1064	10	64	,	,	PUNCT
iajs-1064	10	65	the	the	DET
iajs-1064	10	66	result	result	NOUN
iajs-1064	10	67	also	also	ADV
iajs-1064	10	68	highly	highly	ADV
iajs-1064	10	69	significant	significant	ADJ
iajs-1064	10	70	were	be	AUX
iajs-1064	10	71	r=	r=	ADJ
iajs-1064	10	72	-0.183	-0.183	PUNCT
iajs-1064	10	73	for	for	ADP
iajs-1064	10	74	glp-1	glp-1	NOUN
iajs-1064	10	75	with	with	ADP
iajs-1064	10	76	crp	crp	PROPN
iajs-1064	10	77	for	for	ADP
iajs-1064	10	78	control	control	NOUN
iajs-1064	10	79	group	group	NOUN
iajs-1064	10	80	and	and	CCONJ
iajs-1064	10	81	significant	significant	ADJ
iajs-1064	10	82	,	,	PUNCT
iajs-1064	10	83	r=	r=	ADJ
iajs-1064	10	84	0.043	0.043	NUM
iajs-1064	10	85	for	for	ADP
iajs-1064	10	86	glp-1	glp-1	NOUN
iajs-1064	10	87	with	with	ADP
iajs-1064	10	88	crp	crp	PROPN
iajs-1064	10	89	for	for	ADP
iajs-1064	10	90	ra	ra	PROPN
iajs-1064	10	91	group	group	NOUN
iajs-1064	10	92	as	as	SCONJ
iajs-1064	10	93	shown	show	VERB
iajs-1064	10	94	in	in	ADP
iajs-1064	10	95	figure(2	figure(2	NOUN
iajs-1064	10	96	-	-	PUNCT
iajs-1064	10	97	a	a	NOUN
iajs-1064	10	98	)	)	PUNCT
iajs-1064	10	99	and(2	and(2	NOUN
iajs-1064	10	100	-	-	PUNCT
iajs-1064	10	101	b	b	NOUN
iajs-1064	10	102	)	)	PUNCT
iajs-1064	10	103	,	,	PUNCT
iajs-1064	10	104	and	and	CCONJ
iajs-1064	10	105	significant	significant	ADJ
iajs-1064	10	106	,	,	PUNCT
iajs-1064	10	107	r=	r=	ADJ
iajs-1064	10	108	-0.056	-0.056	PUNCT
iajs-1064	10	109	for	for	ADP
iajs-1064	10	110	glp-1with	glp-1with	PROPN
iajs-1064	10	111	aip	aip	PROPN
iajs-1064	10	112	for	for	ADP
iajs-1064	10	113	g1	g1	PROPN
iajs-1064	10	114	and	and	CCONJ
iajs-1064	10	115	no	no	DET
iajs-1064	10	116	significant	significant	ADJ
iajs-1064	10	117	,	,	PUNCT
iajs-1064	10	118	were	be	AUX
iajs-1064	10	119	r=	r=	ADJ
iajs-1064	10	120	0.042	0.042	NUM
iajs-1064	10	121	for	for	ADP
iajs-1064	10	122	glp-1	glp-1	NOUN
iajs-1064	10	123	with	with	ADP
iajs-1064	10	124	aip	aip	PROPN
iajs-1064	10	125	for	for	ADP
iajs-1064	10	126	g2	g2	PROPN
iajs-1064	10	127	as	as	SCONJ
iajs-1064	10	128	shown	show	VERB
iajs-1064	10	129	in	in	ADP
iajs-1064	10	130	figure	figure	NOUN
iajs-1064	10	131	(	(	PUNCT
iajs-1064	10	132	3	3	NUM
iajs-1064	10	133	-	-	PUNCT
iajs-1064	10	134	a)and	a)and	NOUN
iajs-1064	10	135	(	(	PUNCT
iajs-1064	10	136	3	3	NUM
iajs-1064	10	137	-	-	SYM
iajs-1064	10	138	b	b	NOUN
iajs-1064	10	139	)	)	PUNCT
iajs-1064	10	140	.	.	PUNCT
iajs-1064	11	1	conclusion	conclusion	NOUN
iajs-1064	11	2	that	that	SCONJ
iajs-1064	11	3	summarized	summarize	VERB
iajs-1064	11	4	from	from	ADP
iajs-1064	11	5	this	this	DET
iajs-1064	11	6	study	study	NOUN
iajs-1064	11	7	is	be	AUX
iajs-1064	11	8	glucagon	glucagon	NOUN
iajs-1064	11	9	-	-	PUNCT
iajs-1064	11	10	like	like	ADJ
iajs-1064	11	11	peptide-1	peptide-1	NOUN
iajs-1064	11	12	and	and	CCONJ
iajs-1064	11	13	visfatin	visfatin	NOUN
iajs-1064	11	14	plays	play	VERB
iajs-1064	11	15	a	a	DET
iajs-1064	11	16	role	role	NOUN
iajs-1064	11	17	in	in	ADP
iajs-1064	11	18	ra	ra	PROPN
iajs-1064	11	19	pathogenesis	pathogenesis	NOUN
iajs-1064	11	20	that	that	PRON
iajs-1064	11	21	can	can	AUX
iajs-1064	11	22	be	be	AUX
iajs-1064	11	23	considered	consider	VERB
iajs-1064	11	24	marker	marker	NOUN
iajs-1064	11	25	in	in	ADP
iajs-1064	11	26	ra	ra	PROPN
iajs-1064	11	27	.	.	PUNCT
iajs-1064	12	1	and	and	CCONJ
iajs-1064	12	2	may	may	AUX
iajs-1064	12	3	be	be	AUX
iajs-1064	12	4	used	use	VERB
iajs-1064	12	5	as	as	ADP
iajs-1064	12	6	a	a	DET
iajs-1064	12	7	drug	drug	NOUN
iajs-1064	12	8	in	in	ADP
iajs-1064	12	9	future	future	NOUN
iajs-1064	12	10	for	for	ADP
iajs-1064	12	11	ra	ra	PROPN
iajs-1064	12	12	patients	patient	NOUN
iajs-1064	12	13	.	.	PUNCT
iajs-1064	13	1	keyword	keyword	NOUN
iajs-1064	13	2	:	:	PUNCT
iajs-1064	13	3	glp-1	glp-1	NOUN
iajs-1064	13	4	,	,	PUNCT
iajs-1064	13	5	rheumatoid	rheumatoid	NOUN
iajs-1064	13	6	arthritis	arthritis	NOUN
iajs-1064	13	7	,	,	PUNCT
iajs-1064	13	8	atherosclerosis	atherosclerosis	NOUN
iajs-1064	13	9	.	.	PUNCT
iajs-1064	14	1	abbreviation	abbreviation	NOUN
iajs-1064	14	2	:	:	PUNCT
iajs-1064	14	3	rheumatoid	rheumatoid	VERB
iajs-1064	14	4	arthritis	arthritis	NOUN
iajs-1064	14	5	(	(	PUNCT
iajs-1064	14	6	ra	ra	PROPN
iajs-1064	14	7	)	)	PUNCT
iajs-1064	14	8	,	,	PUNCT
iajs-1064	14	9	esr	esr	PROPN
iajs-1064	14	10	(	(	PUNCT
iajs-1064	14	11	erythrocyte	erythrocyte	PROPN
iajs-1064	14	12	sedimentation	sedimentation	NOUN
iajs-1064	14	13	rate	rate	NOUN
iajs-1064	14	14	)	)	PUNCT
iajs-1064	14	15	,	,	PUNCT
iajs-1064	14	16	rf(rheumatoid	rf(rheumatoid	NOUN
iajs-1064	14	17	factor	factor	NOUN
iajs-1064	14	18	)	)	PUNCT
iajs-1064	14	19	,	,	PUNCT
iajs-1064	14	20	crp	crp	PROPN
iajs-1064	14	21	(	(	PUNCT
iajs-1064	14	22	c	c	NOUN
iajs-1064	14	23	-	-	PUNCT
iajs-1064	14	24	reactive	reactive	ADJ
iajs-1064	14	25	protein	protein	NOUN
iajs-1064	14	26	)	)	PUNCT
iajs-1064	14	27	chemistry	chemistry	NOUN
iajs-1064	15	1	|	|	ADV
iajs-1064	15	2	108	108	NUM
iajs-1064	15	3	2017عام	2017عام	NUM
iajs-1064	15	4	)	)	PUNCT
iajs-1064	16	1	1(العدد	1(العدد	NUM
iajs-1064	16	2	30مجلة	30مجلة	NUM
iajs-1064	16	3	إبن	إبن	VERB
iajs-1064	16	4	الھيثم	الھيثم	NOUN
iajs-1064	16	5	للعلوم	للعلوم	PROPN
iajs-1064	16	6	الصرفة	الصرفة	PROPN
iajs-1064	16	7	والتطبيقية	والتطبيقية	PRON
iajs-1064	16	8	المجلد	المجلد	VERB
iajs-1064	16	9	ibn	ibn	PROPN
iajs-1064	16	10	al	al	PROPN
iajs-1064	16	11	-	-	PUNCT
iajs-1064	16	12	haitham	haitham	PROPN
iajs-1064	16	13	jour	jour	X
iajs-1064	16	14	.	.	PROPN
iajs-1064	17	1	for	for	ADP
iajs-1064	17	2	pure	pure	ADJ
iajs-1064	17	3	&	&	CCONJ
iajs-1064	17	4	appl	appl	PROPN
iajs-1064	17	5	.	.	PUNCT
iajs-1064	18	1	sci	sci	PROPN
iajs-1064	18	2	.	.	PUNCT
iajs-1064	18	3	vol	vol	NOUN
iajs-1064	18	4	.	.	PROPN
iajs-1064	18	5	30	30	NUM
iajs-1064	18	6	(	(	PUNCT
iajs-1064	18	7	1	1	NUM
iajs-1064	18	8	)	)	PUNCT
iajs-1064	18	9	2017	2017	NUM
iajs-1064	18	10	introduction	introduction	NOUN
iajs-1064	18	11	glucagon	glucagon	NOUN
iajs-1064	18	12	-	-	PUNCT
iajs-1064	18	13	like	like	ADJ
iajs-1064	18	14	peptide-1	peptide-1	PROPN
iajs-1064	18	15	(	(	PUNCT
iajs-1064	18	16	glp-1	glp-1	NOUN
iajs-1064	18	17	)	)	PUNCT
iajs-1064	18	18	is	be	AUX
iajs-1064	18	19	a	a	DET
iajs-1064	18	20	member	member	NOUN
iajs-1064	18	21	of	of	ADP
iajs-1064	18	22	the	the	DET
iajs-1064	18	23	pro	pro	ADJ
iajs-1064	18	24	-	-	ADJ
iajs-1064	18	25	glucagon	glucagon	ADJ
iajs-1064	18	26	incretin	incretin	NOUN
iajs-1064	18	27	family	family	NOUN
iajs-1064	18	28	involved	involve	VERB
iajs-1064	18	29	in	in	ADP
iajs-1064	18	30	the	the	DET
iajs-1064	18	31	control	control	NOUN
iajs-1064	18	32	of	of	ADP
iajs-1064	18	33	zest	zest	NOUN
iajs-1064	18	34	and	and	CCONJ
iajs-1064	18	35	satiety	satiety	NOUN
iajs-1064	18	36	,	,	PUNCT
iajs-1064	18	37	glp-1	glp-1	VERB
iajs-1064	18	38	acts	act	NOUN
iajs-1064	18	39	during	during	ADP
iajs-1064	18	40	glp-1	glp-1	NOUN
iajs-1064	18	41	receptor	receptor	NOUN
iajs-1064	18	42	(	(	PUNCT
iajs-1064	18	43	glp-1r	glp-1r	PROPN
iajs-1064	18	44	)	)	PUNCT
iajs-1064	18	45	,	,	PUNCT
iajs-1064	18	46	a	a	DET
iajs-1064	18	47	463	463	NUM
iajs-1064	18	48	aminoacid	aminoacid	NOUN
iajs-1064	18	49	member	member	NOUN
iajs-1064	18	50	of	of	ADP
iajs-1064	18	51	the	the	DET
iajs-1064	18	52	g	g	PROPN
iajs-1064	18	53	protein	protein	NOUN
iajs-1064	18	54	-	-	PUNCT
iajs-1064	18	55	coupled	couple	VERB
iajs-1064	18	56	receptor	receptor	NOUN
iajs-1064	18	57	(	(	PUNCT
iajs-1064	18	58	gpcr	gpcr	ADJ
iajs-1064	18	59	)	)	PUNCT
iajs-1064	18	60	super	super	ADJ
iajs-1064	18	61	family	family	NOUN
iajs-1064	19	1	[	[	X
iajs-1064	19	2	1	1	NUM
iajs-1064	19	3	]	]	PUNCT
iajs-1064	19	4	.	.	PUNCT
iajs-1064	20	1	bioactive	bioactive	PROPN
iajs-1064	20	2	glp-1	glp-1	SYM
iajs-1064	20	3	found	find	VERB
iajs-1064	20	4	in	in	ADP
iajs-1064	20	5	two	two	NUM
iajs-1064	20	6	equipotent	equipotent	NOUN
iajs-1064	20	7	molecular	molecular	ADJ
iajs-1064	20	8	forms	form	NOUN
iajs-1064	20	9	:	:	PUNCT
iajs-1064	20	10	glp-17–37	glp-17–37	NOUN
iajs-1064	20	11	and	and	CCONJ
iajs-1064	20	12	glp-17–36	glp-17–36	PROPN
iajs-1064	20	13	amide	amide	NOUN
iajs-1064	20	14	.	.	PUNCT
iajs-1064	21	1	glp-1	glp-1	NOUN
iajs-1064	21	2	is	be	AUX
iajs-1064	21	3	rapidly	rapidly	ADV
iajs-1064	21	4	split	split	VERB
iajs-1064	21	5	by	by	ADP
iajs-1064	21	6	dp	dp	NOUN
iajs-1064	21	7	iv	iv	NOUN
iajs-1064	21	8	,	,	PUNCT
iajs-1064	21	9	which	which	PRON
iajs-1064	21	10	results	result	VERB
iajs-1064	21	11	in	in	ADP
iajs-1064	21	12	the	the	DET
iajs-1064	21	13	production	production	NOUN
iajs-1064	21	14	of	of	ADP
iajs-1064	21	15	largely	largely	ADV
iajs-1064	21	16	inactive	inactive	ADJ
iajs-1064	21	17	molecular	molecular	ADJ
iajs-1064	21	18	glp-19	glp-19	NOUN
iajs-1064	21	19	-	-	PUNCT
iajs-1064	21	20	36	36	NUM
iajs-1064	21	21	amide	amide	NOUN
iajs-1064	21	22	and	and	CCONJ
iajs-1064	21	23	glp-17	glp-17	NOUN
iajs-1064	21	24	-	-	PUNCT
iajs-1064	21	25	37	37	NUM
iajs-1064	21	26	forms	form	NOUN
iajs-1064	21	27	.	.	PUNCT
iajs-1064	22	1	in	in	ADP
iajs-1064	22	2	the	the	DET
iajs-1064	22	3	cardiovascular	cardiovascular	ADJ
iajs-1064	22	4	system	system	NOUN
iajs-1064	22	5	,	,	PUNCT
iajs-1064	22	6	incretins	incretin	NOUN
iajs-1064	22	7	have	have	AUX
iajs-1064	22	8	been	be	AUX
iajs-1064	22	9	recently	recently	ADV
iajs-1064	22	10	facilities	facility	NOUN
iajs-1064	22	11	for	for	ADP
iajs-1064	22	12	the	the	DET
iajs-1064	22	13	increase	increase	NOUN
iajs-1064	22	14	of	of	ADP
iajs-1064	22	15	endogenous	endogenous	ADJ
iajs-1064	22	16	antioxidant	antioxidant	ADJ
iajs-1064	22	17	defenses	defense	NOUN
iajs-1064	22	18	,	,	PUNCT
iajs-1064	22	19	repression	repression	NOUN
iajs-1064	22	20	of	of	ADP
iajs-1064	22	21	cardiomyocyte	cardiomyocyte	NOUN
iajs-1064	22	22	apoptosis	apoptosis	NOUN
iajs-1064	22	23	,	,	PUNCT
iajs-1064	22	24	attenuation	attenuation	NOUN
iajs-1064	22	25	of	of	ADP
iajs-1064	22	26	endothelial	endothelial	ADJ
iajs-1064	22	27	inflammation	inflammation	NOUN
iajs-1064	22	28	and	and	CCONJ
iajs-1064	22	29	dysfunction[2	dysfunction[2	NOUN
iajs-1064	22	30	]	]	PUNCT
iajs-1064	22	31	.	.	PUNCT
iajs-1064	23	1	in	in	ADP
iajs-1064	23	2	this	this	DET
iajs-1064	23	3	brief	brief	ADJ
iajs-1064	23	4	review	review	NOUN
iajs-1064	23	5	,	,	PUNCT
iajs-1064	23	6	we	we	PRON
iajs-1064	23	7	will	will	AUX
iajs-1064	23	8	summarize	summarize	VERB
iajs-1064	23	9	recent	recent	ADJ
iajs-1064	23	10	progress	progress	NOUN
iajs-1064	23	11	about	about	ADP
iajs-1064	23	12	the	the	DET
iajs-1064	23	13	important	important	ADJ
iajs-1064	23	14	role	role	NOUN
iajs-1064	23	15	of	of	ADP
iajs-1064	23	16	glp-1	glp-1	NOUN
iajs-1064	23	17	in	in	ADP
iajs-1064	23	18	myocardial	myocardial	ADJ
iajs-1064	23	19	protection	protection	NOUN
iajs-1064	23	20	and	and	CCONJ
iajs-1064	23	21	signaling	signal	VERB
iajs-1064	23	22	pathway	pathway	NOUN
iajs-1064	23	23	.	.	PUNCT
iajs-1064	24	1	[	[	X
iajs-1064	24	2	3	3	NUM
iajs-1064	24	3	]	]	PUNCT
iajs-1064	24	4	.	.	PUNCT
iajs-1064	25	1	in	in	ADP
iajs-1064	25	2	pacing	pace	VERB
iajs-1064	25	3	-	-	PUNCT
iajs-1064	25	4	induced	induce	VERB
iajs-1064	25	5	heart	heart	NOUN
iajs-1064	25	6	failure	failure	NOUN
iajs-1064	25	7	case	case	NOUN
iajs-1064	25	8	,	,	PUNCT
iajs-1064	25	9	the	the	DET
iajs-1064	25	10	stimulation	stimulation	NOUN
iajs-1064	25	11	of	of	ADP
iajs-1064	25	12	glp	glp	NOUN
iajs-1064	25	13	signaling	signal	VERB
iajs-1064	25	14	by	by	ADP
iajs-1064	25	15	glp-1	glp-1	NOUN
iajs-1064	25	16	has	have	AUX
iajs-1064	25	17	also	also	ADV
iajs-1064	25	18	been	be	AUX
iajs-1064	25	19	demonstrated	demonstrate	VERB
iajs-1064	25	20	to	to	PART
iajs-1064	25	21	improve	improve	VERB
iajs-1064	25	22	cardiac	cardiac	ADJ
iajs-1064	25	23	performance	performance	NOUN
iajs-1064	25	24	in	in	ADP
iajs-1064	25	25	conscious	conscious	ADJ
iajs-1064	25	26	dogs	dog	NOUN
iajs-1064	25	27	with	with	ADP
iajs-1064	25	28	dilated	dilated	ADJ
iajs-1064	25	29	cardiomyopathy	cardiomyopathy	ADJ
iajs-1064	25	30	[	[	X
iajs-1064	25	31	4	4	NUM
iajs-1064	25	32	]	]	PUNCT
iajs-1064	25	33	.	.	PUNCT
iajs-1064	26	1	recently	recently	ADV
iajs-1064	26	2	,	,	PUNCT
iajs-1064	26	3	a	a	DET
iajs-1064	26	4	significant	significant	ADJ
iajs-1064	26	5	number	number	NOUN
iajs-1064	26	6	of	of	ADP
iajs-1064	26	7	studies	study	NOUN
iajs-1064	26	8	have	have	AUX
iajs-1064	26	9	indicated	indicate	VERB
iajs-1064	26	10	useful	useful	ADJ
iajs-1064	26	11	effects	effect	NOUN
iajs-1064	26	12	of	of	ADP
iajs-1064	26	13	glp-1	glp-1	NOUN
iajs-1064	26	14	on	on	ADP
iajs-1064	26	15	cardiovascular	cardiovascular	ADJ
iajs-1064	26	16	function	function	NOUN
iajs-1064	26	17	,	,	PUNCT
iajs-1064	26	18	which	which	PRON
iajs-1064	26	19	gave	give	VERB
iajs-1064	26	20	justification	justification	NOUN
iajs-1064	26	21	for	for	ADP
iajs-1064	26	22	the	the	DET
iajs-1064	26	23	use	use	NOUN
iajs-1064	26	24	of	of	ADP
iajs-1064	26	25	glp-1	glp-1	NOUN
iajs-1064	26	26	in	in	ADP
iajs-1064	26	27	the	the	DET
iajs-1064	26	28	treatment	treatment	NOUN
iajs-1064	26	29	of	of	ADP
iajs-1064	26	30	cardiovascular	cardiovascular	ADJ
iajs-1064	26	31	diseases	disease	NOUN
iajs-1064	26	32	.	.	PUNCT
iajs-1064	27	1	[	[	X
iajs-1064	27	2	3	3	NUM
iajs-1064	27	3	]	]	PUNCT
iajs-1064	27	4	.	.	PUNCT
iajs-1064	28	1	infusions	infusion	NOUN
iajs-1064	28	2	of	of	ADP
iajs-1064	28	3	glp-1	glp-1	NOUN
iajs-1064	28	4	have	have	AUX
iajs-1064	28	5	also	also	ADV
iajs-1064	28	6	been	be	AUX
iajs-1064	28	7	shown	show	VERB
iajs-1064	28	8	to	to	PART
iajs-1064	28	9	promote	promote	VERB
iajs-1064	28	10	post	post	ADJ
iajs-1064	28	11	-	-	ADJ
iajs-1064	28	12	prandial	prandial	ADJ
iajs-1064	28	13	lipaemic	lipaemic	ADJ
iajs-1064	28	14	excursions	excursion	NOUN
iajs-1064	28	15	[	[	X
iajs-1064	28	16	5	5	NUM
iajs-1064	28	17	]	]	NUM
iajs-1064	28	18	.	.	PUNCT
iajs-1064	29	1	,	,	PUNCT
iajs-1064	29	2	an	an	DET
iajs-1064	29	3	distinct	distinct	ADJ
iajs-1064	29	4	risk	risk	NOUN
iajs-1064	29	5	factor	factor	NOUN
iajs-1064	29	6	in	in	ADP
iajs-1064	29	7	the	the	DET
iajs-1064	29	8	development	development	NOUN
iajs-1064	29	9	of	of	ADP
iajs-1064	29	10	atherosclerotic	atherosclerotic	ADJ
iajs-1064	29	11	cardiovascular	cardiovascular	ADJ
iajs-1064	29	12	disease	disease	NOUN
iajs-1064	29	13	.	.	PUNCT
iajs-1064	30	1	glp1	glp1	NOUN
iajs-1064	30	2	receptors	receptor	NOUN
iajs-1064	30	3	are	be	AUX
iajs-1064	30	4	expressed	express	VERB
iajs-1064	30	5	on	on	ADP
iajs-1064	30	6	cardiac	cardiac	ADJ
iajs-1064	30	7	tissue	tissue	NOUN
iajs-1064	30	8	,	,	PUNCT
iajs-1064	30	9	so	so	ADV
iajs-1064	30	10	,	,	PUNCT
iajs-1064	30	11	it	it	PRON
iajs-1064	30	12	is	be	AUX
iajs-1064	30	13	possible	possible	ADJ
iajs-1064	30	14	that	that	SCONJ
iajs-1064	30	15	the	the	DET
iajs-1064	30	16	hormone	hormone	NOUN
iajs-1064	30	17	,	,	PUNCT
iajs-1064	30	18	or	or	CCONJ
iajs-1064	30	19	its	its	PRON
iajs-1064	30	20	synthetic	synthetic	ADJ
iajs-1064	30	21	analogues	analogue	NOUN
iajs-1064	30	22	,	,	PUNCT
iajs-1064	30	23	may	may	AUX
iajs-1064	30	24	directly	directly	ADV
iajs-1064	30	25	mediate	mediate	VERB
iajs-1064	30	26	a	a	DET
iajs-1064	30	27	range	range	NOUN
iajs-1064	30	28	of	of	ADP
iajs-1064	30	29	cardiac	cardiac	ADJ
iajs-1064	30	30	functions	function	NOUN
iajs-1064	30	31	.	.	PUNCT
iajs-1064	31	1	recent	recent	ADJ
iajs-1064	31	2	research	research	NOUN
iajs-1064	31	3	include	include	VERB
iajs-1064	31	4	the	the	DET
iajs-1064	31	5	investigation	investigation	NOUN
iajs-1064	31	6	of	of	ADP
iajs-1064	31	7	glp-1	glp-1	NOUN
iajs-1064	31	8	involvement	involvement	NOUN
iajs-1064	31	9	in	in	ADP
iajs-1064	31	10	myocardial	myocardial	ADJ
iajs-1064	31	11	metabolism	metabolism	NOUN
iajs-1064	31	12	,	,	PUNCT
iajs-1064	31	13	coronary	coronary	ADJ
iajs-1064	31	14	blood	blood	NOUN
iajs-1064	31	15	flow	flow	NOUN
iajs-1064	31	16	,	,	PUNCT
iajs-1064	31	17	pre	pre	ADJ
iajs-1064	31	18	/	/	SYM
iajs-1064	31	19	post	post	ADJ
iajs-1064	31	20	-	-	ADJ
iajs-1064	31	21	ischemic	ischemic	ADJ
iajs-1064	31	22	conditioning	conditioning	NOUN
iajs-1064	31	23	,	,	PUNCT
iajs-1064	31	24	left	leave	VERB
iajs-1064	31	25	ventricular	ventricular	ADJ
iajs-1064	31	26	(	(	PUNCT
iajs-1064	31	27	lv	lv	PROPN
iajs-1064	31	28	)	)	PUNCT
iajs-1064	31	29	remodeling	remodeling	NOUN
iajs-1064	31	30	and	and	CCONJ
iajs-1064	31	31	lv	lv	PROPN
iajs-1064	31	32	performance	performance	NOUN
iajs-1064	31	33	.	.	PUNCT
iajs-1064	32	1	studies	study	NOUN
iajs-1064	32	2	including	include	VERB
iajs-1064	32	3	animal	animal	NOUN
iajs-1064	32	4	and	and	CCONJ
iajs-1064	32	5	human	human	NOUN
iajs-1064	32	6	have	have	AUX
iajs-1064	32	7	suggested	suggest	VERB
iajs-1064	32	8	that	that	SCONJ
iajs-1064	32	9	glp-1	glp-1	ADP
iajs-1064	32	10	agonists	agonist	NOUN
iajs-1064	32	11	may	may	AUX
iajs-1064	32	12	have	have	VERB
iajs-1064	32	13	effects	effect	NOUN
iajs-1064	32	14	on	on	ADP
iajs-1064	32	15	myocardial	myocardial	ADJ
iajs-1064	32	16	metabolism	metabolism	NOUN
iajs-1064	32	17	,	,	PUNCT
iajs-1064	32	18	and	and	CCONJ
iajs-1064	32	19	this	this	PRON
iajs-1064	32	20	may	may	AUX
iajs-1064	32	21	be	be	AUX
iajs-1064	32	22	translated	translate	VERB
iajs-1064	32	23	into	into	ADP
iajs-1064	32	24	possible	possible	ADJ
iajs-1064	32	25	therapeutic	therapeutic	ADJ
iajs-1064	32	26	benefit	benefit	NOUN
iajs-1064	32	27	on	on	ADP
iajs-1064	32	28	cardiac	cardiac	ADJ
iajs-1064	32	29	function	function	NOUN
iajs-1064	32	30	.	.	PUNCT
iajs-1064	33	1	in	in	ADP
iajs-1064	33	2	addition	addition	NOUN
iajs-1064	33	3	,	,	PUNCT
iajs-1064	33	4	an	an	DET
iajs-1064	33	5	animal	animal	NOUN
iajs-1064	33	6	study	study	NOUN
iajs-1064	33	7	suggested	suggest	VERB
iajs-1064	33	8	that	that	SCONJ
iajs-1064	33	9	glp-1	glp-1	NOUN
iajs-1064	33	10	may	may	AUX
iajs-1064	33	11	have	have	VERB
iajs-1064	33	12	effects	effect	NOUN
iajs-1064	33	13	on	on	ADP
iajs-1064	33	14	coronary	coronary	ADJ
iajs-1064	33	15	blood	blood	NOUN
iajs-1064	33	16	flow	flow	NOUN
iajs-1064	33	17	and	and	CCONJ
iajs-1064	33	18	protect	protect	VERB
iajs-1064	33	19	against	against	ADP
iajs-1064	33	20	ischemia	ischemia	NOUN
iajs-1064	33	21	and	and	CCONJ
iajs-1064	33	22	reperfusion	reperfusion	NOUN
iajs-1064	33	23	injury	injury	NOUN
iajs-1064	34	1	[	[	X
iajs-1064	34	2	6	6	NUM
iajs-1064	34	3	]	]	PUNCT
iajs-1064	34	4	.	.	PUNCT
iajs-1064	35	1	the	the	DET
iajs-1064	35	2	rheumatoid	rheumatoid	NOUN
iajs-1064	35	3	arthritis	arthritis	NOUN
iajs-1064	35	4	(	(	PUNCT
iajs-1064	35	5	ra	ra	NOUN
iajs-1064	35	6	)	)	PUNCT
iajs-1064	35	7	is	be	AUX
iajs-1064	35	8	a	a	DET
iajs-1064	35	9	chronic	chronic	ADJ
iajs-1064	35	10	autoimmune	autoimmune	ADJ
iajs-1064	35	11	disease	disease	NOUN
iajs-1064	35	12	identified	identify	VERB
iajs-1064	35	13	by	by	ADP
iajs-1064	35	14	synovial	synovial	ADJ
iajs-1064	35	15	inflammation	inflammation	NOUN
iajs-1064	35	16	,	,	PUNCT
iajs-1064	35	17	cartilage	cartilage	NOUN
iajs-1064	35	18	damage	damage	NOUN
iajs-1064	35	19	,	,	PUNCT
iajs-1064	35	20	and	and	CCONJ
iajs-1064	35	21	bone	bone	NOUN
iajs-1064	35	22	erosion	erosion	NOUN
iajs-1064	35	23	,	,	PUNCT
iajs-1064	35	24	[	[	X
iajs-1064	35	25	7	7	NUM
iajs-1064	35	26	]	]	PUNCT
iajs-1064	35	27	.	.	PUNCT
iajs-1064	36	1	visfatin	visfatin	PROPN
iajs-1064	36	2	,	,	PUNCT
iajs-1064	36	3	known	know	VERB
iajs-1064	36	4	as	as	ADP
iajs-1064	36	5	nicotinamide	nicotinamide	NOUN
iajs-1064	36	6	phosphoribosyltransferase	phosphoribosyltransferase	NOUN
iajs-1064	36	7	(	(	PUNCT
iajs-1064	36	8	nampt	nampt	ADJ
iajs-1064	36	9	)	)	PUNCT
iajs-1064	36	10	,	,	PUNCT
iajs-1064	36	11	was	be	AUX
iajs-1064	36	12	originally	originally	ADV
iajs-1064	36	13	described	describe	VERB
iajs-1064	36	14	as	as	ADP
iajs-1064	36	15	a	a	DET
iajs-1064	36	16	cytokine	cytokine	NOUN
iajs-1064	36	17	involved	involve	VERB
iajs-1064	36	18	in	in	ADP
iajs-1064	36	19	early	early	ADJ
iajs-1064	36	20	b	b	NOUN
iajs-1064	36	21	-	-	PUNCT
iajs-1064	36	22	cell	cell	NOUN
iajs-1064	36	23	development	development	NOUN
iajs-1064	36	24	and	and	CCONJ
iajs-1064	36	25	was	be	AUX
iajs-1064	36	26	later	later	ADV
iajs-1064	36	27	renamed	rename	VERB
iajs-1064	36	28	visfatin	visfatin	NOUN
iajs-1064	36	29	since	since	SCONJ
iajs-1064	36	30	it	it	PRON
iajs-1064	36	31	is	be	AUX
iajs-1064	36	32	secreted	secrete	VERB
iajs-1064	36	33	mainly	mainly	ADV
iajs-1064	36	34	by	by	ADP
iajs-1064	36	35	visceral	visceral	ADJ
iajs-1064	36	36	fat	fat	NOUN
iajs-1064	37	1	[	[	X
iajs-1064	37	2	8	8	NUM
iajs-1064	37	3	]	]	PUNCT
iajs-1064	37	4	.	.	PUNCT
iajs-1064	38	1	a	a	DET
iajs-1064	38	2	proinflammatory	proinflammatory	ADJ
iajs-1064	38	3	action	action	NOUN
iajs-1064	38	4	of	of	ADP
iajs-1064	38	5	visfatin	visfatin	NOUN
iajs-1064	38	6	was	be	AUX
iajs-1064	38	7	described	describe	VERB
iajs-1064	38	8	to	to	PART
iajs-1064	38	9	be	be	AUX
iajs-1064	38	10	mediated	mediate	VERB
iajs-1064	38	11	by	by	ADP
iajs-1064	38	12	the	the	DET
iajs-1064	38	13	insulin	insulin	NOUN
iajs-1064	38	14	signaling	signal	VERB
iajs-1064	38	15	pathway	pathway	NOUN
iajs-1064	38	16	through	through	ADP
iajs-1064	38	17	protein	protein	NOUN
iajs-1064	38	18	kinase	kinase	PROPN
iajs-1064	38	19	b	b	PROPN
iajs-1064	38	20	(	(	PUNCT
iajs-1064	38	21	pkb	pkb	PROPN
iajs-1064	38	22	)	)	PUNCT
iajs-1064	38	23	phosphorylation	phosphorylation	NOUN
iajs-1064	39	1	[	[	X
iajs-1064	39	2	9	9	NUM
iajs-1064	39	3	]	]	PUNCT
iajs-1064	39	4	..	..	PUNCT
iajs-1064	40	1	studies	study	NOUN
iajs-1064	40	2	reported	report	VERB
iajs-1064	40	3	the	the	DET
iajs-1064	40	4	up	up	ADJ
iajs-1064	40	5	regulation	regulation	NOUN
iajs-1064	40	6	of	of	ADP
iajs-1064	40	7	visfatin	visfatin	NOUN
iajs-1064	40	8	inactivated	inactivate	VERB
iajs-1064	40	9	ra	ra	NOUN
iajs-1064	40	10	-	-	NOUN
iajs-1064	40	11	sfs	sfs	ADJ
iajs-1064	40	12	in	in	ADP
iajs-1064	40	13	response	response	NOUN
iajs-1064	40	14	to	to	ADP
iajs-1064	40	15	proinflammatory	proinflammatory	ADJ
iajs-1064	40	16	stimuli	stimulus	NOUN
iajs-1064	40	17	in	in	ADP
iajs-1064	40	18	ra	ra	PROPN
iajs-1064	40	19	synovium	synovium	NOUN
iajs-1064	40	20	:	:	PUNCT
iajs-1064	40	21	visfatin	visfatin	NOUN
iajs-1064	40	22	was	be	AUX
iajs-1064	40	23	expressed	express	VERB
iajs-1064	40	24	in	in	ADP
iajs-1064	40	25	the	the	DET
iajs-1064	40	26	lining	lining	NOUN
iajs-1064	40	27	layer	layer	NOUN
iajs-1064	40	28	,	,	PUNCT
iajs-1064	40	29	aggregates	aggregate	NOUN
iajs-1064	40	30	of	of	ADP
iajs-1064	40	31	lymphoid	lymphoid	NOUN
iajs-1064	40	32	,	,	PUNCT
iajs-1064	40	33	and	and	CCONJ
iajs-1064	40	34	vessels	vessel	VERB
iajs-1064	40	35	interstitial	interstitial	ADJ
iajs-1064	40	36	.	.	PUNCT
iajs-1064	41	1	[	[	X
iajs-1064	41	2	10	10	NUM
iajs-1064	41	3	]	]	PUNCT
iajs-1064	41	4	.	.	PUNCT
iajs-1064	42	1	study	study	NOUN
iajs-1064	42	2	demonstrated	demonstrate	VERB
iajs-1064	42	3	that	that	SCONJ
iajs-1064	42	4	heart	heart	NOUN
iajs-1064	42	5	failure	failure	NOUN
iajs-1064	42	6	led	lead	VERB
iajs-1064	42	7	to	to	ADP
iajs-1064	42	8	death	death	NOUN
iajs-1064	42	9	in	in	ADP
iajs-1064	42	10	ra	ra	PROPN
iajs-1064	42	11	patients	patient	NOUN
iajs-1064	43	1	[	[	X
iajs-1064	43	2	11],which	11],which	PROPN
iajs-1064	43	3	accelerated	accelerate	VERB
iajs-1064	43	4	atherosclerosis	atherosclerosis	NOUN
iajs-1064	43	5	than	than	ADP
iajs-1064	43	6	the	the	DET
iajs-1064	43	7	other	other	ADJ
iajs-1064	43	8	subjects	subject	NOUN
iajs-1064	43	9	[	[	X
iajs-1064	43	10	12	12	NUM
iajs-1064	43	11	]	]	PUNCT
iajs-1064	43	12	.	.	PUNCT
iajs-1064	44	1	inflammatory	inflammatory	ADJ
iajs-1064	44	2	processes	process	NOUN
iajs-1064	44	3	resemble	resemble	VERB
iajs-1064	44	4	to	to	ADP
iajs-1064	44	5	the	the	DET
iajs-1064	44	6	other	other	ADJ
iajs-1064	44	7	chronic	chronic	ADJ
iajs-1064	44	8	inflammatory	inflammatory	ADJ
iajs-1064	44	9	diseases	disease	NOUN
iajs-1064	44	10	,	,	PUNCT
iajs-1064	44	11	like	like	ADP
iajs-1064	44	12	atherosclerosis[13	atherosclerosis[13	NOUN
iajs-1064	44	13	]	]	PUNCT
iajs-1064	44	14	.	.	PUNCT
iajs-1064	45	1	expression	expression	NOUN
iajs-1064	45	2	of	of	ADP
iajs-1064	45	3	proinflammatory	proinflammatory	ADJ
iajs-1064	45	4	cytokines	cytokine	NOUN
iajs-1064	45	5	and	and	CCONJ
iajs-1064	45	6	mediators	mediator	NOUN
iajs-1064	45	7	influences	influence	NOUN
iajs-1064	45	8	of	of	ADP
iajs-1064	45	9	atherosclerosis	atherosclerosis	NOUN
iajs-1064	45	10	.	.	PUNCT
iajs-1064	46	1	aclot	aclot	NOUN
iajs-1064	46	2	formation	formation	NOUN
iajs-1064	46	3	to	to	PART
iajs-1064	46	4	thrombus	thrombus	VERB
iajs-1064	46	5	development	development	NOUN
iajs-1064	46	6	responsible	responsible	ADJ
iajs-1064	46	7	for	for	ADP
iajs-1064	46	8	myocardial	myocardial	ADJ
iajs-1064	46	9	infarction[14	infarction[14	PROPN
iajs-1064	46	10	]	]	PUNCT
iajs-1064	46	11	.	.	PUNCT
iajs-1064	47	1	the	the	DET
iajs-1064	47	2	study	study	NOUN
iajs-1064	47	3	aimed	aim	VERB
iajs-1064	47	4	to	to	PART
iajs-1064	47	5	estimate	estimate	VERB
iajs-1064	47	6	the	the	DET
iajs-1064	47	7	role	role	NOUN
iajs-1064	47	8	of	of	ADP
iajs-1064	47	9	glucagon	glucagon	NOUN
iajs-1064	47	10	-	-	PUNCT
iajs-1064	47	11	like	like	ADJ
iajs-1064	47	12	peptide-1	peptide-1	NOUN
iajs-1064	47	13	and	and	CCONJ
iajs-1064	47	14	visfatin	visfatin	NOUN
iajs-1064	47	15	as	as	ADP
iajs-1064	47	16	a	a	DET
iajs-1064	47	17	novel	novel	ADJ
iajs-1064	47	18	pro	pro	ADJ
iajs-1064	47	19	inflammatory	inflammatory	ADJ
iajs-1064	47	20	marker	marker	NOUN
iajs-1064	47	21	in	in	ADP
iajs-1064	47	22	rheumatoid	rheumatoid	NOUN
iajs-1064	47	23	arthritis	arthritis	NOUN
iajs-1064	47	24	patients	patient	NOUN
iajs-1064	47	25	according	accord	VERB
iajs-1064	47	26	to	to	ADP
iajs-1064	47	27	the	the	DET
iajs-1064	47	28	active	active	ADJ
iajs-1064	47	29	scores	score	NOUN
iajs-1064	47	30	of	of	ADP
iajs-1064	47	31	disease	disease	NOUN
iajs-1064	47	32	to	to	PART
iajs-1064	47	33	assess	assess	VERB
iajs-1064	47	34	the	the	DET
iajs-1064	47	35	possibility	possibility	NOUN
iajs-1064	47	36	of	of	ADP
iajs-1064	47	37	introducing	introduce	VERB
iajs-1064	47	38	visfatin	visfatin	NOUN
iajs-1064	47	39	in	in	ADP
iajs-1064	47	40	the	the	DET
iajs-1064	47	41	diagnosis	diagnosis	NOUN
iajs-1064	47	42	and	and	CCONJ
iajs-1064	47	43	monitoring	monitoring	NOUN
iajs-1064	47	44	of	of	ADP
iajs-1064	47	45	ra	ra	PROPN
iajs-1064	47	46	patients	patient	NOUN
iajs-1064	47	47	and	and	CCONJ
iajs-1064	47	48	to	to	PART
iajs-1064	47	49	found	find	VERB
iajs-1064	47	50	the	the	DET
iajs-1064	47	51	correlation	correlation	NOUN
iajs-1064	47	52	of	of	ADP
iajs-1064	47	53	visfatin	visfatin	NOUN
iajs-1064	47	54	level	level	NOUN
iajs-1064	47	55	with	with	ADP
iajs-1064	47	56	glucagon	glucagon	NOUN
iajs-1064	47	57	-	-	PUNCT
iajs-1064	47	58	like	like	ADJ
iajs-1064	47	59	peptide-1	peptide-1	PROPN
iajs-1064	47	60	and	and	CCONJ
iajs-1064	47	61	aip	aip	PROPN
iajs-1064	47	62	in	in	ADP
iajs-1064	47	63	rheumatoid	rheumatoid	NOUN
iajs-1064	47	64	arthritis	arthritis	NOUN
iajs-1064	47	65	patients	patient	NOUN
iajs-1064	47	66	prone	prone	ADJ
iajs-1064	47	67	to	to	ADP
iajs-1064	47	68	atherosclerosis	atherosclerosis	NOUN
iajs-1064	47	69	.	.	PUNCT
iajs-1064	48	1	chemistry	chemistry	NOUN
iajs-1064	48	2	|	|	ADV
iajs-1064	48	3	109	109	NUM
iajs-1064	48	4	2017عام	2017عام	NUM
iajs-1064	48	5	)	)	PUNCT
iajs-1064	48	6	1(العدد	1(العدد	NUM
iajs-1064	48	7	30مجلة	30مجلة	NUM
iajs-1064	48	8	إبن	إبن	VERB
iajs-1064	48	9	الھيثم	الھيثم	NOUN
iajs-1064	48	10	للعلوم	للعلوم	PROPN
iajs-1064	48	11	الصرفة	الصرفة	PROPN
iajs-1064	48	12	والتطبيقية	والتطبيقية	PRON
iajs-1064	48	13	المجلد	المجلد	VERB
iajs-1064	48	14	ibn	ibn	PROPN
iajs-1064	48	15	al	al	PROPN
iajs-1064	48	16	-	-	PUNCT
iajs-1064	48	17	haitham	haitham	PROPN
iajs-1064	48	18	jour	jour	X
iajs-1064	48	19	.	.	PROPN
iajs-1064	49	1	for	for	ADP
iajs-1064	49	2	pure	pure	ADJ
iajs-1064	49	3	&	&	CCONJ
iajs-1064	49	4	appl	appl	PROPN
iajs-1064	49	5	.	.	PUNCT
iajs-1064	50	1	sci	sci	PROPN
iajs-1064	50	2	.	.	PUNCT
iajs-1064	50	3	vol	vol	NOUN
iajs-1064	50	4	.	.	PROPN
iajs-1064	50	5	30	30	NUM
iajs-1064	50	6	(	(	PUNCT
iajs-1064	50	7	1	1	NUM
iajs-1064	50	8	)	)	PUNCT
iajs-1064	50	9	2017	2017	NUM
iajs-1064	50	10	materials	material	NOUN
iajs-1064	50	11	and	and	CCONJ
iajs-1064	50	12	methods	method	NOUN
iajs-1064	50	13	blood	blood	NOUN
iajs-1064	50	14	collected	collect	VERB
iajs-1064	50	15	from	from	ADP
iajs-1064	50	16	fifty	fifty	NUM
iajs-1064	50	17	healthy	healthy	ADJ
iajs-1064	50	18	individuals	individual	NOUN
iajs-1064	50	19	as	as	ADP
iajs-1064	50	20	control	control	NOUN
iajs-1064	50	21	group	group	NOUN
iajs-1064	50	22	(	(	PUNCT
iajs-1064	50	23	g1	g1	PROPN
iajs-1064	50	24	)	)	PUNCT
iajs-1064	50	25	and	and	CCONJ
iajs-1064	50	26	fifty	fifty	NUM
iajs-1064	50	27	rheumatoid	rheumatoid	NOUN
iajs-1064	50	28	arthritis	arthritis	NOUN
iajs-1064	50	29	(	(	PUNCT
iajs-1064	50	30	ra	ra	NOUN
iajs-1064	50	31	)	)	PUNCT
iajs-1064	50	32	patients	patient	NOUN
iajs-1064	50	33	(	(	PUNCT
iajs-1064	50	34	g2	g2	PROPN
iajs-1064	50	35	)	)	PUNCT
iajs-1064	50	36	were	be	AUX
iajs-1064	50	37	enrolled	enrol	VERB
iajs-1064	50	38	in	in	ADP
iajs-1064	50	39	this	this	DET
iajs-1064	50	40	study	study	NOUN
iajs-1064	50	41	with	with	ADP
iajs-1064	50	42	middle	middle	ADJ
iajs-1064	50	43	aged	age	VERB
iajs-1064	50	44	ranged	range	VERB
iajs-1064	50	45	(	(	PUNCT
iajs-1064	50	46	30	30	NUM
iajs-1064	50	47	–	–	SYM
iajs-1064	50	48	40	40	NUM
iajs-1064	50	49	)	)	PUNCT
iajs-1064	50	50	years	year	NOUN
iajs-1064	50	51	and	and	CCONJ
iajs-1064	50	52	bmi	bmi	X
iajs-1064	50	53	≥24	≥24	PROPN
iajs-1064	50	54	kg	kg	PROPN
iajs-1064	50	55	/	/	SYM
iajs-1064	50	56	m2	m2	PROPN
iajs-1064	50	57	.	.	PUNCT
iajs-1064	51	1	esr	esr	PROPN
iajs-1064	51	2	was	be	AUX
iajs-1064	51	3	determined	determine	VERB
iajs-1064	51	4	in	in	ADP
iajs-1064	51	5	blood	blood	NOUN
iajs-1064	51	6	using	use	VERB
iajs-1064	51	7	the	the	DET
iajs-1064	51	8	westergren	westergren	PROPN
iajs-1064	51	9	method	method	NOUN
iajs-1064	51	10	.	.	PUNCT
iajs-1064	52	1	three	three	NUM
iajs-1064	52	2	milliliters	milliliter	NOUN
iajs-1064	52	3	of	of	ADP
iajs-1064	52	4	blood	blood	NOUN
iajs-1064	52	5	was	be	AUX
iajs-1064	52	6	allowed	allow	VERB
iajs-1064	52	7	to	to	PART
iajs-1064	52	8	clot	clot	VERB
iajs-1064	52	9	,	,	PUNCT
iajs-1064	52	10	and	and	CCONJ
iajs-1064	52	11	was	be	AUX
iajs-1064	52	12	centrifuged	centrifuge	VERB
iajs-1064	52	13	1	1	NUM
iajs-1064	52	14	h	h	NOUN
iajs-1064	52	15	,	,	PUNCT
iajs-1064	52	16	.the	.the	DET
iajs-1064	52	17	serum	serum	PROPN
iajs-1064	52	18	collected	collect	VERB
iajs-1064	52	19	was	be	AUX
iajs-1064	52	20	stored	store	VERB
iajs-1064	52	21	until	until	ADP
iajs-1064	52	22	analysis	analysis	NOUN
iajs-1064	52	23	(	(	PUNCT
iajs-1064	52	24	tc	tc	NOUN
iajs-1064	52	25	,	,	PUNCT
iajs-1064	52	26	tg	tg	PROPN
iajs-1064	52	27	,	,	PUNCT
iajs-1064	52	28	hdl	hdl	PROPN
iajs-1064	52	29	)	)	PUNCT
iajs-1064	52	30	were	be	AUX
iajs-1064	52	31	determine	determine	NOUN
iajs-1064	52	32	according	accord	VERB
iajs-1064	52	33	to	to	ADP
iajs-1064	52	34	the	the	DET
iajs-1064	52	35	procedure	procedure	NOUN
iajs-1064	52	36	of	of	ADP
iajs-1064	52	37	the	the	DET
iajs-1064	52	38	hospital	hospital	NOUN
iajs-1064	52	39	laboratory	laboratory	NOUN
iajs-1064	52	40	.	.	PUNCT
iajs-1064	53	1	ldl	ldl	NOUN
iajs-1064	53	2	–	–	PUNCT
iajs-1064	53	3	c	c	NOUN
iajs-1064	53	4	and	and	CCONJ
iajs-1064	53	5	vldl	vldl	PROPN
iajs-1064	53	6	were	be	AUX
iajs-1064	53	7	calculated	calculate	VERB
iajs-1064	53	8	from	from	ADP
iajs-1064	53	9	friedewald	friedewald	ADJ
iajs-1064	53	10	equation	equation	NOUN
iajs-1064	53	11	:	:	PUNCT
iajs-1064	54	1	[	[	X
iajs-1064	54	2	ldlc(mg	ldlc(mg	NOUN
iajs-1064	54	3	/	/	SYM
iajs-1064	54	4	dl)=	dl)=	PROPN
iajs-1064	54	5	tc	tc	PROPN
iajs-1064	54	6	(	(	PUNCT
iajs-1064	54	7	hdl	hdl	NOUN
iajs-1064	54	8	-	-	PUNCT
iajs-1064	54	9	c+	c+	NOUN
iajs-1064	54	10	vldl	vldl	NOUN
iajs-1064	54	11	-	-	PUNCT
iajs-1064	54	12	c	c	NOUN
iajs-1064	54	13	)	)	PUNCT
iajs-1064	54	14	]	]	PUNCT
iajs-1064	54	15	,	,	PUNCT
iajs-1064	54	16	vldl	vldl	NOUN
iajs-1064	54	17	-	-	PUNCT
iajs-1064	54	18	c	c	PROPN
iajs-1064	54	19	(	(	PUNCT
iajs-1064	54	20	mg	mg	PROPN
iajs-1064	54	21	/	/	SYM
iajs-1064	54	22	dl)=tg/5[15	dl)=tg/5[15	PROPN
iajs-1064	54	23	]	]	PUNCT
iajs-1064	54	24	aip	aip	PROPN
iajs-1064	54	25	was	be	AUX
iajs-1064	54	26	calculated	calculate	VERB
iajs-1064	54	27	according	accord	VERB
iajs-1064	54	28	to	to	ADP
iajs-1064	54	29	the	the	DET
iajs-1064	54	30	following	follow	VERB
iajs-1064	54	31	equation	equation	NOUN
iajs-1064	54	32	(	(	PUNCT
iajs-1064	54	33	log	log	VERB
iajs-1064	54	34	tg	tg	PROPN
iajs-1064	54	35	/	/	SYM
iajs-1064	54	36	hdl	hdl	PROPN
iajs-1064	54	37	)	)	PUNCT
iajs-1064	54	38	.	.	PUNCT
iajs-1064	55	1	visfatin	visfatin	PROPN
iajs-1064	55	2	,	,	PUNCT
iajs-1064	55	3	was	be	AUX
iajs-1064	55	4	measured	measure	VERB
iajs-1064	55	5	by	by	ADP
iajs-1064	55	6	(	(	PUNCT
iajs-1064	55	7	elisa	elisa	NOUN
iajs-1064	55	8	)	)	PUNCT
iajs-1064	55	9	kit	kit	NOUN
iajs-1064	55	10	(	(	PUNCT
iajs-1064	55	11	phoenix	phoenix	PROPN
iajs-1064	55	12	pharmaceuticals	pharmaceuticals	PROPN
iajs-1064	55	13	inc	inc	PROPN
iajs-1064	55	14	.	.	PROPN
iajs-1064	55	15	,	,	PUNCT
iajs-1064	55	16	burlingame	burlingame	PROPN
iajs-1064	55	17	,	,	PUNCT
iajs-1064	55	18	california	california	PROPN
iajs-1064	55	19	,	,	PUNCT
iajs-1064	55	20	united	united	PROPN
iajs-1064	55	21	states	states	PROPN
iajs-1064	55	22	)	)	PUNCT
iajs-1064	56	1	[	[	X
iajs-1064	56	2	8	8	NUM
iajs-1064	56	3	]	]	PUNCT
iajs-1064	56	4	.	.	PUNCT
iajs-1064	57	1	serum	serum	PROPN
iajs-1064	57	2	crp	crp	PROPN
iajs-1064	57	3	was	be	AUX
iajs-1064	57	4	assessed	assess	VERB
iajs-1064	57	5	by	by	ADP
iajs-1064	57	6	turbidimetry	turbidimetry	NOUN
iajs-1064	57	7	quantitative	quantitative	ADJ
iajs-1064	57	8	method	method	NOUN
iajs-1064	57	9	[	[	X
iajs-1064	57	10	16].rheumatoid	16].rheumatoid	PROPN
iajs-1064	57	11	factor	factor	NOUN
iajs-1064	57	12	(	(	PUNCT
iajs-1064	57	13	rf	rf	VERB
iajs-1064	57	14	)	)	PUNCT
iajs-1064	57	15	was	be	AUX
iajs-1064	57	16	assessed	assess	VERB
iajs-1064	57	17	by	by	ADP
iajs-1064	57	18	turbidimetry	turbidimetry	NOUN
iajs-1064	57	19	quantitative	quantitative	ADJ
iajs-1064	57	20	method	method	NOUN
iajs-1064	58	1	[	[	X
iajs-1064	58	2	17	17	NUM
iajs-1064	58	3	]	]	PUNCT
iajs-1064	58	4	.	.	PUNCT
iajs-1064	59	1	insulin	insulin	NOUN
iajs-1064	59	2	and	and	CCONJ
iajs-1064	59	3	glp-1were	glp-1were	PROPN
iajs-1064	59	4	determined	determine	VERB
iajs-1064	59	5	by	by	ADP
iajs-1064	59	6	using	use	VERB
iajs-1064	59	7	a	a	DET
iajs-1064	59	8	ready	ready	ADJ
iajs-1064	59	9	kit	kit	NOUN
iajs-1064	59	10	based	base	VERB
iajs-1064	59	11	on	on	ADP
iajs-1064	59	12	elisa	elisa	PROPN
iajs-1064	59	13	technique[18	technique[18	NOUN
iajs-1064	59	14	]	]	PUNCT
iajs-1064	59	15	.	.	PUNCT
iajs-1064	60	1	the	the	DET
iajs-1064	60	2	results	result	NOUN
iajs-1064	60	3	were	be	AUX
iajs-1064	60	4	expressed	express	VERB
iajs-1064	60	5	as	as	ADP
iajs-1064	60	6	mean	mean	NOUN
iajs-1064	60	7	+	+	CCONJ
iajs-1064	60	8	sd	sd	NOUN
iajs-1064	60	9	.	.	PUNCT
iajs-1064	61	1	differences	difference	NOUN
iajs-1064	61	2	between	between	ADP
iajs-1064	61	3	the	the	DET
iajs-1064	61	4	groups	group	NOUN
iajs-1064	61	5	were	be	AUX
iajs-1064	61	6	assassed	assasse	VERB
iajs-1064	61	7	by	by	ADP
iajs-1064	61	8	student	student	NOUN
iajs-1064	61	9	’s	’s	PART
iajs-1064	61	10	t	t	PROPN
iajs-1064	61	11	-	-	PUNCT
iajs-1064	61	12	test	test	NOUN
iajs-1064	61	13	which	which	PRON
iajs-1064	61	14	p	p	NOUN
iajs-1064	61	15	-	-	PUNCT
iajs-1064	61	16	value	value	NOUN
iajs-1064	61	17	of	of	ADP
iajs-1064	61	18	0.05	0.05	NUM
iajs-1064	61	19	and	and	CCONJ
iajs-1064	61	20	0.0001	0.0001	NUM
iajs-1064	61	21	considered	consider	VERB
iajs-1064	61	22	as	as	ADP
iajs-1064	61	23	significant	significant	ADJ
iajs-1064	61	24	and	and	CCONJ
iajs-1064	61	25	highly	highly	ADV
iajs-1064	61	26	significant	significant	ADJ
iajs-1064	61	27	differences	difference	NOUN
iajs-1064	61	28	,	,	PUNCT
iajs-1064	61	29	respectively	respectively	ADV
iajs-1064	61	30	.correlation	.correlation	NUM
iajs-1064	61	31	relation	relation	NOUN
iajs-1064	61	32	was	be	AUX
iajs-1064	61	33	estimated	estimate	VERB
iajs-1064	61	34	for	for	ADP
iajs-1064	61	35	glp-1	glp-1	VERB
iajs-1064	61	36	with	with	ADP
iajs-1064	61	37	visfatin	visfatin	NOUN
iajs-1064	61	38	,	,	PUNCT
iajs-1064	61	39	crp	crp	PROPN
iajs-1064	61	40	and	and	CCONJ
iajs-1064	61	41	aip	aip	PROPN
iajs-1064	61	42	.	.	PUNCT
iajs-1064	62	1	results	result	NOUN
iajs-1064	62	2	and	and	CCONJ
iajs-1064	62	3	discussion	discussion	NOUN
iajs-1064	62	4	:	:	PUNCT
iajs-1064	62	5	table(1)represented	table(1)represented	ADJ
iajs-1064	62	6	levels	level	NOUN
iajs-1064	62	7	of	of	ADP
iajs-1064	62	8	esr	esr	PROPN
iajs-1064	62	9	,	,	PUNCT
iajs-1064	62	10	rf	rf	NOUN
iajs-1064	62	11	,	,	PUNCT
iajs-1064	62	12	tc	tc	NOUN
iajs-1064	62	13	,	,	PUNCT
iajs-1064	62	14	tg	tg	PROPN
iajs-1064	62	15	,	,	PUNCT
iajs-1064	62	16	hdl	hdl	PROPN
iajs-1064	62	17	,	,	PUNCT
iajs-1064	62	18	ldl	ldl	NOUN
iajs-1064	62	19	,	,	PUNCT
iajs-1064	62	20	vldl	vldl	NOUN
iajs-1064	62	21	for	for	ADP
iajs-1064	62	22	patients	patient	NOUN
iajs-1064	62	23	and	and	CCONJ
iajs-1064	62	24	control	control	NOUN
iajs-1064	62	25	groups	group	NOUN
iajs-1064	62	26	,	,	PUNCT
iajs-1064	62	27	results	result	NOUN
iajs-1064	62	28	in	in	ADP
iajs-1064	62	29	table	table	NOUN
iajs-1064	62	30	(	(	PUNCT
iajs-1064	62	31	1	1	X
iajs-1064	62	32	)	)	PUNCT
iajs-1064	62	33	revealed	reveal	VERB
iajs-1064	62	34	highly	highly	ADV
iajs-1064	62	35	significant	significant	ADJ
iajs-1064	62	36	increase	increase	NOUN
iajs-1064	62	37	in	in	ADP
iajs-1064	62	38	esr	esr	PROPN
iajs-1064	62	39	,	,	PUNCT
iajs-1064	62	40	rf	rf	NOUN
iajs-1064	62	41	,	,	PUNCT
iajs-1064	62	42	tc	tc	NOUN
iajs-1064	62	43	,	,	PUNCT
iajs-1064	62	44	tg	tg	PROPN
iajs-1064	62	45	,	,	PUNCT
iajs-1064	62	46	ldl	ldl	NOUN
iajs-1064	62	47	,	,	PUNCT
iajs-1064	62	48	vldl	vldl	NOUN
iajs-1064	62	49	and	and	CCONJ
iajs-1064	62	50	aip	aip	PROPN
iajs-1064	62	51	level	level	NOUN
iajs-1064	62	52	in	in	ADP
iajs-1064	62	53	g2	g2	PROPN
iajs-1064	62	54	comparing	compare	VERB
iajs-1064	62	55	to	to	ADP
iajs-1064	62	56	g1	g1	PROPN
iajs-1064	62	57	while	while	SCONJ
iajs-1064	62	58	significant	significant	ADJ
iajs-1064	62	59	decreased	decrease	VERB
iajs-1064	62	60	noticed	notice	VERB
iajs-1064	62	61	in	in	ADP
iajs-1064	62	62	hdl	hdl	PROPN
iajs-1064	62	63	levels	level	NOUN
iajs-1064	62	64	in	in	ADP
iajs-1064	62	65	g2	g2	PROPN
iajs-1064	62	66	comparing	compare	VERB
iajs-1064	62	67	to	to	ADP
iajs-1064	62	68	g1	g1	PROPN
iajs-1064	62	69	.	.	PUNCT
iajs-1064	63	1	several	several	ADJ
iajs-1064	63	2	immune	immune	ADJ
iajs-1064	63	3	cells	cell	NOUN
iajs-1064	63	4	and	and	CCONJ
iajs-1064	63	5	soluble	soluble	ADJ
iajs-1064	63	6	mediators	mediator	NOUN
iajs-1064	63	7	play	play	VERB
iajs-1064	63	8	important	important	ADJ
iajs-1064	63	9	role	role	NOUN
iajs-1064	63	10	in	in	ADP
iajs-1064	63	11	the	the	DET
iajs-1064	63	12	pathogenesis	pathogenesis	NOUN
iajs-1064	63	13	of	of	ADP
iajs-1064	63	14	atherosclerosis	atherosclerosis	NOUN
iajs-1064	63	15	in	in	ADP
iajs-1064	63	16	ra	ra	PROPN
iajs-1064	63	17	.	.	PUNCT
iajs-1064	64	1	[	[	X
iajs-1064	64	2	19	19	NUM
iajs-1064	64	3	]	]	PUNCT
iajs-1064	64	4	,	,	PUNCT
iajs-1064	64	5	such	such	ADJ
iajs-1064	64	6	as	as	ADP
iajs-1064	64	7	visfatin	visfatin	NOUN
iajs-1064	64	8	that	that	PRON
iajs-1064	64	9	is	be	AUX
iajs-1064	64	10	an	an	DET
iajs-1064	64	11	adipokine	adipokine	ADJ
iajs-1064	64	12	synthesis	synthesis	NOUN
iajs-1064	64	13	visceral	visceral	ADJ
iajs-1064	64	14	white	white	ADJ
iajs-1064	64	15	adipose	adipose	ADP
iajs-1064	64	16	tissue	tissue	NOUN
iajs-1064	64	17	[	[	X
iajs-1064	64	18	4	4	NUM
iajs-1064	64	19	]	]	PUNCT
iajs-1064	64	20	and	and	CCONJ
iajs-1064	64	21	represents	represent	VERB
iajs-1064	64	22	an	an	DET
iajs-1064	64	23	additional	additional	ADJ
iajs-1064	64	24	link	link	NOUN
iajs-1064	64	25	between	between	ADP
iajs-1064	64	26	adipose	adipose	NOUN
iajs-1064	64	27	tissue	tissue	NOUN
iajs-1064	64	28	and	and	CCONJ
iajs-1064	64	29	inflammation[20	inflammation[20	NOUN
iajs-1064	64	30	]	]	X
iajs-1064	64	31	jian	jian	PROPN
iajs-1064	64	32	et	et	PROPN
iajs-1064	64	33	al	al	PROPN
iajs-1064	64	34	.	.	PUNCT
iajs-1064	65	1	[	[	X
iajs-1064	65	2	21	21	NUM
iajs-1064	65	3	]	]	PUNCT
iajs-1064	65	4	and	and	CCONJ
iajs-1064	65	5	nalesnik	nalesnik	X
iajs-1064	65	6	et	et	PROPN
iajs-1064	65	7	al	al	PROPN
iajs-1064	65	8	.	.	PUNCT
iajs-1064	66	1	[	[	X
iajs-1064	66	2	22	22	NUM
iajs-1064	66	3	]	]	PUNCT
iajs-1064	66	4	,	,	PUNCT
iajs-1064	66	5	who	who	PRON
iajs-1064	66	6	observed	observe	VERB
iajs-1064	66	7	that	that	SCONJ
iajs-1064	66	8	esr	esr	PROPN
iajs-1064	66	9	levels	level	NOUN
iajs-1064	66	10	in	in	ADP
iajs-1064	66	11	ra	ra	PROPN
iajs-1064	66	12	patients	patient	NOUN
iajs-1064	66	13	was	be	AUX
iajs-1064	66	14	increase	increase	VERB
iajs-1064	66	15	more	more	ADJ
iajs-1064	66	16	than	than	SCONJ
iajs-1064	66	17	control	control	NOUN
iajs-1064	66	18	group	group	NOUN
iajs-1064	66	19	..	..	PUNCT
iajs-1064	66	20	rheumatoid	rheumatoid	NOUN
iajs-1064	66	21	factor	factor	NOUN
iajs-1064	66	22	(	(	PUNCT
iajs-1064	66	23	rf	rf	NOUN
iajs-1064	66	24	)	)	PUNCT
iajs-1064	66	25	is	be	AUX
iajs-1064	66	26	considered	consider	VERB
iajs-1064	66	27	as	as	ADP
iajs-1064	66	28	a	a	DET
iajs-1064	66	29	nonspecific	nonspecific	ADJ
iajs-1064	66	30	marker	marker	NOUN
iajs-1064	66	31	of	of	ADP
iajs-1064	66	32	ra	ra	PROPN
iajs-1064	66	33	in	in	ADP
iajs-1064	66	34	addition	addition	NOUN
iajs-1064	66	35	to	to	ADP
iajs-1064	66	36	collagen	collagen	NOUN
iajs-1064	66	37	vascular	vascular	ADJ
iajs-1064	66	38	disease	disease	NOUN
iajs-1064	67	1	[	[	X
iajs-1064	67	2	23	23	NUM
iajs-1064	67	3	]	]	PUNCT
iajs-1064	67	4	.	.	PUNCT
iajs-1064	68	1	these	these	DET
iajs-1064	68	2	data	datum	NOUN
iajs-1064	68	3	were	be	AUX
iajs-1064	68	4	in	in	ADP
iajs-1064	68	5	agreement	agreement	NOUN
iajs-1064	68	6	with	with	ADP
iajs-1064	68	7	those	those	PRON
iajs-1064	68	8	of	of	ADP
iajs-1064	68	9	novikov	novikov	NOUN
iajs-1064	68	10	et	et	PROPN
iajs-1064	68	11	al	al	PROPN
iajs-1064	68	12	.	.	PUNCT
iajs-1064	69	1	[	[	X
iajs-1064	69	2	24	24	NUM
iajs-1064	69	3	]	]	PUNCT
iajs-1064	69	4	,	,	PUNCT
iajs-1064	69	5	who	who	PRON
iajs-1064	69	6	noticed	notice	VERB
iajs-1064	69	7	that	that	SCONJ
iajs-1064	69	8	ra	ra	PROPN
iajs-1064	69	9	linked	link	VERB
iajs-1064	69	10	the	the	DET
iajs-1064	69	11	presence	presence	NOUN
iajs-1064	69	12	of	of	ADP
iajs-1064	69	13	rf	rf	PROPN
iajs-1064	69	14	.	.	PUNCT
iajs-1064	70	1	the	the	DET
iajs-1064	70	2	results	result	NOUN
iajs-1064	70	3	were	be	AUX
iajs-1064	70	4	in	in	ADP
iajs-1064	70	5	agreement	agreement	NOUN
iajs-1064	70	6	with	with	ADP
iajs-1064	70	7	those	those	PRON
iajs-1064	70	8	of	of	ADP
iajs-1064	70	9	[	[	X
iajs-1064	70	10	khalifa	khalifa	X
iajs-1064	70	11	and	and	CCONJ
iajs-1064	70	12	abdelfattah	abdelfattah	NOUN
iajs-1064	70	13	]	]	PUNCT
iajs-1064	71	1	[	[	X
iajs-1064	71	2	25	25	NUM
iajs-1064	71	3	]	]	PUNCT
iajs-1064	71	4	and	and	CCONJ
iajs-1064	71	5	[	[	X
iajs-1064	71	6	hui	hui	X
iajs-1064	71	7	et	et	PROPN
iajs-1064	71	8	al	al	PROPN
iajs-1064	71	9	]	]	PUNCT
iajs-1064	71	10	.	.	PUNCT
iajs-1064	72	1	[	[	X
iajs-1064	72	2	26	26	NUM
iajs-1064	72	3	]	]	PUNCT
iajs-1064	72	4	,	,	PUNCT
iajs-1064	72	5	who	who	PRON
iajs-1064	72	6	showed	show	VERB
iajs-1064	72	7	that	that	SCONJ
iajs-1064	72	8	the	the	DET
iajs-1064	72	9	elevation	elevation	NOUN
iajs-1064	72	10	found	find	VERB
iajs-1064	72	11	in	in	ADP
iajs-1064	72	12	rf	rf	NOUN
iajs-1064	72	13	in	in	ADP
iajs-1064	72	14	ra	ra	PROPN
iajs-1064	72	15	group	group	NOUN
iajs-1064	72	16	when	when	SCONJ
iajs-1064	72	17	comparing	compare	VERB
iajs-1064	72	18	to	to	ADP
iajs-1064	72	19	non	non	PROPN
iajs-1064	72	20	ra	ra	PROPN
iajs-1064	72	21	group	group	NOUN
iajs-1064	72	22	.	.	PUNCT
iajs-1064	73	1	lipid	lipid	PROPN
iajs-1064	73	2	disorder	disorder	NOUN
iajs-1064	73	3	have	have	VERB
iajs-1064	73	4	important	important	ADJ
iajs-1064	73	5	role	role	NOUN
iajs-1064	73	6	in	in	ADP
iajs-1064	73	7	atherosclerosis	atherosclerosis	NOUN
iajs-1064	73	8	,	,	PUNCT
iajs-1064	73	9	a	a	DET
iajs-1064	73	10	process	process	NOUN
iajs-1064	73	11	which	which	PRON
iajs-1064	73	12	is	be	AUX
iajs-1064	73	13	accelerated	accelerate	VERB
iajs-1064	73	14	by	by	ADP
iajs-1064	73	15	dysfunction	dysfunction	NOUN
iajs-1064	73	16	characterizing	characterize	VERB
iajs-1064	73	17	ra	ra	PROPN
iajs-1064	73	18	.	.	PUNCT
iajs-1064	74	1	the	the	DET
iajs-1064	74	2	elevation	elevation	NOUN
iajs-1064	74	3	in	in	ADP
iajs-1064	74	4	changed	change	VERB
iajs-1064	74	5	endothelial	endothelial	ADJ
iajs-1064	74	6	cells	cell	NOUN
iajs-1064	74	7	in	in	ADP
iajs-1064	74	8	ra	ra	PROPN
iajs-1064	74	9	patients	patient	NOUN
iajs-1064	74	10	allow	allow	VERB
iajs-1064	74	11	the	the	DET
iajs-1064	74	12	entry	entry	NOUN
iajs-1064	74	13	of	of	ADP
iajs-1064	74	14	ldl	ldl	NOUN
iajs-1064	74	15	,	,	PUNCT
iajs-1064	74	16	which	which	PRON
iajs-1064	74	17	is	be	AUX
iajs-1064	74	18	possess	possess	NOUN
iajs-1064	74	19	in	in	ADP
iajs-1064	74	20	the	the	DET
iajs-1064	74	21	intima	intima	NOUN
iajs-1064	74	22	,	,	PUNCT
iajs-1064	74	23	oxidized	oxidize	VERB
iajs-1064	74	24	with	with	ADP
iajs-1064	74	25	subsequent	subsequent	ADJ
iajs-1064	74	26	recruitment	recruitment	NOUN
iajs-1064	74	27	of	of	ADP
iajs-1064	74	28	circulating	circulate	VERB
iajs-1064	74	29	leukocytes	leukocyte	NOUN
iajs-1064	74	30	within	within	ADP
iajs-1064	74	31	atherosclerotic	atherosclerotic	ADJ
iajs-1064	74	32	plaques[27	plaques[27	PROPN
iajs-1064	74	33	]	]	PUNCT
iajs-1064	74	34	also	also	ADV
iajs-1064	74	35	,	,	PUNCT
iajs-1064	74	36	lowers	lower	VERB
iajs-1064	74	37	in	in	ADP
iajs-1064	74	38	hdl	hdl	PROPN
iajs-1064	74	39	levels	level	NOUN
iajs-1064	74	40	may	may	AUX
iajs-1064	74	41	accelerate	accelerate	VERB
iajs-1064	74	42	atherosclerosis	atherosclerosis	NOUN
iajs-1064	74	43	lead	lead	NOUN
iajs-1064	74	44	to	to	ADP
iajs-1064	74	45	the	the	DET
iajs-1064	74	46	exerting	exert	VERB
iajs-1064	74	47	atheroprotective	atheroprotective	PROPN
iajs-1064	74	48	functions.[28	functions.[28	PROPN
iajs-1064	74	49	]	]	X
iajs-1064	74	50	other	other	ADJ
iajs-1064	74	51	study	study	NOUN
iajs-1064	74	52	,	,	PUNCT
iajs-1064	74	53	demonstrated	demonstrate	VERB
iajs-1064	74	54	that	that	SCONJ
iajs-1064	74	55	tc	tc	NOUN
iajs-1064	74	56	and	and	CCONJ
iajs-1064	74	57	ldl	ldl	NOUN
iajs-1064	74	58	increase	increase	NOUN
iajs-1064	74	59	together	together	ADV
iajs-1064	74	60	in	in	ADP
iajs-1064	74	61	ra	ra	PROPN
iajs-1064	74	62	patients	patient	NOUN
iajs-1064	74	63	with	with	ADP
iajs-1064	74	64	low	low	ADJ
iajs-1064	74	65	levels	level	NOUN
iajs-1064	74	66	of	of	ADP
iajs-1064	74	67	hdl	hdl	PROPN
iajs-1064	74	68	.	.	PUNCT
iajs-1064	75	1	[	[	X
iajs-1064	75	2	29	29	NUM
iajs-1064	75	3	]	]	X
iajs-1064	75	4	an	an	DET
iajs-1064	75	5	elevation	elevation	NOUN
iajs-1064	75	6	in	in	ADP
iajs-1064	75	7	the	the	DET
iajs-1064	75	8	tc	tc	NOUN
iajs-1064	75	9	/	/	SYM
iajs-1064	75	10	hdl	hdl	NOUN
iajs-1064	75	11	ratio	ratio	NOUN
iajs-1064	75	12	,	,	PUNCT
iajs-1064	75	13	which	which	PRON
iajs-1064	75	14	display	display	VERB
iajs-1064	75	15	an	an	DET
iajs-1064	75	16	atherogenic	atherogenic	ADJ
iajs-1064	75	17	index	index	NOUN
iajs-1064	75	18	,	,	PUNCT
iajs-1064	75	19	is	be	AUX
iajs-1064	75	20	a	a	DET
iajs-1064	75	21	signification	signification	NOUN
iajs-1064	75	22	marker	marker	NOUN
iajs-1064	75	23	for	for	ADP
iajs-1064	75	24	heart	heart	NOUN
iajs-1064	75	25	disease[30	disease[30	NOUN
iajs-1064	75	26	]	]	PUNCT
iajs-1064	75	27	in	in	ADP
iajs-1064	75	28	this	this	DET
iajs-1064	75	29	study	study	NOUN
iajs-1064	75	30	,	,	PUNCT
iajs-1064	75	31	the	the	DET
iajs-1064	75	32	ra	ra	PROPN
iajs-1064	75	33	patients	patient	NOUN
iajs-1064	75	34	had	have	VERB
iajs-1064	75	35	an	an	DET
iajs-1064	75	36	atherogenic	atherogenic	ADJ
iajs-1064	75	37	index	index	NOUN
iajs-1064	75	38	,	,	PUNCT
iajs-1064	75	39	indicate	indicate	VERB
iajs-1064	75	40	a	a	DET
iajs-1064	75	41	higher	high	ADJ
iajs-1064	75	42	risk	risk	NOUN
iajs-1064	75	43	of	of	ADP
iajs-1064	75	44	atherosclerosis	atherosclerosis	NOUN
iajs-1064	75	45	.	.	PUNCT
iajs-1064	76	1	thus	thus	ADV
iajs-1064	76	2	,	,	PUNCT
iajs-1064	76	3	it	it	PRON
iajs-1064	76	4	can	can	AUX
iajs-1064	76	5	be	be	AUX
iajs-1064	76	6	inference	inference	NOUN
iajs-1064	76	7	that	that	SCONJ
iajs-1064	76	8	the	the	DET
iajs-1064	76	9	role	role	NOUN
iajs-1064	76	10	of	of	ADP
iajs-1064	76	11	dyslipidaemia	dyslipidaemia	NOUN
iajs-1064	76	12	in	in	ADP
iajs-1064	76	13	the	the	DET
iajs-1064	76	14	pathogenesis	pathogenesis	NOUN
iajs-1064	76	15	of	of	ADP
iajs-1064	76	16	subclinical	subclinical	ADJ
iajs-1064	76	17	atherosclerosis	atherosclerosis	NOUN
iajs-1064	76	18	in	in	ADP
iajs-1064	76	19	ra	ra	PROPN
iajs-1064	76	20	patients	patient	NOUN
iajs-1064	76	21	should	should	AUX
iajs-1064	76	22	be	be	AUX
iajs-1064	76	23	seen	see	VERB
iajs-1064	76	24	in	in	ADP
iajs-1064	76	25	the	the	DET
iajs-1064	76	26	context	context	NOUN
iajs-1064	76	27	of	of	ADP
iajs-1064	76	28	other	other	ADJ
iajs-1064	76	29	operating	operate	VERB
iajs-1064	76	30	mechanisms[19	mechanisms[19	NOUN
iajs-1064	76	31	]	]	PUNCT
iajs-1064	76	32	.	.	PUNCT
iajs-1064	77	1	moreover	moreover	ADV
iajs-1064	77	2	,	,	PUNCT
iajs-1064	77	3	it	it	PRON
iajs-1064	77	4	is	be	AUX
iajs-1064	77	5	potential	potential	ADJ
iajs-1064	77	6	that	that	SCONJ
iajs-1064	77	7	other	other	ADJ
iajs-1064	77	8	fractions	fraction	NOUN
iajs-1064	77	9	of	of	ADP
iajs-1064	77	10	specific	specific	ADJ
iajs-1064	77	11	lipoprotein	lipoprotein	ADJ
iajs-1064	77	12	particles	particle	NOUN
iajs-1064	77	13	as	as	ADP
iajs-1064	77	14	(	(	PUNCT
iajs-1064	77	15	vldl	vldl	NOUN
iajs-1064	77	16	)	)	PUNCT
iajs-1064	77	17	and	and	CCONJ
iajs-1064	77	18	hdl	hdl	PROPN
iajs-1064	77	19	may	may	AUX
iajs-1064	77	20	play	play	VERB
iajs-1064	77	21	a	a	DET
iajs-1064	77	22	important	important	ADJ
iajs-1064	77	23	role	role	NOUN
iajs-1064	77	24	in	in	ADP
iajs-1064	77	25	atherogenesis	atherogenesis	NOUN
iajs-1064	77	26	in	in	ADP
iajs-1064	77	27	ra[31	ra[31	PROPN
iajs-1064	77	28	]	]	PUNCT
iajs-1064	77	29	.	.	PUNCT
iajs-1064	78	1	atherogenesis	atherogenesis	PROPN
iajs-1064	78	2	is	be	AUX
iajs-1064	78	3	accelerated	accelerate	VERB
iajs-1064	78	4	in	in	ADP
iajs-1064	78	5	ra	ra	PROPN
iajs-1064	78	6	patients[13	patients[13	PROPN
iajs-1064	78	7	]	]	PUNCT
iajs-1064	78	8	.and	.and	PUNCT
iajs-1064	79	1	elevation	elevation	NOUN
iajs-1064	79	2	mortality	mortality	NOUN
iajs-1064	79	3	from	from	ADP
iajs-1064	79	4	acute	acute	ADJ
iajs-1064	79	5	cardiovascular	cardiovascular	ADJ
iajs-1064	79	6	events[32	events[32	NOUN
iajs-1064	79	7	]	]	PUNCT
iajs-1064	79	8	.	.	PUNCT
iajs-1064	80	1	chemistry	chemistry	NOUN
iajs-1064	80	2	|	|	ADV
iajs-1064	80	3	110	110	NUM
iajs-1064	80	4	2017عام	2017عام	NUM
iajs-1064	80	5	)	)	PUNCT
iajs-1064	81	1	1(العدد	1(العدد	NUM
iajs-1064	81	2	30مجلة	30مجلة	NUM
iajs-1064	81	3	إبن	إبن	VERB
iajs-1064	81	4	الھيثم	الھيثم	NOUN
iajs-1064	81	5	للعلوم	للعلوم	PROPN
iajs-1064	81	6	الصرفة	الصرفة	PROPN
iajs-1064	81	7	والتطبيقية	والتطبيقية	PRON
iajs-1064	81	8	المجلد	المجلد	VERB
iajs-1064	81	9	ibn	ibn	PROPN
iajs-1064	81	10	al	al	PROPN
iajs-1064	81	11	-	-	PUNCT
iajs-1064	81	12	haitham	haitham	PROPN
iajs-1064	81	13	jour	jour	X
iajs-1064	81	14	.	.	PROPN
iajs-1064	82	1	for	for	ADP
iajs-1064	82	2	pure	pure	ADJ
iajs-1064	82	3	&	&	CCONJ
iajs-1064	82	4	appl	appl	PROPN
iajs-1064	82	5	.	.	PUNCT
iajs-1064	83	1	sci	sci	PROPN
iajs-1064	83	2	.	.	PUNCT
iajs-1064	83	3	vol	vol	NOUN
iajs-1064	83	4	.	.	PROPN
iajs-1064	83	5	30	30	NUM
iajs-1064	83	6	(	(	PUNCT
iajs-1064	83	7	1	1	NUM
iajs-1064	83	8	)	)	PUNCT
iajs-1064	83	9	2017	2017	NUM
iajs-1064	83	10	results	result	NOUN
iajs-1064	83	11	in	in	ADP
iajs-1064	83	12	table	table	NOUN
iajs-1064	83	13	(	(	PUNCT
iajs-1064	83	14	2	2	X
iajs-1064	83	15	)	)	PUNCT
iajs-1064	83	16	showed	show	VERB
iajs-1064	83	17	highly	highly	ADV
iajs-1064	83	18	significant	significant	ADJ
iajs-1064	83	19	increase	increase	NOUN
iajs-1064	83	20	in	in	ADP
iajs-1064	83	21	insulin	insulin	NOUN
iajs-1064	83	22	,	,	PUNCT
iajs-1064	83	23	crp	crp	PROPN
iajs-1064	83	24	,	,	PUNCT
iajs-1064	83	25	visfatin	visfatin	NOUN
iajs-1064	83	26	and	and	CCONJ
iajs-1064	83	27	glp-1	glp-1	NOUN
iajs-1064	83	28	levels	level	NOUN
iajs-1064	83	29	.	.	PUNCT
iajs-1064	84	1	both	both	PRON
iajs-1064	84	2	glp-1(7	glp-1(7	PROPN
iajs-1064	84	3	-	-	PUNCT
iajs-1064	84	4	36	36	NUM
iajs-1064	84	5	)	)	PUNCT
iajs-1064	84	6	amide	amide	NOUN
iajs-1064	84	7	and	and	CCONJ
iajs-1064	84	8	the	the	DET
iajs-1064	84	9	glp-1	glp-1	ADJ
iajs-1064	84	10	receptor	receptor	NOUN
iajs-1064	84	11	agonist	agonist	NOUN
iajs-1064	84	12	,	,	PUNCT
iajs-1064	84	13	exendin-4	exendin-4	PRON
iajs-1064	84	14	are	be	AUX
iajs-1064	84	15	shown	show	VERB
iajs-1064	84	16	to	to	PART
iajs-1064	84	17	increase	increase	VERB
iajs-1064	84	18	heart	heart	NOUN
iajs-1064	84	19	rate	rate	NOUN
iajs-1064	84	20	and	and	CCONJ
iajs-1064	84	21	blood	blood	NOUN
iajs-1064	84	22	pressure	pressure	NOUN
iajs-1064	84	23	in	in	ADP
iajs-1064	84	24	both	both	CCONJ
iajs-1064	84	25	anesthetized	anesthetized	ADJ
iajs-1064	84	26	and	and	CCONJ
iajs-1064	84	27	conscious	conscious	ADJ
iajs-1064	84	28	restrained	restrained	ADJ
iajs-1064	84	29	rats	rat	NOUN
iajs-1064	84	30	,	,	PUNCT
iajs-1064	84	31	although	although	SCONJ
iajs-1064	84	32	the	the	DET
iajs-1064	84	33	mechanisms	mechanism	NOUN
iajs-1064	84	34	are	be	AUX
iajs-1064	84	35	controversial	controversial	ADJ
iajs-1064	84	36	[	[	X
iajs-1064	84	37	33	33	NUM
iajs-1064	84	38	]	]	PUNCT
iajs-1064	84	39	.	.	PUNCT
iajs-1064	85	1	in	in	ADP
iajs-1064	85	2	vitro	vitro	X
iajs-1064	85	3	studies	study	NOUN
iajs-1064	85	4	have	have	AUX
iajs-1064	85	5	failed	fail	VERB
iajs-1064	85	6	to	to	PART
iajs-1064	85	7	show	show	VERB
iajs-1064	85	8	any	any	DET
iajs-1064	85	9	effects	effect	NOUN
iajs-1064	85	10	of	of	ADP
iajs-1064	85	11	glp-1	glp-1	NOUN
iajs-1064	85	12	on	on	ADP
iajs-1064	85	13	cardiac	cardiac	ADJ
iajs-1064	85	14	myocyte	myocyte	NOUN
iajs-1064	85	15	contractility	contractility	NOUN
iajs-1064	85	16	.	.	PUNCT
iajs-1064	86	1	very	very	ADV
iajs-1064	86	2	recently	recently	ADV
iajs-1064	86	3	,	,	PUNCT
iajs-1064	86	4	promising	promise	VERB
iajs-1064	86	5	clinical	clinical	ADJ
iajs-1064	86	6	data	datum	NOUN
iajs-1064	86	7	from	from	ADP
iajs-1064	86	8	shannon	shannon	PROPN
iajs-1064	86	9	’s	’s	PART
iajs-1064	86	10	lab	lab	NOUN
iajs-1064	86	11	showed	show	VERB
iajs-1064	86	12	that	that	SCONJ
iajs-1064	86	13	glp-1	glp-1	VERB
iajs-1064	86	14	infusion	infusion	NOUN
iajs-1064	86	15	improved	improve	VERB
iajs-1064	86	16	regional	regional	ADJ
iajs-1064	86	17	and	and	CCONJ
iajs-1064	86	18	global	global	ADJ
iajs-1064	86	19	function	function	NOUN
iajs-1064	86	20	in	in	ADP
iajs-1064	86	21	patients	patient	NOUN
iajs-1064	86	22	with	with	ADP
iajs-1064	86	23	acute	acute	ADJ
iajs-1064	86	24	myocardial	myocardial	ADJ
iajs-1064	86	25	ischemia	ischemia	NOUN
iajs-1064	86	26	and	and	CCONJ
iajs-1064	86	27	severe	severe	ADJ
iajs-1064	86	28	systolic	systolic	ADJ
iajs-1064	86	29	dysfunction	dysfunction	NOUN
iajs-1064	86	30	after	after	ADP
iajs-1064	86	31	successful	successful	ADJ
iajs-1064	86	32	primary	primary	ADJ
iajs-1064	86	33	angioplasty	angioplasty	NOUN
iajs-1064	86	34	[	[	X
iajs-1064	86	35	34	34	NUM
iajs-1064	86	36	]	]	PUNCT
iajs-1064	86	37	.	.	PUNCT
iajs-1064	87	1	several	several	ADJ
iajs-1064	87	2	animal	animal	NOUN
iajs-1064	87	3	studies	study	NOUN
iajs-1064	87	4	and	and	CCONJ
iajs-1064	87	5	analyses	analysis	NOUN
iajs-1064	87	6	in	in	ADP
iajs-1064	87	7	humans	human	NOUN
iajs-1064	87	8	have	have	AUX
iajs-1064	87	9	demonstrated	demonstrate	VERB
iajs-1064	87	10	a	a	DET
iajs-1064	87	11	potential	potential	ADJ
iajs-1064	87	12	cardioprotective	cardioprotective	ADJ
iajs-1064	87	13	effect	effect	NOUN
iajs-1064	87	14	of	of	ADP
iajs-1064	87	15	glp-1	glp-1	NOUN
iajs-1064	87	16	ras[35	ras[35	PROPN
iajs-1064	87	17	]	]	PUNCT
iajs-1064	87	18	.there	.there	VERB
iajs-1064	87	19	is	be	AUX
iajs-1064	87	20	evidence	evidence	NOUN
iajs-1064	87	21	that	that	SCONJ
iajs-1064	87	22	the	the	DET
iajs-1064	87	23	glp-1	glp-1	ADJ
iajs-1064	87	24	protective	protective	ADJ
iajs-1064	87	25	effect	effect	NOUN
iajs-1064	87	26	on	on	ADP
iajs-1064	87	27	myocardium	myocardium	NOUN
iajs-1064	87	28	may	may	AUX
iajs-1064	87	29	be	be	AUX
iajs-1064	87	30	particularly	particularly	ADV
iajs-1064	87	31	important	important	ADJ
iajs-1064	87	32	in	in	ADP
iajs-1064	87	33	ischemic	ischemic	ADJ
iajs-1064	87	34	conditions	condition	NOUN
iajs-1064	87	35	and	and	CCONJ
iajs-1064	87	36	may	may	AUX
iajs-1064	87	37	also	also	ADV
iajs-1064	87	38	attenuate	attenuate	VERB
iajs-1064	87	39	other	other	ADJ
iajs-1064	87	40	factors	factor	NOUN
iajs-1064	87	41	causing	cause	VERB
iajs-1064	87	42	premature	premature	ADJ
iajs-1064	87	43	atherosclerosis	atherosclerosis	NOUN
iajs-1064	87	44	.	.	PUNCT
iajs-1064	88	1	[	[	X
iajs-1064	88	2	36	36	NUM
iajs-1064	88	3	]	]	PUNCT
iajs-1064	88	4	other	other	ADJ
iajs-1064	88	5	study	study	NOUN
iajs-1064	88	6	demonstrated	demonstrate	VERB
iajs-1064	88	7	when	when	SCONJ
iajs-1064	88	8	glp-1	glp-1	NUM
iajs-1064	88	9	was	be	AUX
iajs-1064	88	10	infused	infuse	VERB
iajs-1064	88	11	into	into	ADP
iajs-1064	88	12	isolated	isolated	ADJ
iajs-1064	88	13	mouse	mouse	NOUN
iajs-1064	88	14	hearts	heart	NOUN
iajs-1064	88	15	,	,	PUNCT
iajs-1064	88	16	cgmp	cgmp	PROPN
iajs-1064	88	17	production	production	NOUN
iajs-1064	88	18	markedly	markedly	ADV
iajs-1064	88	19	increased	increase	VERB
iajs-1064	88	20	compared	compare	VERB
iajs-1064	88	21	with	with	ADP
iajs-1064	88	22	non	non	ADJ
iajs-1064	88	23	treated	treat	VERB
iajs-1064	88	24	hearts	heart	NOUN
iajs-1064	88	25	,	,	PUNCT
iajs-1064	88	26	suggesting	suggest	VERB
iajs-1064	88	27	a	a	DET
iajs-1064	88	28	role	role	NOUN
iajs-1064	88	29	for	for	ADP
iajs-1064	88	30	this	this	DET
iajs-1064	88	31	signaling	signal	VERB
iajs-1064	88	32	pathway	pathway	NOUN
iajs-1064	88	33	in	in	ADP
iajs-1064	88	34	glp-1	glp-1	NOUN
iajs-1064	88	35	activity	activity	NOUN
iajs-1064	88	36	.	.	PUNCT
iajs-1064	89	1	if	if	SCONJ
iajs-1064	89	2	the	the	DET
iajs-1064	89	3	signaling	signal	VERB
iajs-1064	89	4	mechanisms	mechanism	NOUN
iajs-1064	89	5	observed	observe	VERB
iajs-1064	89	6	in	in	ADP
iajs-1064	89	7	pancreatic	pancreatic	ADJ
iajs-1064	89	8	cells	cell	NOUN
iajs-1064	89	9	are	be	AUX
iajs-1064	89	10	stimulated	stimulate	VERB
iajs-1064	89	11	by	by	ADP
iajs-1064	89	12	glp-1	glp-1	NOUN
iajs-1064	89	13	in	in	ADP
iajs-1064	89	14	vascular	vascular	ADJ
iajs-1064	89	15	and	and	CCONJ
iajs-1064	89	16	cardiac	cardiac	ADJ
iajs-1064	89	17	cells	cell	NOUN
iajs-1064	89	18	,	,	PUNCT
iajs-1064	89	19	vascular	vascular	ADJ
iajs-1064	89	20	tone	tone	NOUN
iajs-1064	89	21	,	,	PUNCT
iajs-1064	89	22	muscle	muscle	NOUN
iajs-1064	89	23	contractility	contractility	NOUN
iajs-1064	89	24	,	,	PUNCT
iajs-1064	89	25	cell	cell	NOUN
iajs-1064	89	26	growth	growth	NOUN
iajs-1064	89	27	/	/	SYM
iajs-1064	89	28	differentiation	differentiation	NOUN
iajs-1064	89	29	,	,	PUNCT
iajs-1064	89	30	extracellular	extracellular	ADJ
iajs-1064	89	31	matrix	matrix	NOUN
iajs-1064	89	32	remodeling	remodeling	NOUN
iajs-1064	89	33	,	,	PUNCT
iajs-1064	89	34	and	and	CCONJ
iajs-1064	89	35	apoptosis	apoptosis	NOUN
iajs-1064	89	36	may	may	AUX
iajs-1064	89	37	be	be	AUX
iajs-1064	89	38	affected	affect	VERB
iajs-1064	89	39	.	.	PUNCT
iajs-1064	90	1	[	[	X
iajs-1064	90	2	37	37	NUM
iajs-1064	90	3	]	]	PUNCT
iajs-1064	90	4	.	.	PUNCT
iajs-1064	91	1	determination	determination	NOUN
iajs-1064	91	2	of	of	ADP
iajs-1064	91	3	crp	crp	PROPN
iajs-1064	91	4	and	and	CCONJ
iajs-1064	91	5	esr	esr	PROPN
iajs-1064	91	6	,	,	PUNCT
iajs-1064	91	7	which	which	PRON
iajs-1064	91	8	used	use	VERB
iajs-1064	91	9	as	as	ADP
iajs-1064	91	10	a	a	DET
iajs-1064	91	11	marker	marker	NOUN
iajs-1064	91	12	of	of	ADP
iajs-1064	91	13	inflammation	inflammation	NOUN
iajs-1064	91	14	disease	disease	NOUN
iajs-1064	91	15	have	have	VERB
iajs-1064	91	16	significant	significant	ADJ
iajs-1064	91	17	role	role	NOUN
iajs-1064	91	18	in	in	ADP
iajs-1064	91	19	ra	ra	PROPN
iajs-1064	92	1	[	[	X
iajs-1064	92	2	38	38	NUM
iajs-1064	92	3	]	]	PUNCT
iajs-1064	92	4	.	.	PUNCT
iajs-1064	93	1	these	these	DET
iajs-1064	93	2	results	result	NOUN
iajs-1064	93	3	are	be	AUX
iajs-1064	93	4	in	in	ADP
iajs-1064	93	5	agreement	agreement	NOUN
iajs-1064	93	6	with	with	ADP
iajs-1064	93	7	those	those	PRON
iajs-1064	93	8	of	of	ADP
iajs-1064	93	9	al	al	PROPN
iajs-1064	93	10	-	-	PUNCT
iajs-1064	93	11	mesryet	mesryet	PROPN
iajs-1064	93	12	al	al	PROPN
iajs-1064	93	13	.	.	PUNCT
iajs-1064	94	1	[	[	X
iajs-1064	94	2	39	39	NUM
iajs-1064	94	3	]	]	PUNCT
iajs-1064	94	4	,	,	PUNCT
iajs-1064	94	5	who	who	PRON
iajs-1064	94	6	found	find	VERB
iajs-1064	94	7	that	that	SCONJ
iajs-1064	94	8	crp	crp	PROPN
iajs-1064	94	9	is	be	AUX
iajs-1064	94	10	a	a	DET
iajs-1064	94	11	protein	protein	NOUN
iajs-1064	94	12	produced	produce	VERB
iajs-1064	94	13	in	in	ADP
iajs-1064	94	14	response	response	NOUN
iajs-1064	94	15	to	to	ADP
iajs-1064	94	16	tissue	tissue	NOUN
iajs-1064	94	17	injury	injury	NOUN
iajs-1064	94	18	,	,	PUNCT
iajs-1064	94	19	infection	infection	NOUN
iajs-1064	94	20	,	,	PUNCT
iajs-1064	94	21	and	and	CCONJ
iajs-1064	94	22	inflammation	inflammation	NOUN
iajs-1064	94	23	.	.	PUNCT
iajs-1064	95	1	another	another	DET
iajs-1064	95	2	study	study	NOUN
iajs-1064	95	3	revealed	reveal	VERB
iajs-1064	95	4	that	that	SCONJ
iajs-1064	95	5	increase	increase	VERB
iajs-1064	95	6	visfatin	visfatin	NOUN
iajs-1064	95	7	levels	level	NOUN
iajs-1064	95	8	in	in	ADP
iajs-1064	95	9	ra	ra	PROPN
iajs-1064	95	10	patients	patient	NOUN
iajs-1064	95	11	as	as	ADP
iajs-1064	95	12	a	a	DET
iajs-1064	95	13	result	result	NOUN
iajs-1064	95	14	of	of	ADP
iajs-1064	95	15	alteration	alteration	NOUN
iajs-1064	95	16	in	in	ADP
iajs-1064	95	17	the	the	DET
iajs-1064	95	18	gene	gene	NOUN
iajs-1064	95	19	encoding	encode	VERB
iajs-1064	95	20	visfatin	visfatin	NOUN
iajs-1064	95	21	may	may	AUX
iajs-1064	95	22	be	be	AUX
iajs-1064	95	23	due	due	ADJ
iajs-1064	95	24	to	to	ADP
iajs-1064	95	25	the	the	DET
iajs-1064	95	26	ra	ra	PROPN
iajs-1064	95	27	triggering	trigger	VERB
iajs-1064	95	28	factors	factor	NOUN
iajs-1064	95	29	:	:	PUNCT
iajs-1064	95	30	a	a	DET
iajs-1064	95	31	condition	condition	NOUN
iajs-1064	95	32	that	that	PRON
iajs-1064	95	33	causes	cause	VERB
iajs-1064	95	34	elevation	elevation	NOUN
iajs-1064	95	35	in	in	ADP
iajs-1064	95	36	its	its	PRON
iajs-1064	95	37	production	production	NOUN
iajs-1064	95	38	autonomously	autonomously	ADV
iajs-1064	95	39	independent	independent	ADJ
iajs-1064	95	40	of	of	ADP
iajs-1064	95	41	disease	disease	NOUN
iajs-1064	95	42	activity	activity	NOUN
iajs-1064	95	43	.	.	PUNCT
iajs-1064	96	1	[	[	X
iajs-1064	96	2	40	40	NUM
iajs-1064	96	3	]	]	PUNCT
iajs-1064	96	4	another	another	DET
iajs-1064	96	5	study	study	NOUN
iajs-1064	96	6	demonstrated	demonstrate	VERB
iajs-1064	96	7	that	that	SCONJ
iajs-1064	96	8	visfatin	visfatin	NOUN
iajs-1064	96	9	have	have	VERB
iajs-1064	96	10	a	a	DET
iajs-1064	96	11	critical	critical	ADJ
iajs-1064	96	12	role	role	NOUN
iajs-1064	96	13	in	in	ADP
iajs-1064	96	14	atherogenesis	atherogenesis	NOUN
iajs-1064	96	15	and	and	CCONJ
iajs-1064	96	16	destabilization	destabilization	NOUN
iajs-1064	96	17	of	of	ADP
iajs-1064	96	18	plaque	plaque	NOUN
iajs-1064	96	19	[	[	X
iajs-1064	96	20	41	41	NUM
iajs-1064	96	21	]	]	PUNCT
iajs-1064	96	22	results	result	NOUN
iajs-1064	96	23	in	in	ADP
iajs-1064	96	24	table	table	NOUN
iajs-1064	96	25	(	(	PUNCT
iajs-1064	96	26	3	3	NUM
iajs-1064	96	27	)	)	PUNCT
iajs-1064	96	28	illustrated	illustrate	VERB
iajs-1064	96	29	correlation	correlation	NOUN
iajs-1064	96	30	relation	relation	NOUN
iajs-1064	96	31	data	datum	NOUN
iajs-1064	96	32	and	and	CCONJ
iajs-1064	96	33	t	t	NOUN
iajs-1064	96	34	-	-	PUNCT
iajs-1064	96	35	test	test	NOUN
iajs-1064	96	36	for	for	ADP
iajs-1064	96	37	glp-1	glp-1	VERB
iajs-1064	96	38	with	with	ADP
iajs-1064	96	39	visfatin	visfatin	NOUN
iajs-1064	96	40	,	,	PUNCT
iajs-1064	96	41	crp	crp	PROPN
iajs-1064	96	42	and	and	CCONJ
iajs-1064	96	43	aip	aip	PROPN
iajs-1064	96	44	for	for	ADP
iajs-1064	96	45	g2	g2	PROPN
iajs-1064	96	46	and	and	CCONJ
iajs-1064	96	47	g1	g1	PROPN
iajs-1064	96	48	groups	group	NOUN
iajs-1064	96	49	.	.	PUNCT
iajs-1064	97	1	results	result	NOUN
iajs-1064	97	2	revealed	reveal	VERB
iajs-1064	97	3	highly	highly	ADV
iajs-1064	97	4	significant	significant	ADJ
iajs-1064	97	5	,	,	PUNCT
iajs-1064	97	6	were	be	AUX
iajs-1064	97	7	r=0.035	r=0.035	NOUN
iajs-1064	97	8	for	for	ADP
iajs-1064	97	9	glp-1	glp-1	NOUN
iajs-1064	97	10	with	with	ADP
iajs-1064	97	11	visfatin	visfatin	NOUN
iajs-1064	97	12	for	for	ADP
iajs-1064	97	13	g1	g1	NOUN
iajs-1064	97	14	and	and	CCONJ
iajs-1064	98	1	highly	highly	ADV
iajs-1064	98	2	significant	significant	ADJ
iajs-1064	98	3	,	,	PUNCT
iajs-1064	98	4	r=-0.089	r=-0.089	NOUN
iajs-1064	98	5	for	for	ADP
iajs-1064	98	6	g2	g2	PROPN
iajs-1064	98	7	as	as	SCONJ
iajs-1064	98	8	shown	show	VERB
iajs-1064	98	9	in	in	ADP
iajs-1064	98	10	figure(1	figure(1	NOUN
iajs-1064	98	11	-	-	PUNCT
iajs-1064	98	12	a	a	NOUN
iajs-1064	98	13	)	)	PUNCT
iajs-1064	98	14	and(1	and(1	NOUN
iajs-1064	98	15	-	-	PUNCT
iajs-1064	98	16	b	b	NOUN
iajs-1064	98	17	)	)	PUNCT
iajs-1064	98	18	.	.	PUNCT
iajs-1064	99	1	the	the	DET
iajs-1064	99	2	result	result	NOUN
iajs-1064	99	3	also	also	ADV
iajs-1064	99	4	highly	highly	ADV
iajs-1064	99	5	significant	significant	ADJ
iajs-1064	99	6	,	,	PUNCT
iajs-1064	99	7	r=	r=	ADJ
iajs-1064	99	8	-0.183	-0.183	CCONJ
iajs-1064	99	9	for	for	ADP
iajs-1064	99	10	glp-1	glp-1	NOUN
iajs-1064	99	11	with	with	ADP
iajs-1064	99	12	crp	crp	PROPN
iajs-1064	99	13	for	for	ADP
iajs-1064	99	14	g1	g1	NOUN
iajs-1064	99	15	and	and	CCONJ
iajs-1064	99	16	significant	significant	ADJ
iajs-1064	99	17	,	,	PUNCT
iajs-1064	99	18	r=	r=	ADJ
iajs-1064	99	19	0.043	0.043	NUM
iajs-1064	99	20	for	for	ADP
iajs-1064	99	21	glp-1	glp-1	NOUN
iajs-1064	99	22	with	with	ADP
iajs-1064	99	23	crp	crp	PROPN
iajs-1064	99	24	for	for	ADP
iajs-1064	99	25	g2	g2	PROPN
iajs-1064	99	26	as	as	SCONJ
iajs-1064	99	27	shown	show	VERB
iajs-1064	99	28	in	in	ADP
iajs-1064	99	29	figure(2	figure(2	NOUN
iajs-1064	99	30	-	-	PUNCT
iajs-1064	99	31	a	a	NOUN
iajs-1064	99	32	)	)	PUNCT
iajs-1064	99	33	and	and	CCONJ
iajs-1064	99	34	(	(	PUNCT
iajs-1064	99	35	2	2	NUM
iajs-1064	99	36	-	-	PUNCT
iajs-1064	99	37	b	b	NOUN
iajs-1064	99	38	)	)	PUNCT
iajs-1064	99	39	.	.	PUNCT
iajs-1064	100	1	and	and	CCONJ
iajs-1064	100	2	significant	significant	ADJ
iajs-1064	100	3	,	,	PUNCT
iajs-1064	100	4	r=	r=	ADJ
iajs-1064	100	5	0.056	0.056	NUM
iajs-1064	100	6	for	for	ADP
iajs-1064	100	7	glp-1	glp-1	NOUN
iajs-1064	100	8	with	with	ADP
iajs-1064	100	9	aip	aip	PROPN
iajs-1064	100	10	for	for	ADP
iajs-1064	100	11	g1	g1	PROPN
iajs-1064	100	12	and	and	CCONJ
iajs-1064	100	13	no	no	DET
iajs-1064	100	14	significant	significant	ADJ
iajs-1064	100	15	,	,	PUNCT
iajs-1064	100	16	were	be	AUX
iajs-1064	100	17	r=	r=	ADJ
iajs-1064	100	18	0.042	0.042	NUM
iajs-1064	100	19	for	for	ADP
iajs-1064	100	20	glp-1	glp-1	NOUN
iajs-1064	100	21	with	with	ADP
iajs-1064	100	22	aip	aip	PROPN
iajs-1064	100	23	for	for	ADP
iajs-1064	100	24	g2	g2	PROPN
iajs-1064	100	25	as	as	SCONJ
iajs-1064	100	26	shown	show	VERB
iajs-1064	100	27	in	in	ADP
iajs-1064	100	28	figure	figure	NOUN
iajs-1064	100	29	(	(	PUNCT
iajs-1064	100	30	3	3	NUM
iajs-1064	100	31	-	-	PUNCT
iajs-1064	100	32	a)and	a)and	NOUN
iajs-1064	100	33	(	(	PUNCT
iajs-1064	100	34	3	3	NUM
iajs-1064	100	35	-	-	SYM
iajs-1064	100	36	b	b	NOUN
iajs-1064	100	37	)	)	PUNCT
iajs-1064	100	38	.	.	PUNCT
iajs-1064	101	1	gonzalez	gonzalez	PROPN
iajs-1064	101	2	-	-	PUNCT
iajs-1064	101	3	gay	gay	PROPN
iajs-1064	101	4	et	et	PROPN
iajs-1064	101	5	al	al	PROPN
iajs-1064	101	6	.	.	PUNCT
iajs-1064	102	1	[	[	X
iajs-1064	102	2	40	40	NUM
iajs-1064	102	3	]	]	PUNCT
iajs-1064	102	4	and	and	CCONJ
iajs-1064	102	5	senolt	senolt	NOUN
iajs-1064	102	6	et	et	PROPN
iajs-1064	102	7	al	al	PROPN
iajs-1064	102	8	.	.	PUNCT
iajs-1064	103	1	[	[	X
iajs-1064	103	2	42	42	NUM
iajs-1064	103	3	]	]	PUNCT
iajs-1064	103	4	,	,	PUNCT
iajs-1064	103	5	illustrated	illustrate	VERB
iajs-1064	103	6	that	that	SCONJ
iajs-1064	103	7	visfatin	visfatin	NOUN
iajs-1064	103	8	levels	level	NOUN
iajs-1064	103	9	did	do	AUX
iajs-1064	103	10	not	not	PART
iajs-1064	103	11	correlate	correlate	VERB
iajs-1064	103	12	with	with	ADP
iajs-1064	103	13	bmi	bmi	NOUN
iajs-1064	103	14	,	,	PUNCT
iajs-1064	103	15	age	age	NOUN
iajs-1064	103	16	,	,	PUNCT
iajs-1064	103	17	and	and	CCONJ
iajs-1064	103	18	duration	duration	NOUN
iajs-1064	103	19	of	of	ADP
iajs-1064	103	20	disease	disease	NOUN
iajs-1064	103	21	in	in	ADP
iajs-1064	103	22	patients	patient	NOUN
iajs-1064	103	23	with	with	ADP
iajs-1064	103	24	active	active	ADJ
iajs-1064	103	25	ra	ra	NOUN
iajs-1064	103	26	when	when	SCONJ
iajs-1064	103	27	company	company	NOUN
iajs-1064	103	28	with	with	ADP
iajs-1064	103	29	control	control	NOUN
iajs-1064	103	30	subjects	subject	NOUN
iajs-1064	103	31	which	which	PRON
iajs-1064	103	32	indicate	indicate	VERB
iajs-1064	103	33	that	that	DET
iajs-1064	103	34	adipocytokine	adipocytokine	NOUN
iajs-1064	103	35	production	production	NOUN
iajs-1064	103	36	in	in	ADP
iajs-1064	103	37	ra	ra	PROPN
iajs-1064	103	38	patients	patient	NOUN
iajs-1064	103	39	due	due	ADP
iajs-1064	103	40	to	to	ADP
iajs-1064	103	41	the	the	DET
iajs-1064	103	42	processes	process	NOUN
iajs-1064	103	43	of	of	ADP
iajs-1064	103	44	disease	disease	NOUN
iajs-1064	103	45	part	part	NOUN
iajs-1064	103	46	of	of	ADP
iajs-1064	103	47	the	the	DET
iajs-1064	103	48	inflammation	inflammation	ADJ
iajs-1064	103	49	systemic	systemic	NOUN
iajs-1064	103	50	and	and	CCONJ
iajs-1064	103	51	destruction	destruction	NOUN
iajs-1064	103	52	of	of	ADP
iajs-1064	103	53	bone	bone	NOUN
iajs-1064	103	54	led	lead	VERB
iajs-1064	103	55	to	to	PART
iajs-1064	103	56	suggested	suggest	VERB
iajs-1064	103	57	a	a	DET
iajs-1064	103	58	role	role	NOUN
iajs-1064	103	59	visfatin	visfatin	NOUN
iajs-1064	103	60	in	in	ADP
iajs-1064	103	61	the	the	DET
iajs-1064	103	62	pathogenesis	pathogenesis	NOUN
iajs-1064	103	63	of	of	ADP
iajs-1064	103	64	ra	ra	PROPN
iajs-1064	103	65	.	.	PUNCT
iajs-1064	104	1	the	the	DET
iajs-1064	104	2	current	current	ADJ
iajs-1064	104	3	study	study	NOUN
iajs-1064	104	4	also	also	ADV
iajs-1064	104	5	found	find	VERB
iajs-1064	104	6	that	that	SCONJ
iajs-1064	104	7	there	there	PRON
iajs-1064	104	8	was	be	VERB
iajs-1064	104	9	a	a	DET
iajs-1064	104	10	positive	positive	ADJ
iajs-1064	104	11	correlation	correlation	NOUN
iajs-1064	104	12	between	between	ADP
iajs-1064	104	13	visfatin	visfatin	NOUN
iajs-1064	104	14	and	and	CCONJ
iajs-1064	104	15	both	both	DET
iajs-1064	104	16	crp	crp	PROPN
iajs-1064	104	17	and	and	CCONJ
iajs-1064	104	18	esr	esr	PROPN
iajs-1064	104	19	in	in	ADP
iajs-1064	104	20	ra	ra	PROPN
iajs-1064	104	21	patients	patient	NOUN
iajs-1064	104	22	.	.	PUNCT
iajs-1064	105	1	these	these	DET
iajs-1064	105	2	observation	observation	NOUN
iajs-1064	105	3	are	be	AUX
iajs-1064	105	4	in	in	ADP
iajs-1064	105	5	agreement	agreement	NOUN
iajs-1064	105	6	with	with	ADP
iajs-1064	105	7	other	other	ADJ
iajs-1064	105	8	study	study	NOUN
iajs-1064	105	9	reported	report	VERB
iajs-1064	105	10	that	that	SCONJ
iajs-1064	105	11	visfatin	visfatin	NOUN
iajs-1064	105	12	was	be	AUX
iajs-1064	105	13	correlated	correlate	VERB
iajs-1064	105	14	with	with	ADP
iajs-1064	105	15	(	(	PUNCT
iajs-1064	105	16	crp	crp	PROPN
iajs-1064	105	17	and	and	CCONJ
iajs-1064	105	18	esr	esr	NOUN
iajs-1064	105	19	)	)	PUNCT
iajs-1064	105	20	,	,	PUNCT
iajs-1064	105	21	study	study	NOUN
iajs-1064	105	22	seen	see	VERB
iajs-1064	105	23	that	that	SCONJ
iajs-1064	105	24	visfatin	visfatin	NOUN
iajs-1064	105	25	has	have	VERB
iajs-1064	105	26	a	a	DET
iajs-1064	105	27	catabolic	catabolic	ADJ
iajs-1064	105	28	function	function	NOUN
iajs-1064	105	29	in	in	ADP
iajs-1064	105	30	cartilage	cartilage	NOUN
iajs-1064	105	31	and	and	CCONJ
iajs-1064	105	32	may	may	AUX
iajs-1064	105	33	play	play	VERB
iajs-1064	105	34	significant	significant	ADJ
iajs-1064	105	35	role	role	NOUN
iajs-1064	105	36	in	in	ADP
iajs-1064	105	37	the	the	DET
iajs-1064	105	38	pathophysiology	pathophysiology	NOUN
iajs-1064	105	39	of	of	ADP
iajs-1064	105	40	arthritis	arthritis	NOUN
iajs-1064	105	41	.	.	PUNCT
iajs-1064	106	1	there	there	PRON
iajs-1064	106	2	is	be	VERB
iajs-1064	106	3	proof	proof	NOUN
iajs-1064	106	4	for	for	ADP
iajs-1064	106	5	an	an	DET
iajs-1064	106	6	important	important	ADJ
iajs-1064	106	7	function	function	NOUN
iajs-1064	106	8	of	of	ADP
iajs-1064	106	9	innate	innate	ADJ
iajs-1064	106	10	immunity	immunity	NOUN
iajs-1064	106	11	in	in	ADP
iajs-1064	106	12	the	the	DET
iajs-1064	106	13	pathogenesis	pathogenesis	NOUN
iajs-1064	106	14	of	of	ADP
iajs-1064	106	15	ra	ra	PROPN
iajs-1064	107	1	[	[	X
iajs-1064	107	2	12	12	NUM
iajs-1064	107	3	]	]	PUNCT
iajs-1064	107	4	.	.	PUNCT
iajs-1064	108	1	although	although	SCONJ
iajs-1064	108	2	a	a	DET
iajs-1064	108	3	study	study	NOUN
iajs-1064	108	4	by	by	ADP
iajs-1064	108	5	luk	luk	PROPN
iajs-1064	108	6	et	et	PROPN
iajs-1064	108	7	al	al	PROPN
iajs-1064	108	8	.	.	PUNCT
iajs-1064	109	1	[	[	X
iajs-1064	109	2	43	43	NUM
iajs-1064	109	3	]	]	PUNCT
iajs-1064	109	4	showed	show	VERB
iajs-1064	109	5	that	that	SCONJ
iajs-1064	109	6	visfatin	visfatin	NOUN
iajs-1064	109	7	considered	consider	VERB
iajs-1064	109	8	as	as	ADP
iajs-1064	109	9	a	a	DET
iajs-1064	109	10	novel	novel	ADJ
iajs-1064	109	11	mediator	mediator	NOUN
iajs-1064	109	12	of	of	ADP
iajs-1064	109	13	in	in	ADP
iajs-1064	109	14	nateimmunity	nateimmunity	NOUN
iajs-1064	109	15	,	,	PUNCT
iajs-1064	109	16	which	which	PRON
iajs-1064	109	17	led	lead	VERB
iajs-1064	109	18	to	to	PART
iajs-1064	109	19	improved	improve	VERB
iajs-1064	109	20	that	that	PRON
iajs-1064	109	21	visfatin	visfatin	NOUN
iajs-1064	109	22	is	be	AUX
iajs-1064	109	23	involved	involve	VERB
iajs-1064	109	24	in	in	ADP
iajs-1064	109	25	activity	activity	NOUN
iajs-1064	109	26	of	of	ADP
iajs-1064	109	27	proinflammatory	proinflammatory	NOUN
iajs-1064	109	28	,	,	PUNCT
iajs-1064	109	29	innateimmunity	innateimmunity	NOUN
iajs-1064	109	30	,	,	PUNCT
iajs-1064	109	31	and	and	CCONJ
iajs-1064	109	32	cartilage	cartilage	NOUN
iajs-1064	109	33	-	-	PUNCT
iajs-1064	109	34	catabolic	catabolic	NOUN
iajs-1064	109	35	functions	function	NOUN
iajs-1064	109	36	in	in	ADP
iajs-1064	109	37	the	the	DET
iajs-1064	109	38	processes	process	NOUN
iajs-1064	109	39	of	of	ADP
iajs-1064	109	40	ra	ra	PROPN
iajs-1064	110	1	[	[	X
iajs-1064	110	2	44	44	NUM
iajs-1064	110	3	]	]	PUNCT
iajs-1064	110	4	.	.	PUNCT
iajs-1064	111	1	the	the	DET
iajs-1064	111	2	conclusion	conclusion	NOUN
iajs-1064	111	3	could	could	AUX
iajs-1064	111	4	be	be	AUX
iajs-1064	111	5	drown	drown	VERB
iajs-1064	111	6	from	from	ADP
iajs-1064	111	7	this	this	DET
iajs-1064	111	8	studyglp-1	studyglp-1	NOUN
iajs-1064	111	9	and	and	CCONJ
iajs-1064	111	10	visfatin	visfatin	NOUN
iajs-1064	111	11	plays	play	VERB
iajs-1064	111	12	a	a	DET
iajs-1064	111	13	role	role	NOUN
iajs-1064	111	14	in	in	ADP
iajs-1064	111	15	the	the	DET
iajs-1064	111	16	pathogenesis	pathogenesis	NOUN
iajs-1064	111	17	of	of	ADP
iajs-1064	111	18	ra	ra	PROPN
iajs-1064	111	19	and	and	CCONJ
iajs-1064	111	20	can	can	AUX
iajs-1064	111	21	be	be	AUX
iajs-1064	111	22	considered	consider	VERB
iajs-1064	111	23	as	as	ADP
iajs-1064	111	24	a	a	DET
iajs-1064	111	25	marker	marker	NOUN
iajs-1064	111	26	in	in	ADP
iajs-1064	111	27	ra	ra	PROPN
iajs-1064	111	28	,	,	PUNCT
iajs-1064	111	29	and	and	CCONJ
iajs-1064	111	30	may	may	AUX
iajs-1064	111	31	be	be	AUX
iajs-1064	111	32	used	use	VERB
iajs-1064	111	33	as	as	ADP
iajs-1064	111	34	a	a	DET
iajs-1064	111	35	drug	drug	NOUN
iajs-1064	111	36	in	in	ADP
iajs-1064	111	37	future	future	NOUN
iajs-1064	111	38	for	for	ADP
iajs-1064	111	39	ra	ra	PROPN
iajs-1064	111	40	patients	patient	NOUN
iajs-1064	111	41	.	.	PUNCT
iajs-1064	112	1	chemistry	chemistry	NOUN
iajs-1064	112	2	|	|	ADV
iajs-1064	112	3	111	111	NUM
iajs-1064	112	4	2017عام	2017عام	NUM
iajs-1064	112	5	)	)	PUNCT
iajs-1064	112	6	1(العدد	1(العدد	NUM
iajs-1064	112	7	30مجلة	30مجلة	NUM
iajs-1064	112	8	إبن	إبن	VERB
iajs-1064	112	9	الھيثم	الھيثم	NOUN
iajs-1064	112	10	للعلوم	للعلوم	PROPN
iajs-1064	112	11	الصرفة	الصرفة	PROPN
iajs-1064	112	12	والتطبيقية	والتطبيقية	PRON
iajs-1064	112	13	المجلد	المجلد	VERB
iajs-1064	112	14	ibn	ibn	PROPN
iajs-1064	112	15	al	al	PROPN
iajs-1064	112	16	-	-	PUNCT
iajs-1064	112	17	haitham	haitham	PROPN
iajs-1064	112	18	jour	jour	X
iajs-1064	112	19	.	.	PROPN
iajs-1064	113	1	for	for	ADP
iajs-1064	113	2	pure	pure	ADJ
iajs-1064	113	3	&	&	CCONJ
iajs-1064	113	4	appl	appl	PROPN
iajs-1064	113	5	.	.	PUNCT
iajs-1064	114	1	sci	sci	PROPN
iajs-1064	114	2	.	.	PUNCT
iajs-1064	114	3	vol	vol	NOUN
iajs-1064	114	4	.	.	PROPN
iajs-1064	114	5	30	30	NUM
iajs-1064	114	6	(	(	PUNCT
iajs-1064	114	7	1	1	NUM
iajs-1064	114	8	)	)	PUNCT
iajs-1064	114	9	2017	2017	NUM
iajs-1064	114	10	references	reference	NOUN
iajs-1064	114	11	1nikolaidis	1nikolaidis	NUM
iajs-1064	114	12	,	,	PUNCT
iajs-1064	114	13	la	la	NOUN
iajs-1064	114	14	;	;	PUNCT
iajs-1064	114	15	mankad	mankad	NOUN
iajs-1064	114	16	,	,	PUNCT
iajs-1064	114	17	s	s	PART
iajs-1064	114	18	;	;	PUNCT
iajs-1064	114	19	sokos	sokos	ADV
iajs-1064	114	20	,	,	PUNCT
iajs-1064	114	21	gg	gg	PROPN
iajs-1064	114	22	;	;	PUNCT
iajs-1064	114	23	miske	miske	X
iajs-1064	114	24	,	,	PUNCT
iajs-1064	114	25	g	g	NOUN
iajs-1064	114	26	;	;	PUNCT
iajs-1064	114	27	shah	shah	NOUN
iajs-1064	114	28	,	,	PUNCT
iajs-1064	114	29	a	a	PRON
iajs-1064	114	30	;	;	PUNCT
iajs-1064	114	31	elahi	elahi	NOUN
iajs-1064	114	32	,	,	PUNCT
iajs-1064	114	33	d	d	X
iajs-1064	114	34	;	;	PUNCT
iajs-1064	114	35	shannon	shannon	PROPN
iajs-1064	114	36	,	,	PUNCT
iajs-1064	114	37	rp	rp	NOUN
iajs-1064	114	38	;	;	PUNCT
iajs-1064	114	39	(	(	PUNCT
iajs-1064	114	40	2004	2004	NUM
iajs-1064	114	41	)	)	PUNCT
iajs-1064	114	42	.	.	PUNCT
iajs-1064	115	1	effects	effect	NOUN
iajs-1064	115	2	of	of	ADP
iajs-1064	115	3	glucagon	glucagon	NOUN
iajs-1064	115	4	-	-	PUNCT
iajs-1064	115	5	like	like	ADJ
iajs-1064	115	6	peptide-1	peptide-1	NOUN
iajs-1064	115	7	in	in	ADP
iajs-1064	115	8	patients	patient	NOUN
iajs-1064	115	9	with	with	ADP
iajs-1064	115	10	acute	acute	ADJ
iajs-1064	115	11	myocardialinfarction	myocardialinfarction	NOUN
iajs-1064	115	12	and	and	CCONJ
iajs-1064	115	13	left	leave	VERB
iajs-1064	115	14	ventricular	ventricular	ADJ
iajs-1064	115	15	dysfunction	dysfunction	NOUN
iajs-1064	115	16	after	after	ADP
iajs-1064	115	17	successful	successful	ADJ
iajs-1064	115	18	reperfusion	reperfusion	NOUN
iajs-1064	115	19	.	.	PUNCT
iajs-1064	116	1	circulation	circulation	NOUN
iajs-1064	116	2	,	,	PUNCT
iajs-1064	116	3	109(8):962–965	109(8):962–965	NUM
iajs-1064	116	4	2erdogdu	2erdogdu	NUM
iajs-1064	116	5	,	,	PUNCT
iajs-1064	116	6	o	o	NOUN
iajs-1064	116	7	;	;	PUNCT
iajs-1064	116	8	nathanson	nathanson	PROPN
iajs-1064	116	9	,	,	PUNCT
iajs-1064	116	10	d	d	PROPN
iajs-1064	116	11	;	;	PUNCT
iajs-1064	116	12	sjöholm	sjöholm	PROPN
iajs-1064	116	13	,	,	PUNCT
iajs-1064	116	14	a	a	PRON
iajs-1064	116	15	;	;	PUNCT
iajs-1064	116	16	nyström	nyström	NUM
iajs-1064	116	17	,	,	PUNCT
iajs-1064	116	18	t	t	PROPN
iajs-1064	116	19	;	;	PUNCT
iajs-1064	116	20	zhang	zhang	PROPN
iajs-1064	116	21	,	,	PUNCT
iajs-1064	116	22	q	q	X
iajs-1064	116	23	;	;	PUNCT
iajs-1064	116	24	(	(	PUNCT
iajs-1064	116	25	2010	2010	NUM
iajs-1064	116	26	)	)	PUNCT
iajs-1064	117	1	.exendin-4	.exendin-4	PROPN
iajs-1064	117	2	stimulates	stimulate	VERB
iajs-1064	117	3	proliferation	proliferation	NOUN
iajs-1064	117	4	of	of	ADP
iajs-1064	117	5	human	human	ADJ
iajs-1064	117	6	coronary	coronary	ADJ
iajs-1064	117	7	artery	artery	NOUN
iajs-1064	117	8	endothelial	endothelial	NOUN
iajs-1064	117	9	cells	cell	NOUN
iajs-1064	117	10	through	through	ADP
iajs-1064	117	11	enos-	enos-	ADP
iajs-1064	117	12	,	,	PUNCT
iajs-1064	117	13	pkaand	pkaand	NOUN
iajs-1064	117	14	pi3k	pi3k	NOUN
iajs-1064	117	15	/	/	SYM
iajs-1064	117	16	akt	akt	NOUN
iajs-1064	117	17	-	-	PUNCT
iajs-1064	117	18	dependent	dependent	ADJ
iajs-1064	117	19	pathways	pathway	NOUN
iajs-1064	117	20	and	and	CCONJ
iajs-1064	117	21	requires	require	VERB
iajs-1064	117	22	glp-1	glp-1	PRON
iajs-1064	117	23	receptor	receptor	NOUN
iajs-1064	117	24	.	.	PUNCT
iajs-1064	118	1	mol	mol	ADP
iajs-1064	118	2	cell	cell	NOUN
iajs-1064	118	3	endocrinol	endocrinol	NOUN
iajs-1064	118	4	,	,	PUNCT
iajs-1064	118	5	325:26–35	325:26–35	PROPN
iajs-1064	118	6	3zhao	3zhao	NUM
iajs-1064	118	7	,	,	PUNCT
iajs-1064	118	8	tc.(2013	tc.(2013	PROPN
iajs-1064	118	9	)	)	PUNCT
iajs-1064	118	10	.	.	PUNCT
iajs-1064	119	1	glucagon	glucagon	NOUN
iajs-1064	119	2	-	-	PUNCT
iajs-1064	119	3	like	like	ADJ
iajs-1064	119	4	peptide-1	peptide-1	PROPN
iajs-1064	119	5	(	(	PUNCT
iajs-1064	119	6	glp-1	glp-1	X
iajs-1064	119	7	)	)	PUNCT
iajs-1064	119	8	and	and	CCONJ
iajs-1064	119	9	protective	protective	ADJ
iajs-1064	119	10	effects	effect	NOUN
iajs-1064	119	11	in	in	ADP
iajs-1064	119	12	cardiovascular	cardiovascular	ADJ
iajs-1064	119	13	disease	disease	NOUN
iajs-1064	119	14	:	:	PUNCT
iajs-1064	119	15	a	a	DET
iajs-1064	119	16	new	new	ADJ
iajs-1064	119	17	therapeutic	therapeutic	ADJ
iajs-1064	119	18	approach	approach	NOUN
iajs-1064	119	19	for	for	ADP
iajs-1064	119	20	myocardial	myocardial	ADJ
iajs-1064	119	21	protection	protection	NOUN
iajs-1064	119	22	.	.	PUNCT
iajs-1064	120	1	zhao	zhao	ADJ
iajs-1064	120	2	cardiovascular	cardiovascular	ADJ
iajs-1064	120	3	diabetology	diabetology	NOUN
iajs-1064	120	4	,	,	PUNCT
iajs-1064	120	5	12:90	12:90	NUM
iajs-1064	120	6	.	.	PUNCT
iajs-1064	121	1	4nikolaidis	4nikolaidis	NUM
iajs-1064	121	2	,	,	PUNCT
iajs-1064	121	3	l.	l.	PROPN
iajs-1064	121	4	;	;	PUNCT
iajs-1064	121	5	elahi	elahi	PROPN
iajs-1064	121	6	,	,	PUNCT
iajs-1064	121	7	d.	d.	PROPN
iajs-1064	121	8	;	;	PUNCT
iajs-1064	121	9	shen	shen	PROPN
iajs-1064	121	10	,	,	PUNCT
iajs-1064	121	11	y.	y.	PROPN
iajs-1064	121	12	;	;	PUNCT
iajs-1064	121	13	shannon	shannon	PROPN
iajs-1064	121	14	,	,	PUNCT
iajs-1064	121	15	rp	rp	NOUN
iajs-1064	121	16	:	:	PUNCT
iajs-1064	121	17	(	(	PUNCT
iajs-1064	121	18	2005	2005	NUM
iajs-1064	121	19	)	)	PUNCT
iajs-1064	121	20	active	active	ADJ
iajs-1064	121	21	metabolite	metabolite	NOUN
iajs-1064	121	22	of	of	ADP
iajs-1064	121	23	glp1mediates	glp1mediates	PROPN
iajs-1064	121	24	myocardial	myocardial	ADJ
iajs-1064	121	25	glucose	glucose	NOUN
iajs-1064	121	26	uptake	uptake	ADJ
iajs-1064	121	27	and	and	CCONJ
iajs-1064	121	28	improves	improve	VERB
iajs-1064	121	29	ventricularperformance	ventricularperformance	NOUN
iajs-1064	121	30	in	in	ADP
iajs-1064	121	31	conscious	conscious	ADJ
iajs-1064	121	32	dogs	dog	NOUN
iajs-1064	121	33	with	with	ADP
iajs-1064	121	34	dilated	dilated	ADJ
iajs-1064	121	35	cardiomyopathy	cardiomyopathy	ADJ
iajs-1064	121	36	.	.	PUNCT
iajs-1064	122	1	am	be	AUX
iajs-1064	122	2	jphysiol	jphysiol	NOUN
iajs-1064	122	3	heart	heart	PROPN
iajs-1064	122	4	circ	circ	PROPN
iajs-1064	122	5	physiol	physiol	PROPN
iajs-1064	122	6	,	,	PUNCT
iajs-1064	122	7	289(6):h2401	289(6):h2401	PROPN
iajs-1064	122	8	–	–	PUNCT
iajs-1064	122	9	h2408	h2408	PROPN
iajs-1064	122	10	5meier	5meier	NUM
iajs-1064	122	11	,	,	PUNCT
iajs-1064	122	12	jj	jj	PROPN
iajs-1064	122	13	.	.	PROPN
iajs-1064	122	14	;	;	PUNCT
iajs-1064	123	1	gethmann	gethmann	PROPN
iajs-1064	123	2	,	,	PUNCT
iajs-1064	123	3	a	a	PRON
iajs-1064	123	4	;	;	PUNCT
iajs-1064	123	5	götze	götze	NOUN
iajs-1064	123	6	,	,	PUNCT
iajs-1064	123	7	o	o	INTJ
iajs-1064	123	8	et	et	NOUN
iajs-1064	123	9	al	al	PROPN
iajs-1064	123	10	.	.	PROPN
iajs-1064	123	11	(	(	PUNCT
iajs-1064	123	12	2006	2006	NUM
iajs-1064	123	13	)	)	PUNCT
iajs-1064	123	14	glucagon	glucagon	NOUN
iajs-1064	123	15	-	-	PUNCT
iajs-1064	123	16	like	like	ADJ
iajs-1064	123	17	peptide	peptide	NOUN
iajs-1064	123	18	1	1	NUM
iajs-1064	123	19	abolishes	abolish	VERB
iajs-1064	123	20	the	the	DET
iajs-1064	123	21	postprandial	postprandial	ADJ
iajs-1064	123	22	rise	rise	NOUN
iajs-1064	123	23	in	in	ADP
iajs-1064	123	24	triglyceride	triglyceride	ADJ
iajs-1064	123	25	concentrations	concentration	NOUN
iajs-1064	123	26	and	and	CCONJ
iajs-1064	123	27	lowers	lower	VERB
iajs-1064	123	28	levels	level	NOUN
iajs-1064	123	29	of	of	ADP
iajs-1064	123	30	non	non	ADJ
iajs-1064	123	31	-	-	ADJ
iajs-1064	123	32	esterified	esterify	VERB
iajs-1064	123	33	fatty	fatty	NOUN
iajs-1064	123	34	acids	acid	NOUN
iajs-1064	123	35	in	in	ADP
iajs-1064	123	36	humans	human	NOUN
iajs-1064	123	37	.	.	PUNCT
iajs-1064	124	1	diabetologia;3:452–8	diabetologia;3:452–8	NOUN
iajs-1064	124	2	.	.	PUNCT
iajs-1064	125	1	6ban	6ban	NUM
iajs-1064	125	2	,	,	PUNCT
iajs-1064	125	3	k	k	NOUN
iajs-1064	125	4	;	;	PUNCT
iajs-1064	125	5	noyan	noyan	ADJ
iajs-1064	125	6	-	-	PUNCT
iajs-1064	125	7	ashraf	ashraf	PROPN
iajs-1064	125	8	,	,	PUNCT
iajs-1064	125	9	mh	mh	PROPN
iajs-1064	125	10	;	;	PUNCT
iajs-1064	125	11	hoefer	hoefer	PROPN
iajs-1064	125	12	,	,	PUNCT
iajs-1064	125	13	j	j	PROPN
iajs-1064	125	14	.(2008	.(2008	PROPN
iajs-1064	125	15	)	)	PUNCT
iajs-1064	125	16	.	.	PUNCT
iajs-1064	126	1	cardioprotective	cardioprotective	ADJ
iajs-1064	126	2	and	and	CCONJ
iajs-1064	126	3	vasodilatory	vasodilatory	ADJ
iajs-1064	126	4	actions	action	NOUN
iajs-1064	126	5	of	of	ADP
iajs-1064	126	6	glucagon	glucagon	NOUN
iajs-1064	126	7	-	-	PUNCT
iajs-1064	126	8	like	like	ADJ
iajs-1064	126	9	peptide	peptide	NOUN
iajs-1064	126	10	1	1	NUM
iajs-1064	126	11	receptor	receptor	NOUN
iajs-1064	126	12	are	be	AUX
iajs-1064	126	13	mediated	mediate	VERB
iajs-1064	126	14	through	through	ADP
iajs-1064	126	15	both	both	DET
iajs-1064	126	16	glucagon	glucagon	NOUN
iajs-1064	126	17	-	-	PUNCT
iajs-1064	126	18	like	like	ADJ
iajs-1064	126	19	peptide	peptide	NOUN
iajs-1064	126	20	1receptor	1receptor	NOUN
iajs-1064	126	21	-	-	PUNCT
iajs-1064	126	22	dependent	dependent	ADJ
iajs-1064	126	23	and	and	CCONJ
iajs-1064	126	24	-independent	-independent	ADJ
iajs-1064	126	25	pathways	pathway	NOUN
iajs-1064	126	26	.	.	PUNCT
iajs-1064	127	1	circulation	circulation	NOUN
iajs-1064	127	2	;	;	PUNCT
iajs-1064	127	3	117:2340–50	117:2340–50	NUM
iajs-1064	127	4	7omez	7omez	NUM
iajs-1064	127	5	,	,	PUNCT
iajs-1064	127	6	r.	r.	PROPN
iajs-1064	127	7	g.	g.	PROPN
iajs-1064	127	8	´	´	PROPN
iajs-1064	127	9	;	;	PUNCT
iajs-1064	127	10	conde	conde	PROPN
iajs-1064	127	11	,	,	PUNCT
iajs-1064	127	12	j.	j.	PROPN
iajs-1064	127	13	;	;	PUNCT
iajs-1064	127	14	scotece	scotece	PROPN
iajs-1064	127	15	,	,	PUNCT
iajs-1064	127	16	m.	m.	NOUN
iajs-1064	127	17	;	;	PUNCT
iajs-1064	127	18	g´omez	g´omez	NOUN
iajs-1064	127	19	-	-	PUNCT
iajs-1064	127	20	reino	reino	NOUN
iajs-1064	127	21	,	,	PUNCT
iajs-1064	127	22	j.	j.	PROPN
iajs-1064	127	23	j.	j.	PROPN
iajs-1064	127	24	;	;	PUNCT
iajs-1064	127	25	lago	lago	PROPN
iajs-1064	127	26	,	,	PUNCT
iajs-1064	127	27	f.	f.	PROPN
iajs-1064	127	28	and	and	CCONJ
iajs-1064	127	29	gualillo	gualillo	PROPN
iajs-1064	127	30	,	,	PUNCT
iajs-1064	127	31	o.	o.	PROPN
iajs-1064	127	32	(	(	PUNCT
iajs-1064	127	33	2011	2011	NUM
iajs-1064	127	34	)	)	PUNCT
iajs-1064	127	35	“	"	PUNCT
iajs-1064	127	36	what	what	PRON
iajs-1064	127	37	’s	’	VERB
iajs-1064	127	38	new	new	ADJ
iajs-1064	127	39	in	in	ADP
iajs-1064	127	40	our	our	PRON
iajs-1064	127	41	understanding	understanding	NOUN
iajs-1064	127	42	of	of	ADP
iajs-1064	127	43	therole	therole	NOUN
iajs-1064	127	44	of	of	ADP
iajs-1064	127	45	adipokines	adipokine	NOUN
iajs-1064	127	46	in	in	ADP
iajs-1064	127	47	rheumatic	rheumatic	ADJ
iajs-1064	127	48	diseases	disease	NOUN
iajs-1064	127	49	?	?	PUNCT
iajs-1064	127	50	”	"	PUNCT
iajs-1064	127	51	nature	nature	NOUN
iajs-1064	127	52	reviews	review	VERB
iajs-1064	127	53	rheumatology	rheumatology	NOUN
iajs-1064	127	54	,	,	PUNCT
iajs-1064	127	55	vol	vol	NOUN
iajs-1064	127	56	.	.	PROPN
iajs-1064	128	1	7	7	NUM
iajs-1064	128	2	,	,	PUNCT
iajs-1064	128	3	no	no	INTJ
iajs-1064	128	4	.	.	NOUN
iajs-1064	128	5	9	9	NUM
iajs-1064	128	6	,	,	PUNCT
iajs-1064	128	7	pp	pp	ADJ
iajs-1064	128	8	.	.	PUNCT
iajs-1064	129	1	528–536	528–536	NUM
iajs-1064	129	2	.	.	PUNCT
iajs-1064	130	1	8fukuhara	8fukuhara	NUM
iajs-1064	130	2	,	,	PUNCT
iajs-1064	130	3	a.	a.	NOUN
iajs-1064	130	4	;	;	PUNCT
iajs-1064	130	5	matsuda	matsuda	PROPN
iajs-1064	130	6	.	.	PUNCT
iajs-1064	131	1	m.	m.	NOUN
iajs-1064	131	2	;	;	PUNCT
iajs-1064	131	3	m.	m.	NOUN
iajs-1064	131	4	nishizawa	nishizawa	PROPN
iajs-1064	131	5	,	,	PUNCT
iajs-1064	131	6	et	et	PROPN
iajs-1064	131	7	al	al	PROPN
iajs-1064	131	8	.	.	PUNCT
iajs-1064	132	1	(	(	PUNCT
iajs-1064	132	2	2007	2007	NUM
iajs-1064	132	3	)	)	PUNCT
iajs-1064	132	4	“	"	PUNCT
iajs-1064	132	5	erratum	erratum	NOUN
iajs-1064	132	6	(	(	PUNCT
iajs-1064	132	7	retracted	retracted	ADJ
iajs-1064	132	8	article	article	NOUN
iajs-1064	132	9	):	):	PUNCT
iajs-1064	132	10	visfatin	visfatin	NOUN
iajs-1064	132	11	:	:	PUNCT
iajs-1064	132	12	a	a	DET
iajs-1064	132	13	protein	protein	NOUN
iajs-1064	132	14	secreted	secrete	VERB
iajs-1064	132	15	by	by	ADP
iajs-1064	132	16	visceral	visceral	ADJ
iajs-1064	132	17	fat	fat	NOUN
iajs-1064	132	18	that	that	PRON
iajs-1064	132	19	mimics	mimic	VERB
iajs-1064	132	20	the	the	DET
iajs-1064	132	21	effects	effect	NOUN
iajs-1064	132	22	of	of	ADP
iajs-1064	132	23	insulin	insulin	NOUN
iajs-1064	132	24	,	,	PUNCT
iajs-1064	132	25	”	"	PUNCT
iajs-1064	132	26	science	science	NOUN
iajs-1064	132	27	,	,	PUNCT
iajs-1064	132	28	vol	vol	NOUN
iajs-1064	132	29	.	.	PROPN
iajs-1064	132	30	318	318	NUM
iajs-1064	132	31	,	,	PUNCT
iajs-1064	132	32	no	no	INTJ
iajs-1064	132	33	.	.	NOUN
iajs-1064	132	34	5850	5850	NUM
iajs-1064	132	35	,	,	PUNCT
iajs-1064	132	36	p.	p.	NOUN
iajs-1064	132	37	565	565	NUM
iajs-1064	132	38	.	.	PUNCT
iajs-1064	133	1	9jacques	9jacques	NUM
iajs-1064	133	2	,	,	PUNCT
iajs-1064	133	3	c.	c.	NOUN
iajs-1064	133	4	;	;	PUNCT
iajs-1064	133	5	holzenberger	holzenberger	NOUN
iajs-1064	133	6	,	,	PUNCT
iajs-1064	133	7	m.	m.	NOUN
iajs-1064	133	8	and	and	CCONJ
iajs-1064	133	9	mladenovic	mladenovic	PROPN
iajs-1064	133	10	,	,	PUNCT
iajs-1064	133	11	z.	z.	PROPN
iajs-1064	133	12	et	et	PROPN
iajs-1064	133	13	al	al	PROPN
iajs-1064	133	14	.	.	PROPN
iajs-1064	134	1	(	(	PUNCT
iajs-1064	134	2	2012	2012	NUM
iajs-1064	134	3	)	)	PUNCT
iajs-1064	134	4	“	"	PUNCT
iajs-1064	134	5	proinflammatory	proinflammatory	ADJ
iajs-1064	134	6	actions	action	NOUN
iajs-1064	134	7	of	of	ADP
iajs-1064	134	8	visfatin	visfatin	NOUN
iajs-1064	134	9	/	/	SYM
iajs-1064	134	10	nicotinamide	nicotinamide	NOUN
iajs-1064	134	11	phosphoribosyltransferase	phosphoribosyltransferase	NOUN
iajs-1064	134	12	(	(	PUNCT
iajs-1064	134	13	nampt	nampt	ADJ
iajs-1064	134	14	)	)	PUNCT
iajs-1064	134	15	involve	involve	VERB
iajs-1064	134	16	regulation	regulation	NOUN
iajs-1064	134	17	of	of	ADP
iajs-1064	134	18	insulin	insulin	NOUN
iajs-1064	134	19	signaling	signal	VERB
iajs-1064	134	20	pathway	pathway	NOUN
iajs-1064	134	21	and	and	CCONJ
iajs-1064	134	22	nampt	nampt	ADJ
iajs-1064	134	23	enzymatic	enzymatic	ADJ
iajs-1064	134	24	activity	activity	NOUN
iajs-1064	134	25	,	,	PUNCT
iajs-1064	134	26	”	"	PUNCT
iajs-1064	134	27	journal	journal	NOUN
iajs-1064	134	28	of	of	ADP
iajs-1064	134	29	biological	biological	ADJ
iajs-1064	134	30	chemistry	chemistry	NOUN
iajs-1064	134	31	,	,	PUNCT
iajs-1064	134	32	vol	vol	NOUN
iajs-1064	134	33	.	.	PROPN
iajs-1064	135	1	287	287	NUM
iajs-1064	135	2	,	,	PUNCT
iajs-1064	135	3	no	no	INTJ
iajs-1064	135	4	.	.	NOUN
iajs-1064	135	5	18	18	NUM
iajs-1064	135	6	,	,	PUNCT
iajs-1064	135	7	pp	pp	ADJ
iajs-1064	135	8	.	.	PUNCT
iajs-1064	136	1	15100–15108	15100–15108	NUM
iajs-1064	136	2	..	..	PUNCT
iajs-1064	136	3	10matsui	10matsui	NUM
iajs-1064	136	4	,	,	PUNCT
iajs-1064	136	5	h.	h.	PROPN
iajs-1064	136	6	;	;	PUNCT
iajs-1064	136	7	tsutsumi	tsutsumi	PROPN
iajs-1064	136	8	,	,	PUNCT
iajs-1064	136	9	a.	a.	NOUN
iajs-1064	136	10	;	;	PUNCT
iajs-1064	136	11	sugihara	sugihara	NOUN
iajs-1064	136	12	,	,	PUNCT
iajs-1064	136	13	m.	m.	NOUN
iajs-1064	136	14	et	et	PROPN
iajs-1064	136	15	al	al	PROPN
iajs-1064	136	16	.	.	PROPN
iajs-1064	136	17	(	(	PUNCT
iajs-1064	136	18	2008	2008	NUM
iajs-1064	136	19	)	)	PUNCT
iajs-1064	136	20	“	"	PUNCT
iajs-1064	136	21	visfatin	visfatin	NOUN
iajs-1064	136	22	(	(	PUNCT
iajs-1064	136	23	pre	pre	ADJ
iajs-1064	136	24	-	-	ADJ
iajs-1064	136	25	b	b	ADJ
iajs-1064	136	26	cell	cell	NOUN
iajs-1064	136	27	colonyenhancing	colonyenhancing	NOUN
iajs-1064	136	28	factor	factor	NOUN
iajs-1064	136	29	)	)	PUNCT
iajs-1064	136	30	gene	gene	NOUN
iajs-1064	136	31	expression	expression	NOUN
iajs-1064	136	32	in	in	ADP
iajs-1064	136	33	patients	patient	NOUN
iajs-1064	136	34	with	with	ADP
iajs-1064	136	35	rheumatoid	rheumatoid	NOUN
iajs-1064	136	36	arthritis	arthritis	NOUN
iajs-1064	136	37	,	,	PUNCT
iajs-1064	136	38	”	"	PUNCT
iajs-1064	136	39	annals	annals	NOUN
iajs-1064	136	40	of	of	ADP
iajs-1064	136	41	the	the	DET
iajs-1064	136	42	rheumatic	rheumatic	ADJ
iajs-1064	136	43	diseases	disease	NOUN
iajs-1064	136	44	,	,	PUNCT
iajs-1064	136	45	vol	vol	NOUN
iajs-1064	136	46	.	.	PROPN
iajs-1064	136	47	67	67	NUM
iajs-1064	136	48	,	,	PUNCT
iajs-1064	136	49	no	no	INTJ
iajs-1064	136	50	.	.	NOUN
iajs-1064	136	51	4	4	NUM
iajs-1064	136	52	,	,	PUNCT
iajs-1064	136	53	pp	pp	ADJ
iajs-1064	136	54	.	.	PUNCT
iajs-1064	137	1	571–572	571–572	NUM
iajs-1064	137	2	.	.	NOUN
iajs-1064	137	3	11	11	NUM
iajs-1064	137	4	maradit	maradit	NOUN
iajs-1064	137	5	-	-	PUNCT
iajs-1064	137	6	kremers	kremer	NOUN
iajs-1064	137	7	,	,	PUNCT
iajs-1064	137	8	h.	h.	PROPN
iajs-1064	137	9	;	;	PUNCT
iajs-1064	137	10	crowson	crowson	PROPN
iajs-1064	137	11	,	,	PUNCT
iajs-1064	137	12	cs	cs	PROPN
iajs-1064	137	13	.	.	PROPN
iajs-1064	137	14	;	;	PUNCT
iajs-1064	137	15	nicola	nicola	PROPN
iajs-1064	137	16	,	,	PUNCT
iajs-1064	137	17	pj	pj	PROPN
iajs-1064	137	18	;	;	PUNCT
iajs-1064	137	19	ballman	ballman	NOUN
iajs-1064	137	20	.	.	PUNCT
iajs-1064	138	1	kv	kv	PROPN
iajs-1064	138	2	;	;	PUNCT
iajs-1064	139	1	roger	roger	PROPN
iajs-1064	139	2	.	.	PUNCT
iajs-1064	139	3	sj	sj	PROPN
iajs-1064	139	4	;	;	PUNCT
iajs-1064	139	5	jacobsen	jacobsen	PROPN
iajs-1064	139	6	.	.	PUNCT
iajs-1064	140	1	sj	sj	PROPN
iajs-1064	140	2	.	.	PUNCT
iajs-1064	140	3	et	et	PROPN
iajs-1064	140	4	al	al	PROPN
iajs-1064	140	5	.	.	PROPN
iajs-1064	141	1	(	(	PUNCT
iajs-1064	141	2	2005	2005	NUM
iajs-1064	141	3	)	)	PUNCT
iajs-1064	141	4	.	.	PUNCT
iajs-1064	142	1	increased	increase	VERB
iajs-1064	142	2	unrecognized	unrecognized	ADJ
iajs-1064	142	3	coronary	coronary	ADJ
iajs-1064	142	4	heart	heart	NOUN
iajs-1064	142	5	disease	disease	NOUN
iajs-1064	142	6	and	and	CCONJ
iajs-1064	142	7	sudden	sudden	ADJ
iajs-1064	142	8	deaths	death	NOUN
iajs-1064	142	9	in	in	ADP
iajs-1064	142	10	rheumatoid	rheumatoid	NOUN
iajs-1064	142	11	arthritis	arthritis	NOUN
iajs-1064	142	12	:	:	PUNCT
iajs-1064	142	13	a	a	DET
iajs-1064	142	14	populationbased	populationbase	VERB
iajs-1064	142	15	cohort	cohort	NOUN
iajs-1064	142	16	study	study	NOUN
iajs-1064	142	17	.	.	PUNCT
iajs-1064	143	1	arthritis	arthritis	NOUN
iajs-1064	143	2	rheum;52(2):402–11	rheum;52(2):402–11	NOUN
iajs-1064	143	3	.	.	PUNCT
iajs-1064	144	1	12	12	NUM
iajs-1064	144	2	breland	breland	NOUN
iajs-1064	144	3	,	,	PUNCT
iajs-1064	144	4	um	um	INTJ
iajs-1064	144	5	.	.	PUNCT
iajs-1064	144	6	;	;	PUNCT
iajs-1064	144	7	hollan	hollan	PROPN
iajs-1064	144	8	,	,	PUNCT
iajs-1064	144	9	i.	i.	PROPN
iajs-1064	144	10	;	;	PUNCT
iajs-1064	144	11	saatvedt	saatvedt	PROPN
iajs-1064	144	12	,	,	PUNCT
iajs-1064	144	13	k	k	X
iajs-1064	144	14	;	;	PUNCT
iajs-1064	144	15	almdahl	almdahl	PROPN
iajs-1064	144	16	,	,	PUNCT
iajs-1064	144	17	sm	sm	INTJ
iajs-1064	144	18	;	;	PUNCT
iajs-1064	144	19	dama˚	dama˚	PROPN
iajs-1064	144	20	s.	s.	PROPN
iajs-1064	144	21	jk	jk	PROPN
iajs-1064	144	22	;	;	PUNCT
iajs-1064	144	23	yndestad	yndestad	PROPN
iajs-1064	144	24	.a	.a	PROPN
iajs-1064	144	25	.	.	PUNCT
iajs-1064	145	1	et	et	PROPN
iajs-1064	145	2	al	al	PROPN
iajs-1064	145	3	.	.	PROPN
iajs-1064	146	1	(	(	PUNCT
iajs-1064	146	2	2010	2010	NUM
iajs-1064	146	3	)	)	PUNCT
iajs-1064	146	4	.	.	PUNCT
iajs-1064	147	1	inflammatory	inflammatory	ADJ
iajs-1064	147	2	markers	marker	NOUN
iajs-1064	147	3	in	in	ADP
iajs-1064	147	4	patients	patient	NOUN
iajs-1064	147	5	with	with	ADP
iajs-1064	147	6	coronary	coronary	ADJ
iajs-1064	147	7	artery	artery	NOUN
iajs-1064	147	8	disease	disease	NOUN
iajs-1064	147	9	with	with	ADP
iajs-1064	147	10	and	and	CCONJ
iajs-1064	147	11	without	without	ADP
iajs-1064	147	12	inflammatory	inflammatory	ADJ
iajs-1064	147	13	rheumatic	rheumatic	ADJ
iajs-1064	147	14	disease	disease	NOUN
iajs-1064	147	15	.	.	PUNCT
iajs-1064	148	1	rheumatology	rheumatology	NOUN
iajs-1064	148	2	(	(	PUNCT
iajs-1064	148	3	oxf);49(6):1118–27	oxf);49(6):1118–27	PROPN
iajs-1064	148	4	.	.	PUNCT
iajs-1064	149	1	13bacon	13bacon	PROPN
iajs-1064	149	2	,	,	PUNCT
iajs-1064	149	3	pa	pa	PROPN
iajs-1064	149	4	.	.	PROPN
iajs-1064	149	5	;	;	PUNCT
iajs-1064	149	6	stevens	stevens	PROPN
iajs-1064	149	7	,	,	PUNCT
iajs-1064	149	8	rj	rj	PROPN
iajs-1064	149	9	.	.	PROPN
iajs-1064	149	10	;	;	PUNCT
iajs-1064	150	1	carruthers	carruther	NOUN
iajs-1064	150	2	,	,	PUNCT
iajs-1064	150	3	dm	dm	PROPN
iajs-1064	150	4	.	.	PUNCT
iajs-1064	150	5	;	;	PUNCT
iajs-1064	150	6	young	young	ADJ
iajs-1064	150	7	,	,	PUNCT
iajs-1064	150	8	sp	sp	PROPN
iajs-1064	150	9	.	.	PROPN
iajs-1064	150	10	;	;	PUNCT
iajs-1064	150	11	kitas	kitas	PROPN
iajs-1064	150	12	.	.	PUNCT
iajs-1064	151	1	gd.(2002	gd.(2002	NOUN
iajs-1064	151	2	)	)	PUNCT
iajs-1064	151	3	accelerated	accelerate	VERB
iajs-1064	151	4	atherogenesis	atherogenesis	NOUN
iajs-1064	151	5	in	in	ADP
iajs-1064	151	6	autoimmune	autoimmune	ADJ
iajs-1064	151	7	rheumatic	rheumatic	ADJ
iajs-1064	151	8	diseases	disease	NOUN
iajs-1064	151	9	.	.	PUNCT
iajs-1064	152	1	autoimmun	autoimmun	PROPN
iajs-1064	152	2	rev;1:338–47	rev;1:338–47	NOUN
iajs-1064	152	3	.	.	PUNCT
iajs-1064	153	1	14	14	NUM
iajs-1064	153	2	-	-	PUNCT
iajs-1064	153	3	libby	libby	PROPN
iajs-1064	153	4	,	,	PUNCT
iajs-1064	153	5	p.	p.	NOUN
iajs-1064	153	6	(	(	PUNCT
iajs-1064	153	7	2008	2008	NUM
iajs-1064	153	8	)	)	PUNCT
iajs-1064	153	9	.	.	PUNCT
iajs-1064	154	1	role	role	NOUN
iajs-1064	154	2	of	of	ADP
iajs-1064	154	3	inflammation	inflammation	NOUN
iajs-1064	154	4	in	in	ADP
iajs-1064	154	5	atherosclerosis	atherosclerosis	NOUN
iajs-1064	154	6	associated	associate	VERB
iajs-1064	154	7	with	with	ADP
iajs-1064	154	8	rheumatoid	rheumatoid	NOUN
iajs-1064	154	9	arthritis	arthritis	NOUN
iajs-1064	154	10	.	.	PUNCT
iajs-1064	155	1	am	be	AUX
iajs-1064	155	2	j	j	PROPN
iajs-1064	155	3	med;121(10	med;121(10	PROPN
iajs-1064	155	4	suppl	suppl	PROPN
iajs-1064	155	5	.	.	PROPN
iajs-1064	156	1	1):s21–31	1):s21–31	PROPN
iajs-1064	156	2	15del	15del	PROPN
iajs-1064	156	3	rinco	rinco	PROPN
iajs-1064	156	4	.	.	PUNCT
iajs-1064	157	1	´	´	NOUN
iajs-1064	158	1	n	n	PRON
iajs-1064	158	2	i	i	PRON
iajs-1064	158	3	;	;	PUNCT
iajs-1064	158	4	o’leary	o’leary	PROPN
iajs-1064	158	5	.	.	PUNCT
iajs-1064	159	1	dh	dh	NOUN
iajs-1064	159	2	;	;	PUNCT
iajs-1064	159	3	freeman	freeman	PROPN
iajs-1064	159	4	.	.	PROPN
iajs-1064	160	1	gl	gl	PROPN
iajs-1064	160	2	;	;	PUNCT
iajs-1064	160	3	escalante	escalante	PROPN
iajs-1064	160	4	.	.	PUNCT
iajs-1064	160	5	a.	a.	PROPN
iajs-1064	160	6	(	(	PUNCT
iajs-1064	160	7	2007	2007	NUM
iajs-1064	160	8	)	)	PUNCT
iajs-1064	160	9	acceleration	acceleration	NOUN
iajs-1064	160	10	of	of	ADP
iajs-1064	160	11	atherosclerosis	atherosclerosis	NOUN
iajs-1064	160	12	during	during	ADP
iajs-1064	160	13	the	the	DET
iajs-1064	160	14	course	course	NOUN
iajs-1064	160	15	of	of	ADP
iajs-1064	160	16	rheumatoid	rheumatoid	NOUN
iajs-1064	160	17	arthritis	arthritis	NOUN
iajs-1064	160	18	.	.	PUNCT
iajs-1064	161	1	atherosclerosis;195:354–60	atherosclerosis;195:354–60	PROPN
iajs-1064	161	2	16otsuji	16otsuji	NUM
iajs-1064	161	3	,	,	PUNCT
iajs-1064	161	4	s	s	X
iajs-1064	161	5	;	;	PUNCT
iajs-1064	161	6	shibata	shibata	PROPN
iajs-1064	161	7	,	,	PUNCT
iajs-1064	161	8	h.	h.	PROPN
iajs-1064	161	9	;	;	PUNCT
iajs-1064	161	10	umeda	umeda	PROPN
iajs-1064	161	11	.	.	PROPN
iajs-1064	161	12	m.	m.	PROPN
iajs-1064	161	13	(	(	PUNCT
iajs-1064	161	14	1982	1982	NUM
iajs-1064	161	15	)	)	PUNCT
iajs-1064	161	16	.	.	PUNCT
iajs-1064	162	1	turbidimetric	turbidimetric	ADJ
iajs-1064	162	2	immunoassay	immunoassay	PROPN
iajs-1064	162	3	of	of	ADP
iajs-1064	162	4	serum	serum	PROPN
iajs-1064	162	5	creactive	creactive	ADJ
iajs-1064	162	6	protein	protein	NOUN
iajs-1064	162	7	.	.	PUNCT
iajs-1064	163	1	clin	clin	PROPN
iajs-1064	163	2	chem	chem	PROPN
iajs-1064	163	3	;	;	PUNCT
iajs-1064	163	4	28:2121–2124	28:2121–2124	NUM
iajs-1064	163	5	.	.	PUNCT
iajs-1064	164	1	17winkles	17winkles	NUM
iajs-1064	164	2	,	,	PUNCT
iajs-1064	164	3	jw	jw	PROPN
iajs-1064	164	4	;	;	PUNCT
iajs-1064	164	5	lunec	lunec	PROPN
iajs-1064	164	6	,	,	PUNCT
iajs-1064	164	7	j	j	NOUN
iajs-1064	164	8	;	;	PUNCT
iajs-1064	164	9	gray	gray	ADJ
iajs-1064	164	10	,	,	PUNCT
iajs-1064	164	11	l.	l.	PROPN
iajs-1064	164	12	(	(	PUNCT
iajs-1064	164	13	1989)automated	1989)automate	VERB
iajs-1064	164	14	enhanced	enhanced	ADJ
iajs-1064	164	15	latex	latex	NOUN
iajs-1064	164	16	agglutination	agglutination	PROPN
iajs-1064	164	17	assay	assay	VERB
iajs-1064	164	18	for	for	ADP
iajs-1064	164	19	rf	rf	VERB
iajs-1064	164	20	in	in	ADP
iajs-1064	164	21	serum	serum	NOUN
iajs-1064	164	22	.	.	PUNCT
iajs-1064	165	1	clin	clin	PROPN
iajs-1064	165	2	chem	chem	PROPN
iajs-1064	165	3	;	;	PUNCT
iajs-1064	165	4	35:303–307	35:303–307	NUM
iajs-1064	165	5	.	.	PUNCT
iajs-1064	166	1	chemistry	chemistry	NOUN
iajs-1064	166	2	|	|	ADV
iajs-1064	166	3	112	112	NUM
iajs-1064	166	4	2017عام	2017عام	NUM
iajs-1064	166	5	)	)	PUNCT
iajs-1064	167	1	1(العدد	1(العدد	NUM
iajs-1064	167	2	30مجلة	30مجلة	NUM
iajs-1064	167	3	إبن	إبن	VERB
iajs-1064	167	4	الھيثم	الھيثم	NOUN
iajs-1064	167	5	للعلوم	للعلوم	PROPN
iajs-1064	167	6	الصرفة	الصرفة	PROPN
iajs-1064	167	7	والتطبيقية	والتطبيقية	PRON
iajs-1064	167	8	المجلد	المجلد	VERB
iajs-1064	167	9	ibn	ibn	PROPN
iajs-1064	167	10	al	al	PROPN
iajs-1064	167	11	-	-	PUNCT
iajs-1064	167	12	haitham	haitham	PROPN
iajs-1064	167	13	jour	jour	X
iajs-1064	167	14	.	.	PROPN
iajs-1064	168	1	for	for	ADP
iajs-1064	168	2	pure	pure	ADJ
iajs-1064	168	3	&	&	CCONJ
iajs-1064	168	4	appl	appl	PROPN
iajs-1064	168	5	.	.	PUNCT
iajs-1064	169	1	sci	sci	PROPN
iajs-1064	169	2	.	.	PUNCT
iajs-1064	169	3	vol	vol	NOUN
iajs-1064	169	4	.	.	PROPN
iajs-1064	169	5	30	30	NUM
iajs-1064	169	6	(	(	PUNCT
iajs-1064	169	7	1	1	NUM
iajs-1064	169	8	)	)	PUNCT
iajs-1064	169	9	2017	2017	NUM
iajs-1064	169	10	18prasad	18prasad	NUM
iajs-1064	169	11	,	,	PUNCT
iajs-1064	169	12	sk	sk	PROPN
iajs-1064	169	13	.	.	PUNCT
iajs-1064	170	1	(	(	PUNCT
iajs-1064	170	2	2010).biochemistry	2010).biochemistry	NUM
iajs-1064	170	3	of	of	ADP
iajs-1064	170	4	lipids	lipid	NOUN
iajs-1064	170	5	1st	1st	NOUN
iajs-1064	170	6	.discovery	.discovery	PUNCT
iajs-1064	171	1	publishing	publish	VERB
iajs-1064	171	2	house	house	PROPN
iajs-1064	171	3	pvt	pvt	PROPN
iajs-1064	171	4	.	.	PROPN
iajs-1064	171	5	ltd	ltd	PROPN
iajs-1064	171	6	.	.	PROPN
iajs-1064	172	1	new	new	ADJ
iajs-1064	172	2	delhi-110	delhi-110	NOUN
iajs-1064	172	3	002	002	NUM
iajs-1064	172	4	.	.	PUNCT
iajs-1064	173	1	19montecucco	19montecucco	PROPN
iajs-1064	173	2	,	,	PUNCT
iajs-1064	173	3	f.	f.	PROPN
iajs-1064	173	4	;	;	PUNCT
iajs-1064	173	5	mach	mach	PROPN
iajs-1064	173	6	,	,	PUNCT
iajs-1064	173	7	f.	f.	PROPN
iajs-1064	173	8	;	;	PUNCT
iajs-1064	173	9	(	(	PUNCT
iajs-1064	173	10	2009).common	2009).common	NUM
iajs-1064	173	11	inflammatory	inflammatory	ADJ
iajs-1064	173	12	mediatorsorchestrate	mediatorsorchestrate	ADJ
iajs-1064	173	13	pathophysiological	pathophysiological	ADJ
iajs-1064	173	14	processes	process	NOUN
iajs-1064	173	15	in	in	ADP
iajs-1064	173	16	rheumatoid	rheumatoid	NOUN
iajs-1064	173	17	arthritisand	arthritisand	NOUN
iajs-1064	173	18	atherosclerosis	atherosclerosis	NOUN
iajs-1064	173	19	.	.	PUNCT
iajs-1064	174	1	rheumatology;48:11–22	rheumatology;48:11–22	PROPN
iajs-1064	174	2	.	.	PROPN
iajs-1064	175	1	20fantuzzi	20fantuzzi	NUM
iajs-1064	175	2	,	,	PUNCT
iajs-1064	175	3	g.	g.	PROPN
iajs-1064	175	4	(	(	PUNCT
iajs-1064	175	5	2008	2008	NUM
iajs-1064	175	6	)	)	PUNCT
iajs-1064	175	7	.	.	PUNCT
iajs-1064	176	1	adipose	adipose	ADP
iajs-1064	176	2	tissue	tissue	NOUN
iajs-1064	176	3	,	,	PUNCT
iajs-1064	176	4	adipokines	adipokine	NOUN
iajs-1064	176	5	and	and	CCONJ
iajs-1064	176	6	inflammation	inflammation	NOUN
iajs-1064	176	7	.	.	PUNCT
iajs-1064	177	1	j	j	PROPN
iajs-1064	177	2	body	body	NOUN
iajs-1064	177	3	work	work	NOUN
iajs-1064	177	4	mov	mov	NOUN
iajs-1064	177	5	ther;12(2):121–32	ther;12(2):121–32	NOUN
iajs-1064	177	6	.	.	PUNCT
iajs-1064	178	1	21jian	21jian	X
iajs-1064	178	2	.	.	PUNCT
iajs-1064	179	1	liu	liu	PROPN
iajs-1064	179	2	;	;	PUNCT
iajs-1064	179	3	rui	rui	PROPN
iajs-1064	179	4	-	-	PUNCT
iajs-1064	179	5	kai	kai	PROPN
iajs-1064	179	6	,	,	PUNCT
iajs-1064	179	7	z.	z.	PROPN
iajs-1064	179	8	;	;	PUNCT
iajs-1064	179	9	xue	xue	PROPN
iajs-1064	179	10	-	-	PUNCT
iajs-1064	179	11	fang	fang	PROPN
iajs-1064	179	12	,	,	PUNCT
iajs-1064	179	13	yu	yu	PROPN
iajs-1064	179	14	.	.	PROPN
iajs-1064	179	15	;	;	PUNCT
iajs-1064	179	16	yuan	yuan	PROPN
iajs-1064	179	17	,	,	PUNCT
iajs-1064	179	18	w.	w.	PROPN
iajs-1064	179	19	(	(	PUNCT
iajs-1064	179	20	2008	2008	NUM
iajs-1064	179	21	)	)	PUNCT
iajs-1064	179	22	.	.	PUNCT
iajs-1064	180	1	effects	effect	NOUN
iajs-1064	180	2	of	of	ADP
iajs-1064	180	3	xinfeng	xinfeng	PROPN
iajs-1064	180	4	capsule	capsule	PROPN
iajs-1064	180	5	on	on	ADP
iajs-1064	180	6	platelet	platelet	NOUN
iajs-1064	180	7	parameters	parameter	NOUN
iajs-1064	180	8	,	,	PUNCT
iajs-1064	180	9	p	p	NOUN
iajs-1064	180	10	-	-	PUNCT
iajs-1064	180	11	select	select	ADJ
iajs-1064	180	12	,	,	PUNCT
iajs-1064	180	13	platelet	platelet	NOUN
iajs-1064	180	14	ultra	ultra	ADJ
iajs-1064	180	15	-	-	ADJ
iajs-1064	180	16	structure	structure	NOUN
iajs-1064	180	17	and	and	CCONJ
iajs-1064	180	18	its	its	PRON
iajs-1064	180	19	therapeutic	therapeutic	ADJ
iajs-1064	180	20	effect	effect	NOUN
iajs-1064	180	21	on	on	ADP
iajs-1064	180	22	rheumatoid	rheumatoid	NOUN
iajs-1064	180	23	arthritis	arthritis	NOUN
iajs-1064	180	24	patients	patient	NOUN
iajs-1064	180	25	in	in	ADP
iajs-1064	180	26	active	active	ADJ
iajs-1064	180	27	phase	phase	NOUN
iajs-1064	180	28	.	.	PUNCT
iajs-1064	181	1	china	china	PROPN
iajs-1064	181	2	j	j	PROPN
iajs-1064	181	3	chinese	chinese	PROPN
iajs-1064	181	4	med;12–16	med;12–16	PROPN
iajs-1064	181	5	.	.	PUNCT
iajs-1064	182	1	22nalesnik	22nalesnik	NUM
iajs-1064	182	2	,	,	PUNCT
iajs-1064	182	3	m.	m.	NOUN
iajs-1064	182	4	;	;	PUNCT
iajs-1064	182	5	nikolic	nikolic	PROPN
iajs-1064	182	6	.	.	PUNCT
iajs-1064	183	1	´	´	PROPN
iajs-1064	184	1	jm	jm	PROPN
iajs-1064	184	2	;	;	PUNCT
iajs-1064	184	3	jandric	jandric	PROPN
iajs-1064	184	4	,	,	PUNCT
iajs-1064	184	5	s.	s.	PROPN
iajs-1064	184	6	(	(	PUNCT
iajs-1064	184	7	2010	2010	NUM
iajs-1064	184	8	)	)	PUNCT
iajs-1064	184	9	ada	ada	PROPN
iajs-1064	184	10	and	and	CCONJ
iajs-1064	184	11	crp	crp	PROPN
iajs-1064	184	12	in	in	ADP
iajs-1064	184	13	diagnosing	diagnose	VERB
iajs-1064	184	14	and	and	CCONJ
iajs-1064	184	15	monitoring	monitoring	NOUN
iajs-1064	184	16	of	of	ADP
iajs-1064	184	17	ra	ra	PROPN
iajs-1064	184	18	.	.	PUNCT
iajs-1064	184	19	med	med	PROPN
iajs-1064	184	20	glas	glas	PROPN
iajs-1064	184	21	ljek	ljek	PROPN
iajs-1064	184	22	komore	komore	NOUN
iajs-1064	184	23	zenicko	zenicko	NOUN
iajs-1064	184	24	-	-	PUNCT
iajs-1064	184	25	doboj	doboj	NOUN
iajs-1064	184	26	kantona	kantona	NOUN
iajs-1064	184	27	2011	2011	NUM
iajs-1064	184	28	;	;	PUNCT
iajs-1064	184	29	8:163–168	8:163–168	NUM
iajs-1064	184	30	23singh	23singh	NUM
iajs-1064	184	31	,	,	PUNCT
iajs-1064	184	32	u.	u.	PROPN
iajs-1064	184	33	(	(	PUNCT
iajs-1064	184	34	2010	2010	NUM
iajs-1064	184	35	)	)	PUNCT
iajs-1064	184	36	is	be	AUX
iajs-1064	184	37	rheumatoid	rheumatoid	NOUN
iajs-1064	184	38	factor	factor	NOUN
iajs-1064	184	39	still	still	ADV
iajs-1064	184	40	a	a	DET
iajs-1064	184	41	superior	superior	ADJ
iajs-1064	184	42	test	test	NOUN
iajs-1064	184	43	for	for	ADP
iajs-1064	184	44	the	the	DET
iajs-1064	184	45	diagnosis	diagnosis	NOUN
iajs-1064	184	46	of	of	ADP
iajs-1064	184	47	ra	ra	PROPN
iajs-1064	184	48	?	?	PUNCT
iajs-1064	185	1	rheumatol	rheumatol	PROPN
iajs-1064	185	2	int	int	NOUN
iajs-1064	185	3	;	;	PUNCT
iajs-1064	185	4	30:1115–1119	30:1115–1119	NUM
iajs-1064	185	5	.	.	PUNCT
iajs-1064	185	6	24novikov	24novikov	NUM
iajs-1064	185	7	,	,	PUNCT
iajs-1064	185	8	.aa	.aa	PUNCT
iajs-1064	185	9	;	;	PUNCT
iajs-1064	185	10	aleksandrova	aleksandrova	X
iajs-1064	185	11	,	,	PUNCT
iajs-1064	185	12	en	en	X
iajs-1064	185	13	;	;	PUNCT
iajs-1064	185	14	karateev	karateev	NOUN
iajs-1064	185	15	,	,	PUNCT
iajs-1064	185	16	.de	.de	NUM
iajs-1064	185	17	;	;	PUNCT
iajs-1064	185	18	luchikhina	luchikhina	PROPN
iajs-1064	185	19	,	,	PUNCT
iajs-1064	185	20	el	el	PROPN
iajs-1064	185	21	;	;	PUNCT
iajs-1064	185	22	demidova	demidova	PROPN
iajs-1064	185	23	.	.	PUNCT
iajs-1064	186	1	nv	nv	PROPN
iajs-1064	186	2	;	;	PUNCT
iajs-1064	186	3	cherkasova	cherkasova	X
iajs-1064	186	4	.	.	PUNCT
iajs-1064	187	1	mv.et	mv.et	PROPN
iajs-1064	187	2	al	al	PROPN
iajs-1064	187	3	.	.	PUNCT
iajs-1064	187	4	(	(	PUNCT
iajs-1064	187	5	2008	2008	NUM
iajs-1064	187	6	)	)	PUNCT
iajs-1064	187	7	.	.	PUNCT
iajs-1064	188	1	diagnostic	diagnostic	ADJ
iajs-1064	188	2	value	value	NOUN
iajs-1064	188	3	of	of	ADP
iajs-1064	188	4	antibodies	antibody	NOUN
iajs-1064	188	5	to	to	ADP
iajs-1064	188	6	modified	modify	VERB
iajs-1064	188	7	citrullinizedvimentin	citrullinizedvimentin	NOUN
iajs-1064	188	8	in	in	ADP
iajs-1064	188	9	early	early	ADJ
iajs-1064	188	10	rheumatoid	rheumatoid	NOUN
iajs-1064	188	11	arthritis	arthritis	NOUN
iajs-1064	188	12	.	.	PUNCT
iajs-1064	189	1	klin	klin	PROPN
iajs-1064	189	2	lab	lab	PROPN
iajs-1064	189	3	diagn	diagn	NOUN
iajs-1064	189	4	;	;	PUNCT
iajs-1064	189	5	27–29	27–29	NUM
iajs-1064	189	6	25khalifa	25khalifa	NUM
iajs-1064	189	7	,	,	PUNCT
iajs-1064	189	8	aim	aim	NOUN
iajs-1064	189	9	.	.	PUNCT
iajs-1064	189	10	;	;	PUNCT
iajs-1064	190	1	abdelfattah	abdelfattah	PROPN
iajs-1064	190	2	,	,	PUNCT
iajs-1064	190	3	a.	a.	NOUN
iajs-1064	190	4	.	.	PUNCT
iajs-1064	191	1	(	(	PUNCT
iajs-1064	191	2	2008)anti	2008)anti	NUM
iajs-1064	191	3	ccp2	ccp2	NOUN
iajs-1064	191	4	and	and	CCONJ
iajs-1064	191	5	anti	anti	ADJ
iajs-1064	191	6	keratin	keratin	NOUN
iajs-1064	191	7	antibodies	antibodie	VERB
iajs-1064	191	8	in	in	ADP
iajs-1064	191	9	patientswith	patientswith	PROPN
iajs-1064	191	10	ra	ra	PROPN
iajs-1064	191	11	and	and	CCONJ
iajs-1064	191	12	oa	oa	INTJ
iajs-1064	191	13	.	.	PUNCT
iajs-1064	191	14	egyptian	egyptian	ADJ
iajs-1064	191	15	soc	soc	PROPN
iajs-1064	191	16	rheumatol	rheumatol	NOUN
iajs-1064	191	17	rehabil	rehabil	PROPN
iajs-1064	191	18	;	;	PUNCT
iajs-1064	191	19	35:1–10	35:1–10	NUM
iajs-1064	191	20	.	.	PUNCT
iajs-1064	192	1	26	26	NUM
iajs-1064	192	2	hui	hui	PROPN
iajs-1064	192	3	,	,	PUNCT
iajs-1064	192	4	l.	l.	PROPN
iajs-1064	192	5	;	;	PUNCT
iajs-1064	192	6	wuqi	wuqi	PROPN
iajs-1064	192	7	,	,	PUNCT
iajs-1064	192	8	s.	s.	PROPN
iajs-1064	192	9	;	;	PUNCT
iajs-1064	192	10	yang	yang	PROPN
iajs-1064	192	11	,	,	PUNCT
iajs-1064	192	12	l.	l.	PROPN
iajs-1064	192	13	(	(	PUNCT
iajs-1064	192	14	2010	2010	NUM
iajs-1064	192	15	)	)	PUNCT
iajs-1064	192	16	.diagnostic	.diagnostic	ADJ
iajs-1064	192	17	value	value	NOUN
iajs-1064	192	18	of	of	ADP
iajs-1064	192	19	anti	anti	ADJ
iajs-1064	192	20	-	-	ADJ
iajs-1064	192	21	ccp	ccp	PROPN
iajs-1064	192	22	antibodies	antibodie	VERB
iajs-1064	192	23	in	in	ADP
iajs-1064	192	24	northern	northern	ADJ
iajs-1064	192	25	chinese	chinese	ADJ
iajs-1064	192	26	han	han	PROPN
iajs-1064	192	27	patients	patient	NOUN
iajs-1064	192	28	with	with	ADP
iajs-1064	192	29	ra	ra	PROPN
iajs-1064	192	30	and	and	CCONJ
iajs-1064	192	31	its	its	PRON
iajs-1064	192	32	correlation	correlation	NOUN
iajs-1064	192	33	with	with	ADP
iajs-1064	192	34	disease	disease	NOUN
iajs-1064	192	35	activity	activity	NOUN
iajs-1064	192	36	.	.	PUNCT
iajs-1064	193	1	clin	clin	PROPN
iajs-1064	193	2	rheumatol	rheumatol	NOUN
iajs-1064	193	3	;	;	PUNCT
iajs-1064	193	4	29:413–417	29:413–417	PROPN
iajs-1064	193	5	27hahn	27hahn	NUM
iajs-1064	193	6	,	,	PUNCT
iajs-1064	193	7	bh	bh	NOUN
iajs-1064	193	8	.	.	PROPN
iajs-1064	193	9	;	;	PUNCT
iajs-1064	193	10	grossman	grossman	PROPN
iajs-1064	193	11	,	,	PUNCT
iajs-1064	193	12	j.	j.	PROPN
iajs-1064	193	13	;	;	PUNCT
iajs-1064	193	14	chen	chen	PROPN
iajs-1064	193	15	,	,	PUNCT
iajs-1064	193	16	w.	w.	PROPN
iajs-1064	193	17	;	;	PUNCT
iajs-1064	193	18	mcmahon	mcmahon	PROPN
iajs-1064	193	19	,	,	PUNCT
iajs-1064	193	20	m.	m.	NOUN
iajs-1064	193	21	(	(	PUNCT
iajs-1064	193	22	2007	2007	NUM
iajs-1064	193	23	)	)	PUNCT
iajs-1064	193	24	.	.	PUNCT
iajs-1064	194	1	the	the	DET
iajs-1064	194	2	pathogenesis	pathogenesis	NOUN
iajs-1064	194	3	of	of	ADP
iajs-1064	194	4	atherosclerosis	atherosclerosis	NOUN
iajs-1064	194	5	in	in	ADP
iajs-1064	194	6	autoimmune	autoimmune	ADJ
iajs-1064	194	7	rheumatic	rheumatic	ADJ
iajs-1064	194	8	diseases	disease	NOUN
iajs-1064	194	9	:	:	PUNCT
iajs-1064	194	10	roles	role	NOUN
iajs-1064	194	11	of	of	ADP
iajs-1064	194	12	inflammation	inflammation	NOUN
iajs-1064	194	13	and	and	CCONJ
iajs-1064	194	14	dyslipidemia	dyslipidemia	NOUN
iajs-1064	194	15	.	.	PUNCT
iajs-1064	195	1	j	j	PROPN
iajs-1064	195	2	autoimmun;28:69–75	autoimmun;28:69–75	PROPN
iajs-1064	195	3	.	.	PROPN
iajs-1064	196	1	28hansson	28hansson	NUM
iajs-1064	196	2	,	,	PUNCT
iajs-1064	196	3	gk	gk	PROPN
iajs-1064	196	4	.	.	PROPN
iajs-1064	196	5	;	;	PUNCT
iajs-1064	197	1	libby	libby	PROPN
iajs-1064	197	2	,	,	PUNCT
iajs-1064	197	3	p.	p.	NOUN
iajs-1064	197	4	(	(	PUNCT
iajs-1064	197	5	2006	2006	NUM
iajs-1064	197	6	)	)	PUNCT
iajs-1064	197	7	.	.	PUNCT
iajs-1064	198	1	the	the	DET
iajs-1064	198	2	immune	immune	ADJ
iajs-1064	198	3	response	response	NOUN
iajs-1064	198	4	in	in	ADP
iajs-1064	198	5	atherosclerosis	atherosclerosis	NOUN
iajs-1064	198	6	:	:	PUNCT
iajs-1064	198	7	adouble	adouble	ADJ
iajs-1064	198	8	-	-	PUNCT
iajs-1064	198	9	edged	edge	VERB
iajs-1064	198	10	sword	sword	NOUN
iajs-1064	198	11	.	.	PUNCT
iajs-1064	199	1	nat	nat	PROPN
iajs-1064	199	2	rev	rev	PROPN
iajs-1064	199	3	immunol;6:508–19	immunol;6:508–19	PROPN
iajs-1064	199	4	.	.	PUNCT
iajs-1064	200	1	29gotto	29gotto	NUM
iajs-1064	200	2	,	,	PUNCT
iajs-1064	200	3	jr	jr	PROPN
iajs-1064	200	4	.	.	PROPN
iajs-1064	200	5	am	be	AUX
iajs-1064	200	6	.	.	PUNCT
iajs-1064	201	1	(	(	PUNCT
iajs-1064	201	2	2001	2001	NUM
iajs-1064	201	3	)	)	PUNCT
iajs-1064	201	4	.	.	PUNCT
iajs-1064	202	1	low	low	ADJ
iajs-1064	202	2	high	high	ADJ
iajs-1064	202	3	-	-	PUNCT
iajs-1064	202	4	density	density	NOUN
iajs-1064	202	5	lipoprotein	lipoprotein	ADJ
iajs-1064	202	6	cholesterol	cholesterol	NOUN
iajs-1064	202	7	as	as	ADP
iajs-1064	202	8	a	a	DET
iajs-1064	202	9	risk	risk	NOUN
iajs-1064	202	10	factor	factor	NOUN
iajs-1064	202	11	in	in	ADP
iajs-1064	202	12	coronary	coronary	ADJ
iajs-1064	202	13	heart	heart	NOUN
iajs-1064	202	14	disease	disease	NOUN
iajs-1064	202	15	:	:	PUNCT
iajs-1064	202	16	a	a	DET
iajs-1064	202	17	working	work	VERB
iajs-1064	202	18	group	group	NOUN
iajs-1064	202	19	report	report	NOUN
iajs-1064	202	20	.	.	PUNCT
iajs-1064	203	1	circulation;103:2213–8	circulation;103:2213–8	NOUN
iajs-1064	203	2	.	.	PUNCT
iajs-1064	204	1	30georgiadis	30georgiadis	NUM
iajs-1064	204	2	,	,	PUNCT
iajs-1064	204	3	an	an	PRON
iajs-1064	204	4	.	.	NOUN
iajs-1064	204	5	;	;	PUNCT
iajs-1064	204	6	papavasiliou	papavasiliou	NOUN
iajs-1064	204	7	,	,	PUNCT
iajs-1064	204	8	ec	ec	PROPN
iajs-1064	204	9	.	.	PUNCT
iajs-1064	204	10	;	;	PUNCT
iajs-1064	204	11	lourida	lourida	PROPN
iajs-1064	204	12	,	,	PUNCT
iajs-1064	204	13	es	es	ADP
iajs-1064	204	14	;	;	PUNCT
iajs-1064	204	15	alamanos	alamano	NOUN
iajs-1064	204	16	.	.	PUNCT
iajs-1064	205	1	y	y	NOUN
iajs-1064	205	2	;	;	PUNCT
iajs-1064	205	3	kostara	kostara	ADV
iajs-1064	205	4	.	.	PUNCT
iajs-1064	206	1	c	c	X
iajs-1064	206	2	;	;	PUNCT
iajs-1064	206	3	tselepis	tselepis	NOUN
iajs-1064	206	4	.ad.et	.ad.et	PUNCT
iajs-1064	207	1	al	al	PROPN
iajs-1064	207	2	.	.	PROPN
iajs-1064	207	3	(	(	PUNCT
iajs-1064	207	4	2006	2006	NUM
iajs-1064	207	5	)	)	PUNCT
iajs-1064	207	6	.	.	PUNCT
iajs-1064	208	1	atherogenic	atherogenic	ADJ
iajs-1064	208	2	lipid	lipid	NOUN
iajs-1064	208	3	profile	profile	NOUN
iajs-1064	208	4	is	be	AUX
iajs-1064	208	5	afeature	afeature	ADJ
iajs-1064	208	6	characteristic	characteristic	ADJ
iajs-1064	208	7	of	of	ADP
iajs-1064	208	8	patients	patient	NOUN
iajs-1064	208	9	with	with	ADP
iajs-1064	208	10	early	early	ADJ
iajs-1064	208	11	rheumatoid	rheumatoid	NOUN
iajs-1064	208	12	arthritis	arthritis	NOUN
iajs-1064	208	13	:	:	PUNCT
iajs-1064	208	14	effect	effect	NOUN
iajs-1064	208	15	of	of	ADP
iajs-1064	208	16	early	early	ADJ
iajs-1064	208	17	treatment	treatment	NOUN
iajs-1064	208	18	–	–	PUNCT
iajs-1064	208	19	a	a	DET
iajs-1064	208	20	prospective	prospective	ADJ
iajs-1064	208	21	,	,	PUNCT
iajs-1064	208	22	controlled	control	VERB
iajs-1064	208	23	study	study	NOUN
iajs-1064	208	24	.	.	PUNCT
iajs-1064	209	1	arthritisres	arthritisre	NOUN
iajs-1064	209	2	ther;8(3):r82	ther;8(3):r82	PROPN
iajs-1064	209	3	.	.	PUNCT
iajs-1064	210	1	30boers	30boer	NOUN
iajs-1064	210	2	,	,	PUNCT
iajs-1064	210	3	m.	m.	NOUN
iajs-1064	210	4	;	;	PUNCT
iajs-1064	210	5	nurmohamed	nurmohame	VERB
iajs-1064	210	6	,	,	PUNCT
iajs-1064	210	7	mt	mt	PROPN
iajs-1064	210	8	.	.	PROPN
iajs-1064	210	9	;	;	PUNCT
iajs-1064	210	10	doelman	doelman	NOUN
iajs-1064	210	11	,	,	PUNCT
iajs-1064	210	12	cj	cj	PROPN
iajs-1064	210	13	.	.	PUNCT
iajs-1064	210	14	;	;	PUNCT
iajs-1064	210	15	,	,	PUNCT
iajs-1064	210	16	lard	lard	NOUN
iajs-1064	210	17	,	,	PUNCT
iajs-1064	210	18	lr	lr	PROPN
iajs-1064	210	19	.	.	PROPN
iajs-1064	210	20	;	;	PUNCT
iajs-1064	210	21	verhoeven	verhoeven	PROPN
iajs-1064	210	22	,	,	PUNCT
iajs-1064	210	23	ae	ae	PROPN
iajs-1064	210	24	.	.	PUNCT
iajs-1064	210	25	;	;	PUNCT
iajs-1064	210	26	voskuyl	voskuyl	NOUN
iajs-1064	210	27	,	,	PUNCT
iajs-1064	210	28	ae	ae	PROPN
iajs-1064	210	29	.	.	PUNCT
iajs-1064	210	30	et	et	PROPN
iajs-1064	211	1	al	al	PROPN
iajs-1064	211	2	.	.	PROPN
iajs-1064	211	3	(	(	PUNCT
iajs-1064	211	4	2003	2003	NUM
iajs-1064	211	5	)	)	PUNCT
iajs-1064	211	6	.	.	PUNCT
iajs-1064	212	1	influence	influence	NOUN
iajs-1064	212	2	of	of	ADP
iajs-1064	212	3	glucocorticoid	glucocorticoid	ADJ
iajs-1064	212	4	and	and	CCONJ
iajs-1064	212	5	disease	disease	NOUN
iajs-1064	212	6	activity	activity	NOUN
iajs-1064	212	7	on	on	ADP
iajs-1064	212	8	total	total	ADJ
iajs-1064	212	9	and	and	CCONJ
iajs-1064	212	10	high	high	ADJ
iajs-1064	212	11	density	density	NOUN
iajs-1064	212	12	lipoprotein	lipoprotein	ADJ
iajs-1064	212	13	cholesterol	cholesterol	NOUN
iajs-1064	212	14	in	in	ADP
iajs-1064	212	15	patients	patient	NOUN
iajs-1064	212	16	with	with	ADP
iajs-1064	212	17	rheumatoid	rheumatoid	NOUN
iajs-1064	212	18	arthritis	arthritis	NOUN
iajs-1064	212	19	.	.	PUNCT
iajs-1064	213	1	ann	ann	PROPN
iajs-1064	213	2	rheum	rheum	PROPN
iajs-1064	213	3	dis;62:842–5	dis;62:842–5	PROPN
iajs-1064	213	4	.	.	PUNCT
iajs-1064	214	1	31linsel	31linsel	NUM
iajs-1064	214	2	-	-	PUNCT
iajs-1064	214	3	nitschke	nitschke	NOUN
iajs-1064	214	4	,	,	PUNCT
iajs-1064	214	5	p.	p.	NOUN
iajs-1064	214	6	;	;	PUNCT
iajs-1064	214	7	samani	samani	PROPN
iajs-1064	214	8	,	,	PUNCT
iajs-1064	214	9	nj	nj	PROPN
iajs-1064	214	10	.	.	PUNCT
iajs-1064	214	11	;	;	PUNCT
iajs-1064	215	1	schunkert	schunkert	PROPN
iajs-1064	215	2	,	,	PUNCT
iajs-1064	215	3	h.	h.	PROPN
iajs-1064	215	4	(	(	PUNCT
iajs-1064	215	5	2010	2010	NUM
iajs-1064	215	6	)	)	PUNCT
iajs-1064	215	7	.sorting	.sorte	VERB
iajs-1064	215	8	out	out	ADP
iajs-1064	215	9	cholesterol	cholesterol	NOUN
iajs-1064	215	10	and	and	CCONJ
iajs-1064	215	11	coronary	coronary	ADJ
iajs-1064	215	12	artery	artery	NOUN
iajs-1064	215	13	disease	disease	NOUN
iajs-1064	215	14	.	.	PUNCT
iajs-1064	216	1	n	n	PROPN
iajs-1064	216	2	engl	engl	PROPN
iajs-1064	216	3	j	j	PROPN
iajs-1064	216	4	med;363(25):2462–3	med;363(25):2462–3	PROPN
iajs-1064	216	5	.	.	PROPN
iajs-1064	217	1	32chung	32chung	NUM
iajs-1064	217	2	,	,	PUNCT
iajs-1064	217	3	cp	cp	NOUN
iajs-1064	217	4	;	;	PUNCT
iajs-1064	217	5	oeser	oeser	NOUN
iajs-1064	217	6	,	,	PUNCT
iajs-1064	217	7	a	a	PRON
iajs-1064	217	8	;	;	PUNCT
iajs-1064	217	9	avalos	avalos	PROPN
iajs-1064	217	10	,	,	PUNCT
iajs-1064	217	11	i	i	PRON
iajs-1064	217	12	;	;	PUNCT
iajs-1064	217	13	gebretsadik	gebretsadik	PROPN
iajs-1064	217	14	,	,	PUNCT
iajs-1064	217	15	t	t	PROPN
iajs-1064	217	16	;	;	PUNCT
iajs-1064	217	17	shintani	shintani	NOUN
iajs-1064	217	18	,	,	PUNCT
iajs-1064	217	19	a	a	PRON
iajs-1064	217	20	;	;	PUNCT
iajs-1064	217	21	raggi	raggi	NOUN
iajs-1064	217	22	,	,	PUNCT
iajs-1064	217	23	p.	p.	NOUN
iajs-1064	217	24	et	et	NOUN
iajs-1064	218	1	al	al	PROPN
iajs-1064	218	2	.	.	PROPN
iajs-1064	218	3	(	(	PUNCT
iajs-1064	218	4	2006	2006	NUM
iajs-1064	218	5	)	)	PUNCT
iajs-1064	218	6	.utility	.utility	NOUN
iajs-1064	218	7	of	of	ADP
iajs-1064	218	8	the	the	DET
iajs-1064	218	9	framingham	framingham	PROPN
iajs-1064	218	10	risk	risk	NOUN
iajs-1064	218	11	score	score	NOUN
iajs-1064	218	12	to	to	PART
iajs-1064	218	13	predict	predict	VERB
iajs-1064	218	14	the	the	DET
iajs-1064	218	15	presence	presence	NOUN
iajs-1064	218	16	of	of	ADP
iajs-1064	218	17	coronary	coronary	ADJ
iajs-1064	218	18	atherosclerosis	atherosclerosis	NOUN
iajs-1064	218	19	in	in	ADP
iajs-1064	218	20	patients	patient	NOUN
iajs-1064	218	21	with	with	ADP
iajs-1064	218	22	rheumatoid	rheumatoid	NOUN
iajs-1064	218	23	arthritis	arthritis	NOUN
iajs-1064	218	24	.	.	PUNCT
iajs-1064	219	1	arthritis	arthritis	NOUN
iajs-1064	219	2	res	re	NOUN
iajs-1064	219	3	ther;8	ther;8	NOUN
iajs-1064	219	4	:	:	PUNCT
iajs-1064	219	5	r186	r186	PROPN
iajs-1064	219	6	33yamamoto	33yamamoto	NUM
iajs-1064	219	7	,	,	PUNCT
iajs-1064	219	8	h.	h.	PROPN
iajs-1064	219	9	;	;	PUNCT
iajs-1064	219	10	lee	lee	PROPN
iajs-1064	219	11	,	,	PUNCT
iajs-1064	219	12	ce	ce	PROPN
iajs-1064	219	13	;	;	PUNCT
iajs-1064	219	14	marcus	marcus	PROPN
iajs-1064	219	15	,	,	PUNCT
iajs-1064	219	16	jn	jn	PROPN
iajs-1064	219	17	;	;	PUNCT
iajs-1064	219	18	williams	williams	PROPN
iajs-1064	219	19	,	,	PUNCT
iajs-1064	219	20	td	td	PRON
iajs-1064	219	21	;	;	PUNCT
iajs-1064	219	22	overton	overton	PROPN
iajs-1064	219	23	,	,	PUNCT
iajs-1064	219	24	jm	jm	PROPN
iajs-1064	219	25	;	;	PUNCT
iajs-1064	219	26	lopez	lopez	NOUN
iajs-1064	219	27	,	,	PUNCT
iajs-1064	219	28	me	i	PRON
iajs-1064	219	29	;	;	PUNCT
iajs-1064	219	30	hollenberg	hollenberg	PROPN
iajs-1064	219	31	,	,	PUNCT
iajs-1064	219	32	an	an	PRON
iajs-1064	219	33	;	;	PUNCT
iajs-1064	219	34	baggio	baggio	NOUN
iajs-1064	219	35	,	,	PUNCT
iajs-1064	219	36	l	l	NOUN
iajs-1064	219	37	;	;	PUNCT
iajs-1064	219	38	saper	saper	X
iajs-1064	219	39	,	,	PUNCT
iajs-1064	219	40	cb	cb	PROPN
iajs-1064	219	41	;	;	PUNCT
iajs-1064	219	42	drucker	drucker	NOUN
iajs-1064	219	43	,	,	PUNCT
iajs-1064	219	44	dj	dj	PROPN
iajs-1064	219	45	;	;	PUNCT
iajs-1064	219	46	elmquist	elmquist	ADJ
iajs-1064	219	47	,	,	PUNCT
iajs-1064	219	48	jk	jk	PROPN
iajs-1064	219	49	.	.	PROPN
iajs-1064	219	50	(	(	PUNCT
iajs-1064	219	51	2002	2002	NUM
iajs-1064	219	52	)	)	PUNCT
iajs-1064	219	53	glucagon	glucagon	NOUN
iajs-1064	219	54	-	-	PUNCT
iajs-1064	219	55	like	like	ADJ
iajs-1064	219	56	peptide-1	peptide-1	NOUN
iajs-1064	219	57	receptor	receptor	NOUN
iajs-1064	219	58	stimulation	stimulation	NOUN
iajs-1064	219	59	increases	increase	VERB
iajs-1064	219	60	blood	blood	NOUN
iajs-1064	219	61	pressure	pressure	NOUN
iajs-1064	219	62	and	and	CCONJ
iajs-1064	219	63	heart	heart	NOUN
iajs-1064	219	64	rate	rate	NOUN
iajs-1064	219	65	and	and	CCONJ
iajs-1064	219	66	activates	activate	VERB
iajs-1064	219	67	autonomic	autonomic	ADJ
iajs-1064	219	68	regulatory	regulatory	ADJ
iajs-1064	219	69	neurons	neuron	NOUN
iajs-1064	219	70	.	.	PUNCT
iajs-1064	220	1	j	j	PROPN
iajs-1064	220	2	clin	clin	PROPN
iajs-1064	220	3	invest	invest	PROPN
iajs-1064	220	4	,	,	PUNCT
iajs-1064	220	5	110(1):43–52	110(1):43–52	NUM
iajs-1064	220	6	.	.	PUNCT
iajs-1064	221	1	34sokos	34sokos	NUM
iajs-1064	221	2	,	,	PUNCT
iajs-1064	221	3	gg	gg	PROPN
iajs-1064	221	4	;	;	PUNCT
iajs-1064	221	5	bolukoglu	bolukoglu	PROPN
iajs-1064	221	6	,	,	PUNCT
iajs-1064	221	7	h	h	NOUN
iajs-1064	221	8	;	;	PUNCT
iajs-1064	221	9	german	german	ADJ
iajs-1064	221	10	,	,	PUNCT
iajs-1064	221	11	j	j	PROPN
iajs-1064	221	12	;	;	PUNCT
iajs-1064	221	13	hentosz	hentosz	NOUN
iajs-1064	221	14	,	,	PUNCT
iajs-1064	221	15	t	t	PROPN
iajs-1064	221	16	;	;	PUNCT
iajs-1064	221	17	magovern	magovern	ADJ
iajs-1064	221	18	,	,	PUNCT
iajs-1064	221	19	gj	gj	NOUN
iajs-1064	221	20	;	;	PUNCT
iajs-1064	221	21	jr	jr	PROPN
iajs-1064	221	22	,	,	PUNCT
iajs-1064	221	23	maher	maher	PROPN
iajs-1064	221	24	,	,	PUNCT
iajs-1064	221	25	td	td	PRON
iajs-1064	221	26	;	;	PUNCT
iajs-1064	221	27	dean	dean	PROPN
iajs-1064	221	28	,	,	PUNCT
iajs-1064	221	29	da	da	PROPN
iajs-1064	221	30	;	;	PUNCT
iajs-1064	221	31	bailey	bailey	PROPN
iajs-1064	221	32	,	,	PUNCT
iajs-1064	221	33	sh	sh	PROPN
iajs-1064	221	34	;	;	PUNCT
iajs-1064	221	35	marrone	marrone	PROPN
iajs-1064	221	36	,	,	PUNCT
iajs-1064	221	37	g	g	NOUN
iajs-1064	221	38	;	;	PUNCT
iajs-1064	221	39	benckart	benckart	NOUN
iajs-1064	221	40	,	,	PUNCT
iajs-1064	221	41	dh	dh	NOUN
iajs-1064	221	42	;	;	PUNCT
iajs-1064	221	43	elahi	elahi	PROPN
iajs-1064	221	44	,	,	PUNCT
iajs-1064	221	45	d	d	X
iajs-1064	221	46	;	;	PUNCT
iajs-1064	221	47	shannon	shannon	PROPN
iajs-1064	221	48	,	,	PUNCT
iajs-1064	221	49	rp	rp	NOUN
iajs-1064	221	50	.	.	PROPN
iajs-1064	221	51	effect	effect	VERB
iajs-1064	221	52	ofglucagon	ofglucagon	PROPN
iajs-1064	221	53	-	-	PUNCT
iajs-1064	221	54	like	like	ADJ
iajs-1064	221	55	peptide-1	peptide-1	PROPN
iajs-1064	221	56	(	(	PUNCT
iajs-1064	221	57	glp-1	glp-1	X
iajs-1064	221	58	)	)	PUNCT
iajs-1064	221	59	on	on	ADP
iajs-1064	221	60	glycemic	glycemic	ADJ
iajs-1064	221	61	control	control	NOUN
iajs-1064	221	62	and	and	CCONJ
iajs-1064	221	63	left	leave	VERB
iajs-1064	221	64	ventricular	ventricular	ADJ
iajs-1064	221	65	function	function	NOUN
iajs-1064	221	66	in	in	ADP
iajs-1064	221	67	patients	patient	NOUN
iajs-1064	221	68	undergoing	undergo	VERB
iajs-1064	221	69	coronary	coronary	ADJ
iajs-1064	221	70	artery	artery	NOUN
iajs-1064	221	71	bypass	bypass	NOUN
iajs-1064	221	72	grafting	grafting	NOUN
iajs-1064	221	73	.	.	PUNCT
iajs-1064	222	1	am	be	AUX
iajs-1064	222	2	jcardiol	jcardiol	NOUN
iajs-1064	222	3	2007	2007	NUM
iajs-1064	222	4	,	,	PUNCT
iajs-1064	222	5	100(5):824–829	100(5):824–829	NUM
iajs-1064	222	6	chemistry	chemistry	NOUN
iajs-1064	222	7	|	|	ADV
iajs-1064	222	8	113	113	NUM
iajs-1064	222	9	2017عام	2017عام	NUM
iajs-1064	222	10	)	)	PUNCT
iajs-1064	223	1	1(العدد	1(العدد	NUM
iajs-1064	223	2	30مجلة	30مجلة	NUM
iajs-1064	223	3	إبن	إبن	VERB
iajs-1064	223	4	الھيثم	الھيثم	NOUN
iajs-1064	223	5	للعلوم	للعلوم	PROPN
iajs-1064	223	6	الصرفة	الصرفة	PROPN
iajs-1064	223	7	والتطبيقية	والتطبيقية	PRON
iajs-1064	223	8	المجلد	المجلد	VERB
iajs-1064	223	9	ibn	ibn	PROPN
iajs-1064	223	10	al	al	PROPN
iajs-1064	223	11	-	-	PUNCT
iajs-1064	223	12	haitham	haitham	PROPN
iajs-1064	223	13	jour	jour	X
iajs-1064	223	14	.	.	PROPN
iajs-1064	224	1	for	for	ADP
iajs-1064	224	2	pure	pure	ADJ
iajs-1064	224	3	&	&	CCONJ
iajs-1064	224	4	appl	appl	PROPN
iajs-1064	224	5	.	.	PUNCT
iajs-1064	225	1	sci	sci	PROPN
iajs-1064	225	2	.	.	PUNCT
iajs-1064	225	3	vol	vol	NOUN
iajs-1064	225	4	.	.	PROPN
iajs-1064	225	5	30	30	NUM
iajs-1064	225	6	(	(	PUNCT
iajs-1064	225	7	1	1	NUM
iajs-1064	225	8	)	)	PUNCT
iajs-1064	225	9	2017	2017	NUM
iajs-1064	225	10	35ratner	35ratner	NUM
iajs-1064	225	11	,	,	PUNCT
iajs-1064	225	12	r.	r.	PROPN
iajs-1064	225	13	;	;	PUNCT
iajs-1064	225	14	han	han	PROPN
iajs-1064	225	15	,	,	PUNCT
iajs-1064	225	16	j.	j.	PROPN
iajs-1064	225	17	;	;	PUNCT
iajs-1064	225	18	nicewarner	nicewarner	NOUN
iajs-1064	225	19	,	,	PUNCT
iajs-1064	225	20	d.	d.	PROPN
iajs-1064	225	21	;	;	PUNCT
iajs-1064	225	22	yushmanova	yushmanova	PROPN
iajs-1064	225	23	,	,	PUNCT
iajs-1064	225	24	i.	i.	NOUN
iajs-1064	225	25	;	;	PUNCT
iajs-1064	225	26	hoogwerf	hoogwerf	NOUN
iajs-1064	225	27	,	,	PUNCT
iajs-1064	225	28	bj	bj	VERB
iajs-1064	225	29	.	.	PUNCT
iajs-1064	225	30	;	;	PUNCT
iajs-1064	226	1	shen	shen	PROPN
iajs-1064	226	2	,	,	PUNCT
iajs-1064	226	3	l.	l.	PROPN
iajs-1064	226	4	cardiovascular	cardiovascular	ADJ
iajs-1064	226	5	safety	safety	NOUN
iajs-1064	226	6	of	of	ADP
iajs-1064	226	7	exenatide	exenatide	NOUN
iajs-1064	226	8	bid	bid	NOUN
iajs-1064	226	9	:	:	PUNCT
iajs-1064	226	10	an	an	DET
iajs-1064	226	11	integrated	integrate	VERB
iajs-1064	226	12	analysis	analysis	NOUN
iajs-1064	226	13	from	from	ADP
iajs-1064	226	14	controlled	control	VERB
iajs-1064	226	15	clinical	clinical	ADJ
iajs-1064	226	16	trials	trial	NOUN
iajs-1064	226	17	in	in	ADP
iajs-1064	226	18	participants	participant	NOUN
iajs-1064	226	19	with	with	ADP
iajs-1064	226	20	type	type	NOUN
iajs-1064	226	21	2	2	NUM
iajs-1064	226	22	diabetes	diabetes	NOUN
iajs-1064	226	23	.	.	PUNCT
iajs-1064	227	1	cardiovasc	cardiovasc	PROPN
iajs-1064	227	2	.	.	PROPN
iajs-1064	227	3	diabetol	diabetol	ADJ
iajs-1064	227	4	.	.	PUNCT
iajs-1064	228	1	10	10	NUM
iajs-1064	228	2	,	,	PUNCT
iajs-1064	228	3	22	22	NUM
iajs-1064	228	4	(	(	PUNCT
iajs-1064	228	5	2011	2011	NUM
iajs-1064	228	6	)	)	PUNCT
iajs-1064	228	7	.	.	PUNCT
iajs-1064	229	1	36levantesi	36levantesi	X
iajs-1064	229	2	,	,	PUNCT
iajs-1064	229	3	g.	g.	PROPN
iajs-1064	229	4	;	;	PUNCT
iajs-1064	229	5	macchia	macchia	PROPN
iajs-1064	229	6	,	,	PUNCT
iajs-1064	229	7	a	a	PRON
iajs-1064	229	8	;	;	PUNCT
iajs-1064	229	9	marfisi	marfisi	PROPN
iajs-1064	229	10	,	,	PUNCT
iajs-1064	229	11	rm	rm	PROPN
iajs-1064	229	12	;	;	PUNCT
iajs-1064	229	13	franzosi	franzosi	PROPN
iajs-1064	229	14	,	,	PUNCT
iajs-1064	229	15	mg	mg	PROPN
iajs-1064	229	16	;	;	PUNCT
iajs-1064	229	17	maggioni	maggioni	NOUN
iajs-1064	229	18	,	,	PUNCT
iajs-1064	229	19	ap	ap	PROPN
iajs-1064	229	20	;	;	PUNCT
iajs-1064	229	21	nicolosi	nicolosi	NOUN
iajs-1064	229	22	,	,	PUNCT
iajs-1064	229	23	gl	gl	PROPN
iajs-1064	229	24	;	;	PUNCT
iajs-1064	229	25	schweiger	schweiger	PROPN
iajs-1064	229	26	,	,	PUNCT
iajs-1064	229	27	c	c	X
iajs-1064	229	28	;	;	PUNCT
iajs-1064	229	29	tavazzi	tavazzi	ADJ
iajs-1064	229	30	,	,	PUNCT
iajs-1064	229	31	l	l	NOUN
iajs-1064	229	32	;	;	PUNCT
iajs-1064	229	33	tognoni	tognoni	ADJ
iajs-1064	229	34	,	,	PUNCT
iajs-1064	229	35	g	g	NOUN
iajs-1064	229	36	;	;	PUNCT
iajs-1064	229	37	valagussa	valagussa	ADJ
iajs-1064	229	38	,	,	PUNCT
iajs-1064	229	39	f	f	X
iajs-1064	229	40	;	;	PUNCT
iajs-1064	229	41	marchioli	marchioli	ADJ
iajs-1064	229	42	,	,	PUNCT
iajs-1064	229	43	r	r	NOUN
iajs-1064	229	44	;	;	PUNCT
iajs-1064	229	45	(	(	PUNCT
iajs-1064	229	46	2005	2005	NUM
iajs-1064	229	47	)	)	PUNCT
iajs-1064	229	48	.	.	PUNCT
iajs-1064	230	1	on	on	ADP
iajs-1064	230	2	behalf	behalf	NOUN
iajs-1064	230	3	of	of	ADP
iajs-1064	230	4	thegissi	thegissi	ADJ
iajs-1064	230	5	-	-	PUNCT
iajs-1064	230	6	prevenzione	prevenzione	NOUN
iajs-1064	230	7	investigators	investigator	NOUN
iajs-1064	230	8	:	:	PUNCT
iajs-1064	230	9	metabolic	metabolic	NOUN
iajs-1064	230	10	syndrome	syndrome	NOUN
iajs-1064	230	11	and	and	CCONJ
iajs-1064	230	12	risk	risk	VERB
iajs-1064	230	13	ofcardiovascular	ofcardiovascular	ADJ
iajs-1064	230	14	events	event	NOUN
iajs-1064	230	15	after	after	ADP
iajs-1064	230	16	myocardial	myocardial	ADJ
iajs-1064	230	17	infarction	infarction	NOUN
iajs-1064	230	18	.	.	PUNCT
iajs-1064	231	1	j	j	PROPN
iajs-1064	231	2	am	be	AUX
iajs-1064	231	3	coll	coll	PROPN
iajs-1064	231	4	cardiol	cardiol	PROPN
iajs-1064	231	5	,	,	PUNCT
iajs-1064	231	6	46:277–283	46:277–283	PROPN
iajs-1064	231	7	.	.	PUNCT
iajs-1064	232	1	37ban	37ban	PROPN
iajs-1064	232	2	,	,	PUNCT
iajs-1064	232	3	k	k	X
iajs-1064	232	4	;	;	PUNCT
iajs-1064	232	5	noyan	noyan	ADJ
iajs-1064	232	6	-	-	PUNCT
iajs-1064	232	7	ashraf	ashraf	PROPN
iajs-1064	232	8	,	,	PUNCT
iajs-1064	232	9	mh	mh	PROPN
iajs-1064	232	10	;	;	PUNCT
iajs-1064	232	11	hoefer	hoefer	PROPN
iajs-1064	232	12	,	,	PUNCT
iajs-1064	232	13	j	j	NOUN
iajs-1064	232	14	;	;	PUNCT
iajs-1064	232	15	bolz	bolz	PROPN
iajs-1064	232	16	,	,	PUNCT
iajs-1064	232	17	ss	ss	NOUN
iajs-1064	232	18	;	;	PUNCT
iajs-1064	232	19	drucker	drucker	NOUN
iajs-1064	232	20	,	,	PUNCT
iajs-1064	232	21	dj	dj	PROPN
iajs-1064	232	22	;	;	PUNCT
iajs-1064	232	23	husain	husain	PROPN
iajs-1064	232	24	,	,	PUNCT
iajs-1064	232	25	m	m	PROPN
iajs-1064	232	26	;	;	PUNCT
iajs-1064	232	27	(	(	PUNCT
iajs-1064	232	28	2008	2008	NUM
iajs-1064	232	29	)	)	PUNCT
iajs-1064	232	30	.cardioprotective	.cardioprotective	PRON
iajs-1064	233	1	andvasodilatory	andvasodilatory	PROPN
iajs-1064	233	2	actions	action	NOUN
iajs-1064	233	3	of	of	ADP
iajs-1064	233	4	glucagon	glucagon	NOUN
iajs-1064	233	5	-	-	PUNCT
iajs-1064	233	6	like	like	ADJ
iajs-1064	233	7	peptide	peptide	NOUN
iajs-1064	233	8	1receptor	1receptor	PROPN
iajs-1064	233	9	are	be	AUX
iajs-1064	233	10	mediated	mediate	VERB
iajs-1064	233	11	through	through	ADP
iajs-1064	233	12	bothglucagon	bothglucagon	NOUN
iajs-1064	233	13	-	-	PUNCT
iajs-1064	233	14	like	like	ADJ
iajs-1064	233	15	peptide	peptide	NOUN
iajs-1064	233	16	1	1	NUM
iajs-1064	233	17	receptor	receptor	NOUN
iajs-1064	233	18	-	-	PUNCT
iajs-1064	233	19	dependent	dependent	ADJ
iajs-1064	233	20	and	and	CCONJ
iajs-1064	233	21	-	-	PUNCT
iajs-1064	233	22	independent	independent	ADJ
iajs-1064	233	23	pathways.[erratum	pathways.[erratum	NOUN
iajs-1064	233	24	appears	appear	VERB
iajs-1064	233	25	in	in	ADP
iajs-1064	233	26	circulation;118(4):e81	circulation;118(4):e81	NOUN
iajs-1064	233	27	]	]	PUNCT
iajs-1064	233	28	.	.	PUNCT
iajs-1064	234	1	circulation	circulation	NOUN
iajs-1064	234	2	;	;	PUNCT
iajs-1064	234	3	117:2340–2350	117:2340–2350	NUM
iajs-1064	234	4	.	.	PUNCT
iajs-1064	235	1	38nam	38nam	NOUN
iajs-1064	235	2	.	.	PUNCT
iajs-1064	236	1	j	j	PROPN
iajs-1064	236	2	;	;	PUNCT
iajs-1064	236	3	villeneuve	villeneuve	PROPN
iajs-1064	236	4	.	.	PUNCT
iajs-1064	237	1	e	e	PROPN
iajs-1064	237	2	and	and	CCONJ
iajs-1064	237	3	emery	emery	PROPN
iajs-1064	237	4	.	.	PUNCT
iajs-1064	238	1	p.	p.	NOUN
iajs-1064	238	2	(	(	PUNCT
iajs-1064	238	3	2009	2009	NUM
iajs-1064	238	4	)	)	PUNCT
iajs-1064	238	5	.	.	PUNCT
iajs-1064	239	1	the	the	DET
iajs-1064	239	2	role	role	NOUN
iajs-1064	239	3	of	of	ADP
iajs-1064	239	4	biomarkers	biomarker	NOUN
iajs-1064	239	5	in	in	ADP
iajs-1064	239	6	the	the	DET
iajs-1064	239	7	management	management	NOUN
iajs-1064	239	8	of	of	ADP
iajs-1064	239	9	patients	patient	NOUN
iajs-1064	239	10	with	with	ADP
iajs-1064	239	11	ra	ra	PROPN
iajs-1064	239	12	.	.	PUNCT
iajs-1064	240	1	curr	curr	PROPN
iajs-1064	240	2	rheumatol	rheumatol	PROPN
iajs-1064	240	3	rep	rep	PROPN
iajs-1064	240	4	;	;	PUNCT
iajs-1064	240	5	11:371–377	11:371–377	NUM
iajs-1064	240	6	.	.	PUNCT
iajs-1064	241	1	39al	39al	ADJ
iajs-1064	241	2	-	-	PUNCT
iajs-1064	241	3	mesry	mesry	NOUN
iajs-1064	241	4	.mr;attwa	.mr;attwa	NOUN
iajs-1064	241	5	.	.	PUNCT
iajs-1064	242	1	et	et	NOUN
iajs-1064	242	2	;	;	PUNCT
iajs-1064	242	3	omar	omar	PROPN
iajs-1064	242	4	.	.	PUNCT
iajs-1064	243	1	hm	hm	INTJ
iajs-1064	243	2	.	.	PUNCT
iajs-1064	244	1	(	(	PUNCT
iajs-1064	244	2	2003	2003	NUM
iajs-1064	244	3	)	)	PUNCT
iajs-1064	244	4	.	.	PUNCT
iajs-1064	245	1	assessment	assessment	NOUN
iajs-1064	245	2	of	of	ADP
iajs-1064	245	3	cardiovascular	cardiovascular	ADJ
iajs-1064	245	4	risk	risk	NOUN
iajs-1064	245	5	factors	factor	NOUN
iajs-1064	245	6	in	in	ADP
iajs-1064	245	7	ra	ra	PROPN
iajs-1064	245	8	and	and	CCONJ
iajs-1064	245	9	oa	oa	INTJ
iajs-1064	245	10	.	.	PROPN
iajs-1064	245	11	egypt	egypt	PROPN
iajs-1064	245	12	rheumatol	rheumatol	PROPN
iajs-1064	245	13	rehabil	rehabil	PROPN
iajs-1064	245	14	;	;	PUNCT
iajs-1064	245	15	30:323–332	30:323–332	NUM
iajs-1064	245	16	.	.	PUNCT
iajs-1064	246	1	40gonzalez	40gonzalez	X
iajs-1064	246	2	-	-	PUNCT
iajs-1064	246	3	gay	gay	PROPN
iajs-1064	246	4	,	,	PUNCT
iajs-1064	246	5	ma	ma	PROPN
iajs-1064	246	6	;	;	PUNCT
iajs-1064	246	7	vazquez	vazquez	NOUN
iajs-1064	246	8	-	-	PUNCT
iajs-1064	246	9	rodriguez	rodriguez	PROPN
iajs-1064	246	10	,	,	PUNCT
iajs-1064	246	11	tr	tr	VERB
iajs-1064	246	12	;	;	PUNCT
iajs-1064	246	13	garcia	garcia	PROPN
iajs-1064	246	14	-	-	PUNCT
iajs-1064	246	15	unzeuta	unzeuta	PROPN
iajs-1064	246	16	,	,	PUNCT
iajs-1064	246	17	a	a	DET
iajs-1064	246	18	;	;	PUNCT
iajs-1064	246	19	berja	berja	PROPN
iajs-1064	246	20	,	,	PUNCT
iajs-1064	246	21	a	a	PRON
iajs-1064	246	22	;	;	PUNCT
iajs-1064	246	23	mirandafilloy	mirandafilloy	PROPN
iajs-1064	246	24	,	,	PUNCT
iajs-1064	246	25	ja	ja	PROPN
iajs-1064	246	26	;	;	PUNCT
iajs-1064	246	27	de	de	X
iajs-1064	246	28	matias	matias	PROPN
iajs-1064	246	29	,	,	PUNCT
iajs-1064	246	30	jm	jm	PROPN
iajs-1064	246	31	.	.	PROPN
iajs-1064	246	32	et	et	PROPN
iajs-1064	246	33	al	al	PROPN
iajs-1064	246	34	.	.	PROPN
iajs-1064	247	1	(	(	PUNCT
iajs-1064	247	2	2010	2010	NUM
iajs-1064	247	3	)	)	PUNCT
iajs-1064	247	4	visfatin	visfatin	NOUN
iajs-1064	247	5	is	be	AUX
iajs-1064	247	6	not	not	PART
iajs-1064	247	7	associated	associate	VERB
iajs-1064	247	8	with	with	ADP
iajs-1064	247	9	inflammation	inflammation	NOUN
iajs-1064	247	10	or	or	CCONJ
iajs-1064	247	11	metabolic	metabolic	NOUN
iajs-1064	247	12	syndromes	syndrome	NOUN
iajs-1064	247	13	in	in	ADP
iajs-1064	247	14	patients	patient	NOUN
iajs-1064	247	15	with	with	ADP
iajs-1064	247	16	severe	severe	ADJ
iajs-1064	247	17	rheumatoid	rheumatoid	NOUN
iajs-1064	247	18	arthritis	arthritis	NOUN
iajs-1064	247	19	undergoing	undergo	VERB
iajs-1064	247	20	anti	anti	NOUN
iajs-1064	247	21	-	-	ADJ
iajs-1064	247	22	tna	tna	ADJ
iajs-1064	247	23	alpha	alpha	NOUN
iajs-1064	247	24	therapy	therapy	NOUN
iajs-1064	247	25	.	.	PUNCT
iajs-1064	248	1	clin	clin	PROPN
iajs-1064	248	2	exp	exp	PROPN
iajs-1064	248	3	rheumatol;28(1):56–62	rheumatol;28(1):56–62	PROPN
iajs-1064	248	4	.	.	PROPN
iajs-1064	248	5	41hahn	41hahn	NUM
iajs-1064	248	6	bh	bh	PROPN
iajs-1064	248	7	,	,	PUNCT
iajs-1064	248	8	grossman	grossman	PROPN
iajs-1064	248	9	j	j	PROPN
iajs-1064	248	10	,	,	PUNCT
iajs-1064	248	11	chen	chen	PROPN
iajs-1064	248	12	w	w	PROPN
iajs-1064	248	13	,	,	PUNCT
iajs-1064	248	14	mcmahon	mcmahon	PROPN
iajs-1064	248	15	m.	m.	NOUN
iajs-1064	248	16	(	(	PUNCT
iajs-1064	248	17	2007).the	2007).the	NUM
iajs-1064	248	18	pathogenesis	pathogenesis	NOUN
iajs-1064	248	19	of	of	ADP
iajs-1064	248	20	atherosclerosis	atherosclerosis	NOUN
iajs-1064	248	21	in	in	ADP
iajs-1064	248	22	autoimmune	autoimmune	ADJ
iajs-1064	248	23	rheumatic	rheumatic	ADJ
iajs-1064	248	24	diseases	disease	NOUN
iajs-1064	248	25	:	:	PUNCT
iajs-1064	248	26	roles	role	NOUN
iajs-1064	248	27	of	of	ADP
iajs-1064	248	28	inflammation	inflammation	NOUN
iajs-1064	248	29	and	and	CCONJ
iajs-1064	248	30	dyslipidemia	dyslipidemia	NOUN
iajs-1064	248	31	.	.	PUNCT
iajs-1064	249	1	j	j	PROPN
iajs-1064	249	2	autoimmun;28:69–75	autoimmun;28:69–75	PROPN
iajs-1064	249	3	.	.	PROPN
iajs-1064	249	4	42	42	NUM
iajs-1064	249	5	senolt	senolt	PROPN
iajs-1064	249	6	.l	.l	PROPN
iajs-1064	249	7	;	;	PUNCT
iajs-1064	249	8	krysˇ	krysˇ	PROPN
iajs-1064	249	9	.tu	.tu	PUNCT
iajs-1064	249	10	;	;	PUNCT
iajs-1064	249	11	fkova	fkova	PROPN
iajs-1064	249	12	.	.	PUNCT
iajs-1064	250	1	o	o	NOUN
iajs-1064	250	2	;	;	PUNCT
iajs-1064	250	3	hulejova	hulejova	ADJ
iajs-1064	250	4	.h	.h	NOUN
iajs-1064	250	5	.	.	PUNCT
iajs-1064	251	1	(	(	PUNCT
iajs-1064	251	2	2011	2011	NUM
iajs-1064	251	3	)	)	PUNCT
iajs-1064	251	4	.	.	PUNCT
iajs-1064	252	1	the	the	DET
iajs-1064	252	2	level	level	NOUN
iajs-1064	252	3	of	of	ADP
iajs-1064	252	4	serum	serum	NOUN
iajs-1064	252	5	visfatin	visfatin	NOUN
iajs-1064	252	6	(	(	PUNCT
iajs-1064	252	7	pbef	pbef	NOUN
iajs-1064	252	8	)	)	PUNCT
iajs-1064	252	9	is	be	AUX
iajs-1064	252	10	associated	associate	VERB
iajs-1064	252	11	with	with	ADP
iajs-1064	252	12	total	total	ADJ
iajs-1064	252	13	number	number	NOUN
iajs-1064	252	14	of	of	ADP
iajs-1064	252	15	b	b	NOUN
iajs-1064	252	16	cells	cell	NOUN
iajs-1064	252	17	in	in	ADP
iajs-1064	252	18	patients	patient	NOUN
iajs-1064	252	19	with	with	ADP
iajs-1064	252	20	rheumatoid	rheumatoid	NOUN
iajs-1064	252	21	arthritis	arthritis	NOUN
iajs-1064	252	22	and	and	CCONJ
iajs-1064	252	23	decreases	decrease	NOUN
iajs-1064	252	24	following	follow	VERB
iajs-1064	252	25	b	b	DET
iajs-1064	252	26	cell	cell	NOUN
iajs-1064	252	27	depletion	depletion	NOUN
iajs-1064	252	28	therapy	therapy	NOUN
iajs-1064	252	29	.	.	PUNCT
iajs-1064	253	1	cytokine	cytokine	NOUN
iajs-1064	253	2	;	;	PUNCT
iajs-1064	253	3	55:116–121	55:116–121	NUM
iajs-1064	253	4	43luk	43luk	NOUN
iajs-1064	253	5	,	,	PUNCT
iajs-1064	253	6	t.	t.	PROPN
iajs-1064	253	7	;	;	PUNCT
iajs-1064	253	8	malam	malam	PROPN
iajs-1064	253	9	,	,	PUNCT
iajs-1064	253	10	z.	z.	PROPN
iajs-1064	253	11	;	;	PUNCT
iajs-1064	253	12	marshall	marshall	PROPN
iajs-1064	253	13	,	,	PUNCT
iajs-1064	253	14	j.	j.	PROPN
iajs-1064	253	15	(	(	PUNCT
iajs-1064	253	16	2008	2008	NUM
iajs-1064	253	17	)	)	PUNCT
iajs-1064	253	18	.	.	PUNCT
iajs-1064	254	1	pre	pre	ADJ
iajs-1064	254	2	-	-	ADJ
iajs-1064	254	3	b	b	ADJ
iajs-1064	254	4	cell	cell	NOUN
iajs-1064	254	5	colony	colony	NOUN
iajs-1064	254	6	enhancing	enhance	VERB
iajs-1064	254	7	factor	factor	NOUN
iajs-1064	254	8	(	(	PUNCT
iajs-1064	254	9	pbef)/	pbef)/	PROPN
iajs-1064	254	10	visfatin	visfatin	NOUN
iajs-1064	254	11	:	:	PUNCT
iajs-1064	254	12	a	a	DET
iajs-1064	254	13	novel	novel	ADJ
iajs-1064	254	14	media	medium	NOUN
iajs-1064	254	15	innate	innate	ADJ
iajs-1064	254	16	immunity	immunity	NOUN
iajs-1064	254	17	.	.	PUNCT
iajs-1064	255	1	j	j	PROPN
iajs-1064	255	2	leukoc	leukoc	PROPN
iajs-1064	255	3	biol	biol	PROPN
iajs-1064	255	4	;	;	PUNCT
iajs-1064	255	5	83:804–816	83:804–816	PROPN
iajs-1064	255	6	44bao	44bao	PROPN
iajs-1064	255	7	,	,	PUNCT
iajs-1064	255	8	jp	jp	PROPN
iajs-1064	255	9	.	.	PUNCT
iajs-1064	255	10	;	;	PUNCT
iajs-1064	255	11	hen	hen	X
iajs-1064	255	12	.	.	PUNCT
iajs-1064	256	1	wp	wp	PROPN
iajs-1064	256	2	;	;	PUNCT
iajs-1064	256	3	wu	wu	PROPN
iajs-1064	256	4	.	.	PUNCT
iajs-1064	257	1	ld	ld	PROPN
iajs-1064	257	2	.	.	PROPN
iajs-1064	258	1	(	(	PUNCT
iajs-1064	258	2	2009	2009	NUM
iajs-1064	258	3	)	)	PUNCT
iajs-1064	258	4	.visfatin	.visfatin	NOUN
iajs-1064	258	5	;	;	PUNCT
iajs-1064	258	6	a	a	DET
iajs-1064	258	7	potential	potential	ADJ
iajs-1064	258	8	therapeutic	therapeutic	ADJ
iajs-1064	258	9	target	target	NOUN
iajs-1064	258	10	for	for	ADP
iajs-1064	258	11	rheumatoidarthritis	rheumatoidarthritis	NOUN
iajs-1064	258	12	.	.	PUNCT
iajs-1064	259	1	j	j	PROPN
iajs-1064	259	2	int	int	PROPN
iajs-1064	259	3	med	med	PROPN
iajs-1064	259	4	res	re	NOUN
iajs-1064	259	5	;	;	PUNCT
iajs-1064	259	6	37	37	NUM
iajs-1064	259	7	:	:	PUNCT
iajs-1064	259	8	chemistry	chemistry	NOUN
iajs-1064	259	9	|	|	ADV
iajs-1064	259	10	114	114	NUM
iajs-1064	259	11	2017عام	2017عام	NUM
iajs-1064	259	12	)	)	PUNCT
iajs-1064	259	13	1(العدد	1(العدد	NUM
iajs-1064	259	14	30مجلة	30مجلة	NUM
iajs-1064	259	15	إبن	إبن	VERB
iajs-1064	259	16	الھيثم	الھيثم	NOUN
iajs-1064	259	17	للعلوم	للعلوم	PROPN
iajs-1064	259	18	الصرفة	الصرفة	PROPN
iajs-1064	259	19	والتطبيقية	والتطبيقية	PRON
iajs-1064	259	20	المجلد	المجلد	VERB
iajs-1064	259	21	ibn	ibn	PROPN
iajs-1064	259	22	al	al	PROPN
iajs-1064	259	23	-	-	PUNCT
iajs-1064	259	24	haitham	haitham	PROPN
iajs-1064	259	25	jour	jour	X
iajs-1064	259	26	.	.	PROPN
iajs-1064	259	27	for	for	ADP
iajs-1064	259	28	pure	pure	ADJ
iajs-1064	259	29	&	&	CCONJ
iajs-1064	259	30	appl	appl	PROPN
iajs-1064	259	31	.	.	PUNCT
iajs-1064	260	1	sci	sci	PROPN
iajs-1064	260	2	.	.	PUNCT
iajs-1064	260	3	vol	vol	NOUN
iajs-1064	260	4	.	.	PROPN
iajs-1064	260	5	30	30	NUM
iajs-1064	260	6	(	(	PUNCT
iajs-1064	260	7	1	1	NUM
iajs-1064	260	8	)	)	PUNCT
iajs-1064	260	9	2017	2017	NUM
iajs-1064	260	10	table	table	NOUN
iajs-1064	260	11	(	(	PUNCT
iajs-1064	260	12	1	1	NUM
iajs-1064	260	13	)	)	PUNCT
iajs-1064	260	14	esr	esr	NOUN
iajs-1064	260	15	,	,	PUNCT
iajs-1064	260	16	rf	rf	NOUN
iajs-1064	260	17	,	,	PUNCT
iajs-1064	260	18	tc	tc	NOUN
iajs-1064	260	19	,	,	PUNCT
iajs-1064	260	20	tg	tg	PROPN
iajs-1064	260	21	,	,	PUNCT
iajs-1064	260	22	hdl	hdl	PROPN
iajs-1064	260	23	,	,	PUNCT
iajs-1064	260	24	ldl	ldl	NOUN
iajs-1064	260	25	,	,	PUNCT
iajs-1064	260	26	vldl	vldl	NOUN
iajs-1064	260	27	levels	level	NOUN
iajs-1064	260	28	in	in	ADP
iajs-1064	260	29	g1	g1	PROPN
iajs-1064	260	30	and	and	CCONJ
iajs-1064	260	31	g2	g2	PROPN
iajs-1064	260	32	:	:	PUNCT
iajs-1064	260	33	groups	group	NOUN
iajs-1064	260	34	parameters	parameter	NOUN
iajs-1064	260	35	mean±	mean±	PROPN
iajs-1064	260	36	sem	sem	PROPN
iajs-1064	260	37	g2	g2	PROPN
iajs-1064	260	38	mean±	mean±	PROPN
iajs-1064	260	39	sem	sem	PROPN
iajs-1064	260	40	g1	g1	PROPN
iajs-1064	260	41	t	t	PROPN
iajs-1064	260	42	-	-	PUNCT
iajs-1064	260	43	test	test	NOUN
iajs-1064	260	44	g1	g1	PROPN
iajs-1064	260	45	vs	vs	ADP
iajs-1064	260	46	g2	g2	PROPN
iajs-1064	260	47	esr(mm	esr(mm	PROPN
iajs-1064	260	48	/	/	SYM
iajs-1064	260	49	h	h	NOUN
iajs-1064	260	50	)	)	PUNCT
iajs-1064	260	51	42.35	42.35	NUM
iajs-1064	260	52	±	±	NUM
iajs-1064	260	53	5.52	5.52	NUM
iajs-1064	260	54	12.34±2.28	12.34±2.28	NUM
iajs-1064	260	55	<	<	X
iajs-1064	260	56	0.0001	0.0001	NUM
iajs-1064	260	57	rf(iu	rf(iu	NOUN
iajs-1064	260	58	/	/	SYM
iajs-1064	260	59	ml	ml	NOUN
iajs-1064	260	60	)	)	PUNCT
iajs-1064	260	61	135.52	135.52	NUM
iajs-1064	260	62	±	±	NUM
iajs-1064	260	63	9.14	9.14	NUM
iajs-1064	260	64	33.89±9.5	33.89±9.5	NUM
iajs-1064	260	65	<	<	NOUN
iajs-1064	260	66	0.0001	0.0001	NUM
iajs-1064	260	67	t	t	NOUN
iajs-1064	260	68	c	c	NOUN
iajs-1064	260	69	(	(	PUNCT
iajs-1064	260	70	mg	mg	PROPN
iajs-1064	260	71	/	/	SYM
iajs-1064	260	72	dl	dl	NOUN
iajs-1064	260	73	)	)	PUNCT
iajs-1064	260	74	264.73	264.73	NUM
iajs-1064	260	75	±	±	NUM
iajs-1064	260	76	32.87	32.87	NUM
iajs-1064	260	77	110.85±14.11	110.85±14.11	NUM
iajs-1064	260	78	<	<	NOUN
iajs-1064	260	79	0.0001	0.0001	NUM
iajs-1064	260	80	tg(mg	tg(mg	PROPN
iajs-1064	260	81	/	/	SYM
iajs-1064	260	82	dl	dl	PROPN
iajs-1064	260	83	)	)	PUNCT
iajs-1064	260	84	245.14±35.5	245.14±35.5	NUM
iajs-1064	260	85	98.77±28.6	98.77±28.6	NUM
iajs-1064	260	86	<	<	X
iajs-1064	260	87	0.001	0.001	NUM
iajs-1064	260	88	hdl	hdl	PROPN
iajs-1064	260	89	32.74±3.65	32.74±3.65	PROPN
iajs-1064	260	90	42.64±3.96	42.64±3.96	PROPN
iajs-1064	260	91	<	<	X
iajs-1064	260	92	0.001	0.001	NUM
iajs-1064	260	93	ldl	ldl	NOUN
iajs-1064	260	94	178.24±37.87	178.24±37.87	PROPN
iajs-1064	260	95	58.19±18.9	58.19±18.9	NUM
iajs-1064	260	96	<	<	X
iajs-1064	260	97	0.001	0.001	NUM
iajs-1064	260	98	vldl	vldl	PROPN
iajs-1064	260	99	42.14±5.03	42.14±5.03	PROPN
iajs-1064	260	100	25.42±1.57	25.42±1.57	NUM
iajs-1064	261	1	<	<	X
iajs-1064	261	2	0.0001	0.0001	NUM
iajs-1064	261	3	aip	aip	PROPN
iajs-1064	261	4	0.874±0	0.874±0	PROPN
iajs-1064	261	5	.	.	PUNCT
iajs-1064	262	1	98	98	NUM
iajs-1064	262	2	0.36±0.85	0.36±0.85	NOUN
iajs-1064	262	3	<	<	X
iajs-1064	262	4	0.001	0.001	NUM
iajs-1064	262	5	̽˚(s	̽˚(s	NOUN
iajs-1064	262	6	)	)	PUNCT
iajs-1064	262	7	significant	significant	ADJ
iajs-1064	262	8	differences	difference	NOUN
iajs-1064	263	1	which	which	PRON
iajs-1064	263	2	p	p	NOUN
iajs-1064	263	3	-	-	PUNCT
iajs-1064	263	4	value	value	NOUN
iajs-1064	263	5	0.05	0.05	NUM
iajs-1064	263	6	,	,	PUNCT
iajs-1064	263	7	(	(	PUNCT
iajs-1064	263	8	hs	hs	NOUN
iajs-1064	263	9	)	)	PUNCT
iajs-1064	263	10	high	high	ADJ
iajs-1064	263	11	significant	significant	ADJ
iajs-1064	263	12	differences	difference	NOUN
iajs-1064	263	13	which	which	PRON
iajs-1064	263	14	p	p	NOUN
iajs-1064	263	15	-	-	PUNCT
iajs-1064	263	16	value	value	NOUN
iajs-1064	263	17	0.001,(ns	0.001,(ns	NOUN
iajs-1064	263	18	)	)	PUNCT
iajs-1064	263	19	no	no	DET
iajs-1064	263	20	significant	significant	ADJ
iajs-1064	263	21	differences	difference	NOUN
iajs-1064	263	22	which	which	PRON
iajs-1064	263	23	p	p	NOUN
iajs-1064	263	24	-	-	PUNCT
iajs-1064	263	25	value	value	NOUN
iajs-1064	263	26	0.05,(crp	0.05,(crp	NOUN
iajs-1064	263	27	,	,	PUNCT
iajs-1064	263	28	c	c	NOUN
iajs-1064	263	29	-	-	PUNCT
iajs-1064	263	30	reactive	reactive	ADJ
iajs-1064	263	31	protein	protein	NOUN
iajs-1064	263	32	;	;	PUNCT
iajs-1064	263	33	esr	esr	NOUN
iajs-1064	263	34	)	)	PUNCT
iajs-1064	263	35	.	.	PUNCT
iajs-1064	264	1	table	table	NOUN
iajs-1064	264	2	(	(	PUNCT
iajs-1064	264	3	2	2	NUM
iajs-1064	264	4	)	)	PUNCT
iajs-1064	264	5	glp-1,crp	glp-1,crp	NOUN
iajs-1064	264	6	,	,	PUNCT
iajs-1064	264	7	visfatin	visfatin	NOUN
iajs-1064	264	8	,	,	PUNCT
iajs-1064	264	9	insulin	insulin	NOUN
iajs-1064	264	10	levels	level	NOUN
iajs-1064	264	11	for	for	ADP
iajs-1064	264	12	studied	study	VERB
iajs-1064	264	13	groups	group	NOUN
iajs-1064	264	14	group	group	NOUN
iajs-1064	264	15	variables	variable	VERB
iajs-1064	264	16	mean±	mean±	PROPN
iajs-1064	264	17	sem	sem	PROPN
iajs-1064	264	18	g1	g1	PROPN
iajs-1064	264	19	mean±	mean±	PROPN
iajs-1064	265	1	sem	sem	PROPN
iajs-1064	265	2	g2	g2	PROPN
iajs-1064	265	3	t	t	PROPN
iajs-1064	265	4	-	-	PUNCT
iajs-1064	265	5	test	test	NOUN
iajs-1064	265	6	g1	g1	PROPN
iajs-1064	265	7	vs	vs	ADP
iajs-1064	265	8	g2	g2	PROPN
iajs-1064	265	9	glp-1	glp-1	ADP
iajs-1064	265	10	2.24±1.48	2.24±1.48	NOUN
iajs-1064	265	11	0.46±0,07	0.46±0,07	NUM
iajs-1064	266	1	<	<	X
iajs-1064	266	2	0.05	0.05	NUM
iajs-1064	266	3	crp(mg	crp(mg	PROPN
iajs-1064	266	4	/	/	SYM
iajs-1064	266	5	dl	dl	NOUN
iajs-1064	266	6	)	)	PUNCT
iajs-1064	266	7	4.96±0.82	4.96±0.82	NOUN
iajs-1064	266	8	1.76±0.48	1.76±0.48	NUM
iajs-1064	266	9	<	<	X
iajs-1064	266	10	0.0001	0.0001	NUM
iajs-1064	266	11	visfatin	visfatin	NOUN
iajs-1064	266	12	(	(	PUNCT
iajs-1064	266	13	ng	ng	NOUN
iajs-1064	266	14	/	/	SYM
iajs-1064	266	15	ml	ml	PROPN
iajs-1064	266	16	)	)	PUNCT
iajs-1064	266	17	63.3±6.5	63.3±6.5	NUM
iajs-1064	267	1	12.71±1.7	12.71±1.7	NUM
iajs-1064	267	2	<	<	X
iajs-1064	267	3	0.0001	0.0001	NUM
iajs-1064	267	4	insulin(iu	insulin(iu	NOUN
iajs-1064	267	5	/	/	SYM
iajs-1064	267	6	ml	ml	NOUN
iajs-1064	267	7	)	)	PUNCT
iajs-1064	267	8	15.44±2.43	15.44±2.43	NUM
iajs-1064	267	9	3.92±0.60	3.92±0.60	NUM
iajs-1064	267	10	<	<	X
iajs-1064	267	11	0.0001	0.0001	NUM
iajs-1064	267	12	˚(s	˚(s	ADJ
iajs-1064	267	13	)	)	PUNCT
iajs-1064	267	14	significant	significant	ADJ
iajs-1064	267	15	differences	difference	NOUN
iajs-1064	267	16	which	which	PRON
iajs-1064	267	17	p	p	NOUN
iajs-1064	267	18	-	-	PUNCT
iajs-1064	267	19	value	value	NOUN
iajs-1064	267	20	0.05	0.05	NUM
iajs-1064	267	21	,	,	PUNCT
iajs-1064	267	22	(	(	PUNCT
iajs-1064	267	23	hs	hs	NOUN
iajs-1064	267	24	)	)	PUNCT
iajs-1064	267	25	high	high	ADJ
iajs-1064	267	26	significant	significant	ADJ
iajs-1064	267	27	differences	difference	NOUN
iajs-1064	267	28	which	which	PRON
iajs-1064	267	29	p	p	NOUN
iajs-1064	267	30	-	-	PUNCT
iajs-1064	267	31	value	value	NOUN
iajs-1064	267	32	0.001,(ns	0.001,(ns	NOUN
iajs-1064	267	33	)	)	PUNCT
iajs-1064	267	34	no	no	DET
iajs-1064	267	35	significant	significant	ADJ
iajs-1064	267	36	differences	difference	NOUN
iajs-1064	267	37	which	which	PRON
iajs-1064	267	38	p	p	NOUN
iajs-1064	267	39	-	-	PUNCT
iajs-1064	267	40	value	value	NOUN
iajs-1064	267	41	0.05	0.05	NUM
iajs-1064	267	42	chemistry	chemistry	NOUN
iajs-1064	267	43	|	|	ADV
iajs-1064	267	44	115	115	NUM
iajs-1064	267	45	2017عام	2017عام	NUM
iajs-1064	267	46	)	)	PUNCT
iajs-1064	268	1	1(العدد	1(العدد	NUM
iajs-1064	268	2	30مجلة	30مجلة	NUM
iajs-1064	268	3	إبن	إبن	VERB
iajs-1064	268	4	الھيثم	الھيثم	NOUN
iajs-1064	268	5	للعلوم	للعلوم	PROPN
iajs-1064	268	6	الصرفة	الصرفة	PROPN
iajs-1064	268	7	والتطبيقية	والتطبيقية	PRON
iajs-1064	268	8	المجلد	المجلد	VERB
iajs-1064	268	9	ibn	ibn	PROPN
iajs-1064	268	10	al	al	PROPN
iajs-1064	268	11	-	-	PUNCT
iajs-1064	268	12	haitham	haitham	PROPN
iajs-1064	268	13	jour	jour	X
iajs-1064	268	14	.	.	PROPN
iajs-1064	269	1	for	for	ADP
iajs-1064	269	2	pure	pure	ADJ
iajs-1064	269	3	&	&	CCONJ
iajs-1064	269	4	appl	appl	PROPN
iajs-1064	269	5	.	.	PUNCT
iajs-1064	270	1	sci	sci	PROPN
iajs-1064	270	2	.	.	PUNCT
iajs-1064	270	3	vol	vol	NOUN
iajs-1064	270	4	.	.	PROPN
iajs-1064	270	5	30	30	NUM
iajs-1064	270	6	(	(	PUNCT
iajs-1064	270	7	1	1	NUM
iajs-1064	270	8	)	)	PUNCT
iajs-1064	270	9	2017	2017	NUM
iajs-1064	270	10	table	table	NOUN
iajs-1064	270	11	(	(	PUNCT
iajs-1064	270	12	3	3	NUM
iajs-1064	270	13	)	)	PUNCT
iajs-1064	270	14	correlation	correlation	NOUN
iajs-1064	270	15	coefficient	coefficient	NOUN
iajs-1064	270	16	and	and	CCONJ
iajs-1064	270	17	p	p	NOUN
iajs-1064	270	18	-	-	PUNCT
iajs-1064	270	19	value	value	NOUN
iajs-1064	270	20	between	between	ADP
iajs-1064	270	21	glp-1	glp-1	NOUN
iajs-1064	270	22	levels	level	NOUN
iajs-1064	270	23	and	and	CCONJ
iajs-1064	270	24	visfatin.crp	visfatin.crp	PROPN
iajs-1064	270	25	and	and	CCONJ
iajs-1064	270	26	aip	aip	PROPN
iajs-1064	270	27	.	.	PUNCT
iajs-1064	271	1	for	for	ADP
iajs-1064	271	2	studied	study	VERB
iajs-1064	271	3	groups	group	NOUN
iajs-1064	271	4	.	.	PUNCT
iajs-1064	272	1	groups	group	NOUN
iajs-1064	272	2	parameters	parameter	NOUN
iajs-1064	272	3	g2	g2	PROPN
iajs-1064	272	4	g1	g1	PROPN
iajs-1064	272	5	r	r	NOUN
iajs-1064	272	6	-	-	PUNCT
iajs-1064	272	7	value	value	NOUN
iajs-1064	272	8	p	p	NOUN
iajs-1064	272	9	-	-	PUNCT
iajs-1064	272	10	value	value	NOUN
iajs-1064	272	11	r	r	NOUN
iajs-1064	272	12	-	-	PUNCT
iajs-1064	272	13	value	value	NOUN
iajs-1064	272	14	p	p	NOUN
iajs-1064	272	15	-	-	PUNCT
iajs-1064	272	16	value	value	NOUN
iajs-1064	272	17	glp-1with	glp-1with	NOUN
iajs-1064	272	18	vis	vis	X
iajs-1064	272	19	-0.089	-0.089	X
iajs-1064	272	20	<	<	X
iajs-1064	272	21	0.0001	0.0001	NUM
iajs-1064	272	22	0.035	0.035	NUM
iajs-1064	272	23	<	<	NOUN
iajs-1064	272	24	0.0001	0.0001	NUM
iajs-1064	272	25	glp1withcrp	glp1withcrp	PROPN
iajs-1064	272	26	0.043	0.043	NUM
iajs-1064	272	27	<	<	X
iajs-1064	272	28	0.0001	0.0001	NUM
iajs-1064	272	29	-0.183	-0.183	PUNCT
iajs-1064	272	30	<	<	X
iajs-1064	272	31	0.0001	0.0001	NUM
iajs-1064	272	32	glp-1withaip	glp-1withaip	NOUN
iajs-1064	272	33	-0.042	-0.042	X
iajs-1064	272	34	0.02	0.02	NUM
iajs-1064	272	35	-0.056	-0.056	NUM
iajs-1064	272	36	<	<	X
iajs-1064	272	37	0.05	0.05	NUM
iajs-1064	272	38	a	a	DET
iajs-1064	272	39	b	b	NOUN
iajs-1064	272	40	figure	figure	NOUN
iajs-1064	272	41	(	(	PUNCT
iajs-1064	272	42	1	1	NUM
iajs-1064	272	43	)	)	PUNCT
iajs-1064	272	44	correlation	correlation	NOUN
iajs-1064	272	45	between	between	ADP
iajs-1064	272	46	glp-1	glp-1	NOUN
iajs-1064	272	47	and	and	CCONJ
iajs-1064	272	48	visfatin	visfatin	NOUN
iajs-1064	272	49	in	in	ADP
iajs-1064	272	50	g1(a),g2(b	g1(a),g2(b	ADJ
iajs-1064	272	51	)	)	PUNCT
iajs-1064	272	52	figure	figure	NOUN
iajs-1064	272	53	(	(	PUNCT
iajs-1064	272	54	2	2	NUM
iajs-1064	272	55	)	)	PUNCT
iajs-1064	272	56	correlation	correlation	NOUN
iajs-1064	272	57	between	between	ADP
iajs-1064	272	58	glp-1	glp-1	NOUN
iajs-1064	272	59	and	and	CCONJ
iajs-1064	272	60	crp	crp	PROPN
iajs-1064	272	61	in	in	ADP
iajs-1064	272	62	g1(a),g2(b	g1(a),g2(b	PROPN
iajs-1064	272	63	)	)	PUNCT
iajs-1064	272	64	y	y	NOUN
iajs-1064	272	65	 	 	SPACE
iajs-1064	272	66	=	=	VERB
iajs-1064	272	67	 	 	SPACE
iajs-1064	272	68	‐0.6872x	‐0.6872x	PROPN
iajs-1064	272	69	 	 	SPACE
iajs-1064	272	70	+	+	PROPN
iajs-1064	272	71	 	 	SPACE
iajs-1064	272	72	51.65	51.65	NUM
iajs-1064	272	73	r²	r²	NOUN
iajs-1064	272	74	 	 	SPACE
iajs-1064	272	75	=	=	NOUN
iajs-1064	272	76	 	 	SPACE
iajs-1064	272	77	0.0053	0.0053	NUM
iajs-1064	272	78	0	0	NUM
iajs-1064	272	79	10	10	NUM
iajs-1064	272	80	20	20	NUM
iajs-1064	272	81	30	30	NUM
iajs-1064	272	82	40	40	NUM
iajs-1064	272	83	50	50	NUM
iajs-1064	272	84	60	60	NUM
iajs-1064	272	85	70	70	NUM
iajs-1064	272	86	0	0	NUM
iajs-1064	272	87	2	2	NUM
iajs-1064	272	88	4	4	NUM
iajs-1064	272	89	6	6	NUM
iajs-1064	272	90	v	v	NOUN
iajs-1064	272	91	is	be	AUX
iajs-1064	272	92	glp‐1	glp‐1	PROPN
iajs-1064	272	93	y	y	NOUN
iajs-1064	272	94	 	 	SPACE
iajs-1064	272	95	=	=	NOUN
iajs-1064	272	96	 	 	SPACE
iajs-1064	272	97	0.0231x	0.0231x	NOUN
iajs-1064	272	98	 	 	SPACE
iajs-1064	272	99	+	+	NOUN
iajs-1064	272	100	 	 	SPACE
iajs-1064	272	101	5.1374	5.1374	NUM
iajs-1064	272	102	r²	r²	NOUN
iajs-1064	272	103	 	 	SPACE
iajs-1064	272	104	=	=	NOUN
iajs-1064	272	105	 	 	SPACE
iajs-1064	272	106	0.0026	0.0026	NUM
iajs-1064	272	107	0	0	NUM
iajs-1064	272	108	2	2	NUM
iajs-1064	272	109	4	4	NUM
iajs-1064	272	110	6	6	NUM
iajs-1064	272	111	8	8	NUM
iajs-1064	272	112	0	0	NUM
iajs-1064	272	113	5	5	NUM
iajs-1064	272	114	10	10	NUM
iajs-1064	272	115	15	15	NUM
iajs-1064	272	116	c	c	NOUN
iajs-1064	272	117	r	r	NOUN
iajs-1064	272	118	p	p	X
iajs-1064	272	119	glp‐1	glp‐1	PROPN
iajs-1064	272	120	y	y	NOUN
iajs-1064	272	121	 	 	SPACE
iajs-1064	272	122	=	=	NOUN
iajs-1064	272	123	 	 	SPACE
iajs-1064	272	124	1.1411x	1.1411x	NOUN
iajs-1064	272	125	 	 	SPACE
iajs-1064	272	126	+	+	ADJ
iajs-1064	272	127	 	 	SPACE
iajs-1064	272	128	14.177	14.177	NUM
iajs-1064	272	129	r²	r²	NOUN
iajs-1064	272	130	 	 	SPACE
iajs-1064	272	131	=	=	NOUN
iajs-1064	272	132	 	 	SPACE
iajs-1064	272	133	0.0012	0.0012	NUM
iajs-1064	272	134	0	0	NUM
iajs-1064	272	135	5	5	NUM
iajs-1064	272	136	10	10	NUM
iajs-1064	272	137	15	15	NUM
iajs-1064	272	138	20	20	NUM
iajs-1064	272	139	25	25	NUM
iajs-1064	272	140	0	0	NUM
iajs-1064	272	141	0.2	0.2	NUM
iajs-1064	272	142	0.4	0.4	NUM
iajs-1064	272	143	0.6	0.6	NUM
iajs-1064	272	144	0.8	0.8	NUM
iajs-1064	272	145	vi	vi	NOUN
iajs-1064	272	146	s	s	PROPN
iajs-1064	272	147	glp‐1	glp‐1	PROPN
iajs-1064	272	148	y	y	NOUN
iajs-1064	272	149	 	 	SPACE
iajs-1064	272	150	=	=	NOUN
iajs-1064	272	151	 	 	SPACE
iajs-1064	272	152	‐0.7955x	‐0.7955x	PROPN
iajs-1064	272	153	 	 	SPACE
iajs-1064	272	154	+	+	ADJ
iajs-1064	272	155	 	 	SPACE
iajs-1064	272	156	2.1855	2.1855	NUM
iajs-1064	272	157	r²	r²	NOUN
iajs-1064	272	158	 	 	SPACE
iajs-1064	272	159	=	=	NOUN
iajs-1064	272	160	 	 	SPACE
iajs-1064	272	161	0.0123	0.0123	NUM
iajs-1064	272	162	0	0	NUM
iajs-1064	272	163	1	1	NUM
iajs-1064	272	164	2	2	NUM
iajs-1064	272	165	3	3	NUM
iajs-1064	272	166	4	4	NUM
iajs-1064	272	167	0	0	NUM
iajs-1064	272	168	0.2	0.2	NUM
iajs-1064	272	169	0.4	0.4	NUM
iajs-1064	272	170	0.6	0.6	NUM
iajs-1064	272	171	0.8	0.8	NUM
iajs-1064	272	172	c	c	NOUN
iajs-1064	272	173	r	r	NOUN
iajs-1064	272	174	p	p	X
iajs-1064	272	175	glp‐1	glp‐1	NOUN
iajs-1064	272	176	chemistry	chemistry	NOUN
iajs-1064	272	177	|	|	ADV
iajs-1064	272	178	116	116	NUM
iajs-1064	272	179	2017عام	2017عام	NUM
iajs-1064	272	180	)	)	PUNCT
iajs-1064	273	1	1(العدد	1(العدد	NUM
iajs-1064	273	2	30مجلة	30مجلة	NUM
iajs-1064	273	3	إبن	إبن	VERB
iajs-1064	273	4	الھيثم	الھيثم	NOUN
iajs-1064	273	5	للعلوم	للعلوم	PROPN
iajs-1064	273	6	الصرفة	الصرفة	PROPN
iajs-1064	273	7	والتطبيقية	والتطبيقية	PRON
iajs-1064	273	8	المجلد	المجلد	VERB
iajs-1064	273	9	ibn	ibn	PROPN
iajs-1064	273	10	al	al	PROPN
iajs-1064	273	11	-	-	PUNCT
iajs-1064	273	12	haitham	haitham	PROPN
iajs-1064	273	13	jour	jour	X
iajs-1064	273	14	.	.	PROPN
iajs-1064	274	1	for	for	ADP
iajs-1064	274	2	pure	pure	ADJ
iajs-1064	274	3	&	&	CCONJ
iajs-1064	274	4	appl	appl	PROPN
iajs-1064	274	5	.	.	PUNCT
iajs-1064	275	1	sci	sci	PROPN
iajs-1064	275	2	.	.	PUNCT
iajs-1064	275	3	vol	vol	NOUN
iajs-1064	275	4	.	.	PROPN
iajs-1064	275	5	30	30	NUM
iajs-1064	275	6	(	(	PUNCT
iajs-1064	275	7	1	1	NUM
iajs-1064	275	8	)	)	PUNCT
iajs-1064	275	9	2017	2017	NUM
iajs-1064	275	10	a	a	DET
iajs-1064	275	11	b	b	NOUN
iajs-1064	275	12	figure	figure	NOUN
iajs-1064	275	13	(	(	PUNCT
iajs-1064	275	14	3	3	NUM
iajs-1064	275	15	)	)	PUNCT
iajs-1064	275	16	correlation	correlation	NOUN
iajs-1064	275	17	between	between	ADP
iajs-1064	275	18	glp-1	glp-1	NOUN
iajs-1064	275	19	and	and	CCONJ
iajs-1064	275	20	crp	crp	PROPN
iajs-1064	275	21	in	in	ADP
iajs-1064	275	22	g1(a),g2(b	g1(a),g2(b	PROPN
iajs-1064	275	23	)	)	PUNCT
iajs-1064	275	24	y	y	NOUN
iajs-1064	275	25	 	 	SPACE
iajs-1064	275	26	=	=	NOUN
iajs-1064	275	27	 	 	SPACE
iajs-1064	275	28	0.005x	0.005x	NOUN
iajs-1064	275	29	 	 	SPACE
iajs-1064	275	30	+	+	ADJ
iajs-1064	275	31	 	 	SPACE
iajs-1064	275	32	0.8003	0.8003	NUM
iajs-1064	275	33	r²	r²	NOUN
iajs-1064	275	34	 	 	SPACE
iajs-1064	275	35	=	=	NOUN
iajs-1064	275	36	 	 	SPACE
iajs-1064	275	37	0.0049	0.0049	NUM
iajs-1064	275	38	0	0	NUM
iajs-1064	276	1	0.2	0.2	NUM
iajs-1064	276	2	0.4	0.4	NUM
iajs-1064	276	3	0.6	0.6	NUM
iajs-1064	276	4	0.8	0.8	NUM
iajs-1064	276	5	1	1	NUM
iajs-1064	276	6	0	0	NUM
iajs-1064	276	7	5	5	NUM
iajs-1064	276	8	10	10	NUM
iajs-1064	276	9	15	15	NUM
iajs-1064	276	10	a	a	DET
iajs-1064	276	11	ip	ip	PRON
iajs-1064	276	12	glp‐1	glp‐1	NOUN
iajs-1064	276	13	y	y	NOUN
iajs-1064	276	14	 	 	SPACE
iajs-1064	276	15	=	=	NOUN
iajs-1064	276	16	 	 	SPACE
iajs-1064	276	17	‐0.9469x	‐0.9469x	NOUN
iajs-1064	276	18	 	 	SPACE
iajs-1064	276	19	+	+	NOUN
iajs-1064	276	20	 	 	SPACE
iajs-1064	276	21	1.9309	1.9309	NUM
iajs-1064	276	22	r²	r²	NOUN
iajs-1064	276	23	 	 	SPACE
iajs-1064	276	24	=	=	NOUN
iajs-1064	276	25	 	 	SPACE
iajs-1064	276	26	0.2471	0.2471	NUM
iajs-1064	276	27	0	0	NUM
iajs-1064	277	1	0.5	0.5	NUM
iajs-1064	277	2	1	1	NUM
iajs-1064	277	3	1.5	1.5	NUM
iajs-1064	277	4	2	2	NUM
iajs-1064	277	5	0	0	NUM
iajs-1064	277	6	0.2	0.2	NUM
iajs-1064	277	7	0.4	0.4	NUM
iajs-1064	277	8	0.6	0.6	NUM
iajs-1064	277	9	0.8	0.8	NUM
iajs-1064	277	10	a	a	DET
iajs-1064	277	11	ip	ip	DET
iajs-1064	277	12	glp‐1	glp‐1	NOUN
iajs-1064	277	13	chemistry	chemistry	NOUN
iajs-1064	277	14	|	|	ADV
iajs-1064	277	15	117	117	NUM
iajs-1064	277	16	2017عام	2017عام	NUM
iajs-1064	277	17	)	)	PUNCT
iajs-1064	278	1	1(العدد	1(العدد	NUM
iajs-1064	278	2	30مجلة	30مجلة	NUM
iajs-1064	278	3	إبن	إبن	VERB
iajs-1064	278	4	الھيثم	الھيثم	NOUN
iajs-1064	278	5	للعلوم	للعلوم	PROPN
iajs-1064	278	6	الصرفة	الصرفة	PROPN
iajs-1064	278	7	والتطبيقية	والتطبيقية	PRON
iajs-1064	278	8	المجلد	المجلد	VERB
iajs-1064	278	9	ibn	ibn	PROPN
iajs-1064	278	10	al	al	PROPN
iajs-1064	278	11	-	-	PUNCT
iajs-1064	278	12	haitham	haitham	PROPN
iajs-1064	278	13	jour	jour	X
iajs-1064	278	14	.	.	PROPN
iajs-1064	279	1	for	for	ADP
iajs-1064	279	2	pure	pure	ADJ
iajs-1064	279	3	&	&	CCONJ
iajs-1064	279	4	appl	appl	PROPN
iajs-1064	279	5	.	.	PUNCT
iajs-1064	280	1	sci	sci	PROPN
iajs-1064	280	2	.	.	PUNCT
iajs-1064	280	3	vol	vol	NOUN
iajs-1064	280	4	.	.	PROPN
iajs-1064	280	5	30	30	NUM
iajs-1064	280	6	(	(	PUNCT
iajs-1064	280	7	1	1	NUM
iajs-1064	280	8	)	)	PUNCT
iajs-1064	280	9	2017	2017	NUM
iajs-1064	280	10	في	في	ADP
iajs-1064	280	11	مرضى	مرضى	PROPN
iajs-1064	280	12	الصلةوالمعامالت	الصلةوالمعامالت	ADJ
iajs-1064	280	13	ذات	ذات	NOUN
iajs-1064	280	14	1	1	NUM
iajs-1064	280	15	-	-	PUNCT
iajs-1064	280	16	مستويات	مستويات	ADJ
iajs-1064	280	17	الكلوكاكون	الكلوكاكون	NOUN
iajs-1064	280	18	شبيه	شبيه	PROPN
iajs-1064	280	19	الببيتايد	الببيتايد	PROPN
iajs-1064	280	20	بتصلب	بتصلب	VERB
iajs-1064	280	21	الشرايين	الشرايين	ADP
iajs-1064	280	22	لإلصابةالمعرضين	لإلصابةالمعرضين	PROPN
iajs-1064	280	23	التھاب	التھاب	PROPN
iajs-1064	280	24	المفاصل	المفاصل	VERB
iajs-1064	280	25	الرثوي	الرثوي	PROPN
iajs-1064	280	26	فيقش	فيقش	PROPN
iajs-1064	280	27	نورھان	نورھان	PROPN
iajs-1064	280	28	خالد	خالد	NOUN
iajs-1064	280	29	جامعه	جامعه	VERB
iajs-1064	280	30	بغداد/)ابن	بغداد/)ابن	PROPN
iajs-1064	280	31	الھيثم	الھيثم	PROPN
iajs-1064	280	32	(	(	PUNCT
iajs-1064	280	33	الصرفةللعلوم	الصرفةللعلوم	NOUN
iajs-1064	280	34	التربيةكليه	التربيةكليه	PROPN
iajs-1064	280	35	/قسم	/قسم	PROPN
iajs-1064	280	36	الكيمياء	الكيمياء	PROPN
iajs-1064	280	37	هالجودبان	هالجودبان	PROPN
iajs-1064	280	38	محمود	محمود	PROPN
iajs-1064	280	39	شاكر	شاكر	NOUN
iajs-1064	280	40	جامعه	جامعه	VERB
iajs-1064	280	41	بابل	بابل	NOUN
iajs-1064	280	42	/	/	SYM
iajs-1064	280	43	بطكليه	بطكليه	NOUN
iajs-1064	280	44	ال/	ال/	NOUN
iajs-1064	280	45	الحياتيةقسم	الحياتيةقسم	PROPN
iajs-1064	280	46	الكيمياء	الكيمياء	PROPN
iajs-1064	280	47	تمارا	تمارا	VERB
iajs-1064	280	48	عالء	عالء	PROPN
iajs-1064	280	49	حسين	حسين	PROPN
iajs-1064	280	50	جامعه	جامعه	VERB
iajs-1064	280	51	الكوفة	الكوفة	PROPN
iajs-1064	280	52	/	/	SYM
iajs-1064	280	53	كليه	كليه	NOUN
iajs-1064	281	1	طب	طب	PROPN
iajs-1064	281	2	االسنان	االسنان	NOUN
iajs-1064	281	3	/	/	SYM
iajs-1064	281	4	األساسيةقسم	األساسيةقسم	PROPN
iajs-1064	281	5	العلوم	العلوم	NOUN
iajs-1064	281	6	2016	2016	NUM
iajs-1064	281	7	/	/	SYM
iajs-1064	281	8	أيار/11	أيار/11	NUM
iajs-1064	281	9	:	:	PUNCT
iajs-1064	282	1	قبل	قبل	NOUN
iajs-1064	282	2	في	في	X
iajs-1064	282	3	،	،	NOUN
iajs-1064	282	4	2016	2016	NUM
iajs-1064	282	5	/	/	SYM
iajs-1064	282	6	نيسان/27	نيسان/27	PROPN
iajs-1064	282	7	:	:	PUNCT
iajs-1064	282	8	استلم	استلم	PROPN
iajs-1064	282	9	في	في	ADP
iajs-1064	282	10	الخالصة	الخالصة	PROPN
iajs-1064	282	11	تھدف	تھدف	PROPN
iajs-1064	282	12	ھذه	ھذه	PROPN
iajs-1064	282	13	الدراسه	الدراسه	PROPN
iajs-1064	283	1	الى	الى	PROPN
iajs-1064	283	2	تحدبد	تحدبد	PROPN
iajs-1064	283	3	دور	دور	X
iajs-1064	283	4	الفزفاتين	الفزفاتين	PROPN
iajs-1064	283	5	كداله	كداله	PROPN
iajs-1064	283	6	اساسيه	اساسيه	PROPN
iajs-1064	283	7	لاللتھابات	لاللتھابات	PROPN
iajs-1064	283	8	المتواليه	المتواليه	PROPN
iajs-1064	283	9	في	في	SCONJ
iajs-1064	283	10	مرضى	مرضى	PROPN
iajs-1064	283	11	التھاب	التھاب	PROPN
iajs-1064	283	12	المفاصل	المفاصل	VERB
iajs-1064	283	13	الرثوي	الرثوي	PROPN
iajs-1064	283	14	وفقا	وفقا	PROPN
iajs-1064	283	15	لدرجات	لدرجات	PROPN
iajs-1064	283	16	نشاط	نشاط	PROPN
iajs-1064	283	17	المرض	المرض	PROPN
iajs-1064	283	18	لتقييم	لتقييم	VERB
iajs-1064	284	1	امكانيه	امكانيه	AUX
iajs-1064	284	2	استخدام	استخدام	PROPN
iajs-1064	284	3	الفزفاتين	الفزفاتين	VERB
iajs-1064	284	4	في	في	DET
iajs-1064	284	5	تشخيص	تشخيص	PROPN
iajs-1064	284	6	ومراقبه	ومراقبه	PROPN
iajs-1064	284	7	مرضى	مرضى	PROPN
iajs-1064	284	8	التھاب	التھاب	PROPN
iajs-1064	284	9	المفاصل	المفاصل	VERB
iajs-1064	284	10	الرثوي	الرثوي	PROPN
iajs-1064	284	11	وايجاد	وايجاد	PROPN
iajs-1064	284	12	تم	تم	PROPN
iajs-1064	284	13	جمع	جمع	PROPN
iajs-1064	284	14	نماذج	نماذج	VERB
iajs-1064	284	15	,	,	PUNCT
iajs-1064	284	16	في	في	SCONJ
iajs-1064	284	17	المرضى	المرضى	PROPN
iajs-1064	284	18	العرضين	العرضين	PROPN
iajs-1064	284	19	لالصابه	لالصابه	PROPN
iajs-1064	284	20	بتصلب	بتصلب	VERB
iajs-1064	284	21	الشرايين	الشرايين	ADP
iajs-1064	284	22	glp-1	glp-1	VERB
iajs-1064	284	23	,	,	PUNCT
iajs-1064	285	1	aipمعامالت	aipمعامالت	ADJ
iajs-1064	285	2	االرتباط	االرتباط	PROPN
iajs-1064	285	3	لمستوى	لمستوى	PROPN
iajs-1064	285	4	الفزفاتين	الفزفاتين	PROPN
iajs-1064	285	5	مع	مع	PROPN
iajs-1064	285	6	بلغت	بلغت	VERB
iajs-1064	285	7	متوسط	متوسط	PROPN
iajs-1064	285	8	g2وخمسين	g2وخمسين	PROPN
iajs-1064	285	9	شخصا	شخصا	NOUN
iajs-1064	286	1	من	من	DET
iajs-1064	286	2	مرضى	مرضى	PROPN
iajs-1064	286	3	التھاب	التھاب	PROPN
iajs-1064	286	4	المفاصل	المفاصل	VERB
iajs-1064	286	5	الرثوي	الرثوي	PROPN
iajs-1064	286	6	g1	g1	PROPN
iajs-1064	286	7	الدم	الدم	PROPN
iajs-1064	286	8	من	من	DET
iajs-1064	286	9	خمسين	خمسين	PROPN
iajs-1064	286	10	شخصا	شخصا	PROPN
iajs-1064	287	1	من	من	PRON
iajs-1064	287	2	االصحاء	االصحاء	PROPN
iajs-1064	287	3	ظاھريا	ظاھريا	PROPN
iajs-1064	287	4	ومستويات	ومستويات	PROPN
iajs-1064	287	5	esr	esr	PROPN
iajs-1064	287	6	,	,	PUNCT
iajs-1064	287	7	rf	rf	PROPN
iajs-1064	287	8	,	,	PUNCT
iajs-1064	287	9	crp	crp	PROPN
iajs-1064	287	10	,	,	PUNCT
iajs-1064	287	11	glp-1تم	glp-1تم	NOUN
iajs-1064	287	12	قياس	قياس	NOUN
iajs-1064	287	13	مستويات	مستويات	PROPN
iajs-1064	287	14	.2م	.2م	PROPN
iajs-1064	287	15	/	/	SYM
iajs-1064	287	16	كغم	كغم	PROPN
iajs-1064	287	17	≤24سنه	≤24سنه	PROPN
iajs-1064	287	18	بكتله	بكتله	ADJ
iajs-1064	287	19	جسميه	جسميه	NOUN
iajs-1064	287	20	)	)	PUNCT
iajs-1064	287	21	40	40	NUM
iajs-1064	287	22	-	-	PUNCT
iajs-1064	287	23	30(اعمارھم	30(اعمارھم	NUM
iajs-1064	287	24	تظھر	تظھر	NOUN
iajs-1064	287	25	زياده	زياده	PROPN
iajs-1064	287	26	معنويه	معنويه	ADV
iajs-1064	287	27	عاليه	عاليه	VERB
iajs-1064	287	28	في	في	ADP
iajs-1064	287	29	مستويات	مستويات	NOUN
iajs-1064	287	30	)	)	PUNCT
iajs-1064	288	1	1(النتائج	1(النتائج	NUM
iajs-1064	288	2	في	في	ADP
iajs-1064	288	3	الجدول	الجدول	PROPN
iajs-1064	288	4	.الفزفاتين	.الفزفاتين	PROPN
iajs-1064	288	5	,	,	PUNCT
iajs-1064	288	6	ناالنسولي	ناالنسولي	NOUN
iajs-1064	288	7	,	,	PUNCT
iajs-1064	288	8	الدھون	الدھون	PROPN
iajs-1064	288	9	esr	esr	PROPN
iajs-1064	288	10	,	,	PUNCT
iajs-1064	288	11	rf	rf	NOUN
iajs-1064	288	12	,	,	PUNCT
iajs-1064	288	13	tc	tc	NOUN
iajs-1064	288	14	,	,	PUNCT
iajs-1064	288	15	tg	tg	PROPN
iajs-1064	288	16	,	,	PUNCT
iajs-1064	288	17	ldl	ldl	NOUN
iajs-1064	288	18	,	,	PUNCT
iajs-1064	288	19	vldl	vldl	PROPN
iajs-1064	288	20	,	,	PUNCT
iajs-1064	288	21	aip	aip	PROPN
iajs-1064	289	1	قي	قي	PROPN
iajs-1064	289	2	المجموعهg2	المجموعهg2	PROPN
iajs-1064	289	3	مفارنه	مفارنه	PROPN
iajs-1064	289	4	بالمجموعه	بالمجموعه	PROPN
iajs-1064	289	5	الظابطه	الظابطه	PROPN
iajs-1064	289	6	g12(اما	g12(اما	PROPN
iajs-1064	289	7	نتائج	نتائج	PROPN
iajs-1064	289	8	الجدول	الجدول	PROPN
iajs-1064	289	9	الثاني	الثاني	PROPN
iajs-1064	289	10	(	(	PUNCT
iajs-1064	289	11	ات	ات	SCONJ
iajs-1064	289	12	العالقات	العالقات	NOUN
iajs-1064	289	13	ويوضح	ويوضح	PROPN
iajs-1064	289	14	الجدول	الجدول	PROPN
iajs-1064	289	15	الثالث	الثالث	PROPN
iajs-1064	289	16	بيان	بيان	VERB
iajs-1064	289	17	,	,	PUNCT
iajs-1064	289	18	crp	crp	PROPN
iajs-1064	289	19	,	,	PUNCT
iajs-1064	289	20	glp-1الفزفاتين	glp-1الفزفاتين	PROPN
iajs-1064	289	21	,	,	PUNCT
iajs-1064	289	22	تظھر	تظھر	PROPN
iajs-1064	289	23	زياده	زياده	PROPN
iajs-1064	289	24	معنويه	معنويه	PROPN
iajs-1064	289	25	عاليه	عاليه	VERB
iajs-1064	289	26	في	في	ADP
iajs-1064	289	27	مستويات	مستويات	ADJ
iajs-1064	289	28	االنسولين	االنسولين	NOUN
iajs-1064	289	29	-ارتباط	-ارتباط	NOUN
iajs-1064	289	30	معنوي	معنوي	ADJ
iajs-1064	289	31	ومعامل	ومعامل	NOUN
iajs-1064	289	32	g1مع	g1مع	NOUN
iajs-1064	289	33	الفزفاتين	الفزفاتين	PROPN
iajs-1064	289	34	للمجموعه	للمجموعه	PROPN
iajs-1064	289	35	glp-1	glp-1	ADP
iajs-1064	289	36	لل	لل	ADP
iajs-1064	289	37	0.035االرتباطيه	0.035االرتباطيه	PRON
iajs-1064	289	38	واظھرت	واظھرت	PROPN
iajs-1064	289	39	النتائج	النتائج	PROPN
iajs-1064	289	40	معامل	معامل	PROPN
iajs-1064	289	41	ارتباط	ارتباط	AUX
iajs-1064	289	42	معنوي	معنوي	ADV
iajs-1064	289	43	لل	لل	ADP
iajs-1064	289	44	0.183	0.183	NUM
iajs-1064	289	45	-	-	PUNCT
iajs-1064	289	46	ارتباط	ارتباط	NOUN
iajs-1064	289	47	معنوي	معنوي	NOUN
iajs-1064	289	48	ومعاملكما	ومعاملكما	PROPN
iajs-1064	289	49	اظھرت	اظھرت	PROPN
iajs-1064	289	50	النتائج	النتائج	PROPN
iajs-1064	289	51	,	,	PUNCT
iajs-1064	289	52	(	(	PUNCT
iajs-1064	289	53	1	1	NUM
iajs-1064	289	54	-	-	PUNCT
iajs-1064	289	55	b	b	NOUN
iajs-1064	289	56	)	)	PUNCT
iajs-1064	289	57	,	,	PUNCT
iajs-1064	289	58	(	(	PUNCT
iajs-1064	289	59	a-1)كما	a-1)كما	PROPN
iajs-1064	289	60	موضح	موضح	NOUN
iajs-1064	289	61	بالشكل	بالشكل	PROPN
iajs-1064	289	62	g2للمجموعه	g2للمجموعه	PROPN
iajs-1064	289	63	0.089	0.089	NUM
iajs-1064	289	64	glp-1مع	glp-1مع	PROPN
iajs-1064	289	65	crpللمجموعه	crpللمجموعه	PROPN
iajs-1064	289	66	g1	g1	PROPN
iajs-1064	289	67	لمجموعه	لمجموعه	PROPN
iajs-1064	289	68	المرضى	المرضى	PROPN
iajs-1064	289	69	كما	كما	PROPN
iajs-1064	289	70	موضح	موضح	NOUN
iajs-1064	289	71	بالشكل	بالشكل	ADJ
iajs-1064	289	72	0.043ومعامل	0.043ومعامل	NOUN
iajs-1064	289	73	ارتباط	ارتباط	ADJ
iajs-1064	289	74	معنوي(2	معنوي(2	PROPN
iajs-1064	289	75	-	-	PUNCT
iajs-1064	289	76	a	a	NOUN
iajs-1064	289	77	)	)	PUNCT
iajs-1064	289	78	,	,	PUNCT
iajs-1064	289	79	(	(	PUNCT
iajs-1064	289	80	2	2	NUM
iajs-1064	289	81	-b	-b	NUM
iajs-1064	289	82	)	)	PUNCT
iajs-1064	289	83	لمجموعه	لمجموعه	PROPN
iajs-1064	289	84	0.042	0.042	NUM
iajs-1064	289	85	-	-	PUNCT
iajs-1064	289	86	وغير	وغير	ADJ
iajs-1064	289	87	معنويه	معنويه	PROPN
iajs-1064	289	88	0.056	0.056	NUM
iajs-1064	289	89	-	-	PUNCT
iajs-1064	289	90	بالنسبه	بالنسبه	ADJ
iajs-1064	289	91	للمجموعه	للمجموعه	NOUN
iajs-1064	289	92	الظابطه	الظابطه	PROPN
iajs-1064	289	93	كانت	كانت	PROPN
iajs-1064	289	94	معنويه	معنويه	PROPN
iajs-1064	289	95	aipمع	aipمع	PROPN
iajs-1064	289	96	glp-1	glp-1	ADP
iajs-1064	289	97	اما	اما	NOUN
iajs-1064	289	98	معامل	معامل	NOUN
iajs-1064	289	99	ارتباط	ارتباط	PROPN
iajs-1064	289	100	دورا	دورا	PROPN
iajs-1064	289	101	فعاال	فعاال	NOUN
iajs-1064	289	102	في	في	DET
iajs-1064	289	103	الحاالت	الحاالت	PROPN
iajs-1064	289	104	ونستنتج	ونستنتج	NOUN
iajs-1064	289	105	من	من	INTJ
iajs-1064	289	106	ھذه	ھذه	VERB
iajs-1064	289	107	الدراسه	الدراسه	NOUN
iajs-1064	289	108	ان	ان	INTJ
iajs-1064	289	109	الفزفاتين	الفزفاتين	PROPN
iajs-1064	289	110	يلعب	يلعب	NOUN
iajs-1064	289	111	,	,	PUNCT
iajs-1064	289	112	(	(	PUNCT
iajs-1064	289	113	3	3	NUM
iajs-1064	289	114	-b	-b	NUM
iajs-1064	289	115	)	)	PUNCT
iajs-1064	289	116	,	,	PUNCT
iajs-1064	289	117	(	(	PUNCT
iajs-1064	289	118	a-3)المرضى	a-3)المرضى	PROPN
iajs-1064	289	119	كما	كما	PROPN
iajs-1064	289	120	موضح	موضح	NOUN
iajs-1064	289	121	بالشكل	بالشكل	NOUN
iajs-1064	289	122	المرضيه	المرضيه	PROPN
iajs-1064	289	123	من	من	PROPN
iajs-1064	289	124	التھاب	التھاب	NOUN
iajs-1064	289	125	المفاصل	المفاصل	VERB
iajs-1064	289	126	الرثوي	الرثوي	PROPN
iajs-1064	289	127	وعالقته	وعالقته	PROPN
iajs-1064	289	128	ببقيه	ببقيه	PROPN
iajs-1064	289	129	المعامالت	المعامالت	PROPN
iajs-1064	289	130	التي	التي	PROPN
iajs-1064	289	131	تعتبر	تعتبر	PROPN
iajs-1064	289	132	مؤشرات	مؤشرات	PROPN
iajs-1064	289	133	لالصابه	لالصابه	PROPN
iajs-1064	289	134	بالجلطه	بالجلطه	PROPN
iajs-1064	289	135	القلبيه	القلبيه	PROPN
iajs-1064	289	136	ويعتبر	ويعتبر	PROPN
iajs-1064	289	137	مؤشر	مؤشر	PROPN
iajs-1064	289	138	.raويمكن	.raويمكن	PUNCT
iajs-1064	290	1	ان	ان	INTJ
iajs-1064	290	2	يستخدم	يستخدم	PROPN
iajs-1064	290	3	مستقبال	مستقبال	PROPN
iajs-1064	291	1	كعالج	كعالج	ADJ
iajs-1064	291	2	لمرض	لمرض	PROPN
iajs-1064	291	3	raمرضي	raمرضي	PROPN
iajs-1064	291	4	قوي	قوي	PROPN
iajs-1064	291	5	لل	لل	NOUN
iajs-1064	291	6	.تصلب	.تصلب	PUNCT
iajs-1064	291	7	الشرايين	الشرايين	ADV
iajs-1064	291	8	,	,	PUNCT
iajs-1064	291	9	التھاب	التھاب	PROPN
iajs-1064	291	10	المفاصل	المفاصل	PROPN
iajs-1064	291	11	الرثوي	الرثوي	PROPN
iajs-1064	291	12	,	,	PUNCT
iajs-1064	291	13	glp-1	glp-1	NUM
iajs-1064	291	14	:	:	PUNCT
iajs-1064	291	15	الكلمات	الكلمات	NOUN
iajs-1064	291	16	المفتاحيه	المفتاحيه	NOUN